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This thesis describes studies in which the yeast Saccharomyces cerevisiae was used as a 
model organism for unveiling the mechanisms underlying longevity regulation and 
extension by genetic, dietary and pharmacological interventions. We found that a diet 
known as caloric restriction (CR) modulates oxidation-reduction processes and reactive 
oxygen species (ROS) production in yeast mitochondria, reduces the frequency of 
mitochondrial DNA (mtDNA) mutations, and alters the abundance and mtDNA-binding 
activity of mitochondrial nucleoid-associated proteins. Our findings provide evidence that 
these mitochondrial processes play essential roles in regulating longevity of 
chronologically active yeast by defining their viability following cell entry into a 
quiescent state. Based on these findings, we propose a hypothesis that ROS, which are 
mostly generated as by-products of mitochondrial respiration, play a dual role in 
regulating longevity of chronologically aging yeast. On the one hand, if yeast 
mitochondria are unable (due to a dietary regimen) to maintain ROS concentration below 
a toxic threshold, ROS promote aging by oxidatively damaging certain mitochondrial 
proteins and mtDNA. On the other hand, if yeast mitochondria can (due to a dietary 
regimen) maintain ROS concentration at a certain “optimal” level, ROS delay 
 iv
chronological aging. We propose that this “optimal” level of ROS is insufficient to 
damage cellular macromolecules but can activate certain signaling networks that extend 
lifespan by increasing the abundance or activity of stress-protecting and other anti-aging 
proteins. In addition, studies presented in this thesis imply that mtDNA mutations do not 
contribute to longevity regulation in yeast grown under non-CR conditions but make 
important contribution to longevity regulation in yeast placed on a CR diet. The 
nonreducing disaccharide trehalose has been long considered only as a reserve 
carbohydrate. However, recent studies in yeast suggested that this osmolyte can protect 
cells and cellular proteins from oxidative damage elicited by exogenously added ROS. 
Trehalose has been also shown to affect stability, folding and aggregation of bacterial and 
firefly proteins heterologously expressed in heat-shocked yeast cells. Our investigation of 
how a lifespan-extending CR diet alters the metabolic history of chronologically aging 
yeast suggested that their longevity is programmed by the level of metabolic capacity - 
including trehalose biosynthesis and degradation - that yeast cells developed prior to 
entry into quiescence. To investigate whether trehalose homeostasis in chronologically 
aging yeast may play a role in longevity extension by CR, we examined how single-gene-
deletion mutations affecting trehalose biosynthesis and degradation impact 1) the age-
related dynamics of changes in trehalose concentration; 2) yeast chronological lifespan 
under CR conditions; 3) the chronology of oxidative protein damage, intracellular ROS 
level and protein aggregation; and 4) the timeline of thermal inactivation of a protein in 
heat-shocked yeast cells and its subsequent reactivation in yeast returned to low 
temperature. Our data imply that CR extends yeast chronological lifespan by altering a 
pattern of age-related changes in trehalose concentration.  
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1.1 Yeast as a model organism for elucidating the molecular and cellular 
mechanisms underlying aging of multicellular eukaryotes 
            At the organismal level, aging is a complex biological process of the progressive 
decline in the ability of an organism to resist stress, damage and disease [1 - 7]. 
Demographically, aging manifests itself as an exponential increase in mortality rate with 
the age of the cohort [1, 4, 8, 9 - 12]. Because longevity signaling pathways and 
mechanisms underlying their modulation by genetic, dietary and pharmacological 
interventions are known to be conserved from yeast to humans, the budding yeast 
Saccharomyces cerevisiae is a valuable model organism in aging research [13 - 20]. 
Aging of S. cerevisiae, a unicellular eukaryote amenable to comprehensive biochemical, 
genetic, cell biological, chemical biological and system biological analyses, can be 
measured in two different ways. Replicative aging is defined by the maximum number of 
daughter cells that a mother yeast cell can produce before senescence; it may serve as a 
model for studying aging of mitotically active cells in a multicellular eukaryotic organism 
[15, 21]. In contrast, chronological aging is measured by the length of time a yeast cell 
remains viable following entry into a non-proliferative state; it has been suggested to 
model aging of non-dividing (“post-mitotic”) cells in a multicellular eukaryotic organism 
[13, 15, 22]. A simple clonogenic assay is used to monitor the chronological aging of 
yeast. This assay measures the percentage of yeast cells that remain viable at different 
time points following the entry of a cell population into the non-proliferative stationary 
phase [15, 22]. Both the replicative and chronological aging of yeast can be slowed down 
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by caloric restriction (CR), a low-calorie dietary regimen known to extend lifespan and 
postpone age-related disease in a wide spectrum of organisms [16, 22 - 26]. In yeast, a 
CR diet can be imposed by reducing the initial glucose concentration in a growth medium 
from 2% to 0.5% or lower [15, 16, 27]. The use of yeast as an advantageous model 
organism in aging research has already greatly contributed to the current understanding of 
the molecular and cellular mechanisms underlying longevity regulation in evolutionarily 
distant eukaryotic organisms. Specifically, studies in yeast enabled: 1) to reveal for the 
first time numerous longevity genes, all of which have been later implicated in regulating 
longevity of multicellular eukaryotic organisms; 2) establish the chemical nature of 
molecular damage that causes aging and accelerates the onset of age-related diseases 
across evolutionary spectra of species; and 3) identify several longevity-extending small 
molecules, all of which have been later shown to decelerate aging, improve health, 
attenuate age-related pathologies and slow down the onset of age-related diseases in 
eukaryotic organisms across phyla [9, 13, 15, 16, 21, 24, 25, 28].  
            This thesis describes studies in which the yeast S. cerevisiae was used as a model 
organism for unveiling the molecular and cellular mechanisms underlying longevity 
regulation and extension by genetic, dietary and pharmacological interventions. 
 
1.2 Longevity is regulated by a limited number of “master regulator” proteins 
that in organisms across phyla orchestrate numerous longevity-defining 
cellular processes in space and time 
          Growing evidence supports the view that the fundamental mechanisms of aging 
have been conserved through the evolution process [2, 3, 8, 11, 16 - 20]. The 
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identification of single-gene mutations that extend lifespan in yeast, worms, flies and 
mice revealed numerous proteins whose relative abundances define longevity of an 
organism. These proteins have been implicated in a number of cellular processes 
including cell cycle, cell growth, stress response, protein folding, apoptosis, autophagy, 
proteasomal protein degradation, actin organization, signal transduction, nuclear DNA 
replication, chromatin assembly and maintenance, ribosome biogenesis and translation, 
lipid and carbohydrate metabolism, oxidative metabolism in mitochondria, NAD+ 
homeostasis, amino acid biosynthesis and degradation, and ammonium and amino acid 
uptake [2, 3, 7, 9, 14, 17 - 21, 27 - 36]. The spatiotemporal organization of all these 
numerous cellular processes and their functional states are governed by a limited number 
of so-called master regulators of longevity. These master regulators are evolutionarily 
conserved and include the following proteins: 1) sirtuins, a family of NAD+-dependent 
protein deacetylases and ADP ribosylases, in yeast, worms, flies and mammals [3, 13, 17, 
18, 29, 30, 33, 34, 37, 38]; 2) nutrient- or insulin/IGF-1-like signaling pathways in 
evolutionarily distant organisms [3, 19, 20, 33, 35, 36, 39]; 3) nutrient-responsive protein 
kinases TORC1, Sch9p and PKA in yeast, worms, flies and mammals [3, 16, 27, 36, 37, 
39, 40]; 4) the transcriptional factors Msn2p, Msn4p and Rim15p, whose ability to 
activate expression of numerous stress-response genes in yeast is modulated by TORC1, 
Sch9p and PKA [3, 21, 27, 40]; 5) the transcriptional factors Rtg1p and Rtg3p that in 
yeast are modulated by a mitochondrion-to-nucleus signal transduction pathway required 
for the maintenance of glutamate homeostasis [41 - 44]; 6) the transcription factor DAF-
16, whose ability to activate expression of numerous genes in worms is under the control 
of the insulin/IGF-1 signaling (IIS) pathway and several IIS-independent mechanisms [3, 
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4, 17, 18, 20, 33-36, 39]; 7) the diet-restriction-specific transcription factor PHA-4 in 
worms [3, 9, 30, 33, 36, 45]; and 8) some members of the FOXO family of forkhead 
transcription factors that in flies and mammals activate expression of a number of genes 
[2 - 4, 9, 30, 33, 36, 46]. 
          One of the major objectives of this thesis was to identify previously unknown 
longevity-defining processes in chronologically aging yeast. Studies described in this 
thesis led to the establishment of molecular and cellular mechanisms underlying 
regulation of these novel longevity-defining processes and their integration into a 
network of currently known pro-aging and anti-aging processes. 
 
1.3 Effect of dietary regimens on longevity 
          Most of the genetic manipulations that extend lifespan in organisms across phyla 
(see above) have been shown to cause major side effects, including irreversible 
developmental or reproductive defects [3, 11, 17 - 19, 24, 30, 33 - 35]. An alternative 
way in which lifespan has been shown to be lengthened in various organisms is to impose 
a caloric restriction (CR) diet, which refers to a dietary regimen low in calories without 
undernutrition [3, 7, 9, 23 - 26, 47 - 53]. It is well established that CR significantly 
extends lifespan of a remarkable range of organisms, including yeast, rotifers, spiders, 
worms, fish, mice, rats, and nonhuman primates [3, 9, 47 - 49, 54 - 57]. This longevity 
results from the limitation of total calories derived from carbohydrates, fats, or proteins to 
a level 25% - 60% below that of control animals fed ad libitum [47, 54, 55]. In addition 
to its effect on lifespan per se, the CR dietary regimen delays most diseases of aging 
including cancer, atherosclerosis, type II diabetes and neurodegeneration [3, 7, 9, 24 - 26, 
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49, 55 - 58]. In fact, it has been shown that CR reduces age-associated neuronal loss in 
most mouse models of neurodegenerative disorders such as Parkinson's disease [9, 59] or 
Alzheimer's disease [9, 60]. The CR dietary regimen also prevents age-associated 
declines in psychomotor and spatial memory tasks [61], alleviates loss of dendritic spines 
necessary for learning [62], and improves the brain's plasticity and ability for self-repair 
[63]. 
          In yeast, a CR dietary regimen can be imposed in yeast by reducing the glucose 
concentration in the complete YEPD (yeast extract, peptone, dextrose) medium from the 
usual 2% to 0.5% [64] or to 0.2% (this study; [32]). Because cells continue to feed on 
yeast extract plus peptone, which are rich in amino acids, nucleotides, and vitamins, the 
growth rate remains rapid as glucose levels are lowered. Thus, the reduction in glucose 
from 2% to 0.5% or to 0.2% could impose a state of partial energy (ATP) limitation. 
Other dietary restriction protocols, in particular those that limit amino acids and other 
nutrients [65, 66], have been shown to drastically reduce the growth rate and may make it 
more difficult to impose energy limitation. 
          One of the objectives of this thesis was to gain new insight into the molecular 
mechanisms by which CR extends longevity of chronologically aging yeast. Studies 
described in this thesis revealed that the low-calorie diet delays aging in yeast by altering 
a pattern of age-related changes in trehalose and glycogen concentration. 
 
1.4 Mitochondria and reactive oxygen species (ROS) in aging   
          Even though benefits of CR have been known for many years, the molecular and 
cellular mechanisms that underly its longevity-extending effect remain unclear. The 
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complexity of these mechanisms lies in multiple effects including metabolic, 
neuroendocrine and apoptotic changes, which vary in intensity and exhibit striking 
differences among various cells, tissues, organs and organisms [3, 9, 11, 24, 26, 49, 57, 
67]. The generally (until recently) accepted “free radical theory” of aging postulates that 
aging is caused by cumulative oxidative damage generated by reactive oxygen species 
(ROS) produced during respiration [68, 69]. Indeed, oxidative damage to DNA, RNA, 
proteins and lipids is known to progress and accumulate with aging [70 - 73]. This 
damage may limit lifespan. In fact, overexpression of the enzyme superoxide dismutase 
(SOD), which reduces ROS, extends lifespan in Drosophila [74] and in chronologically 
aging yeast reached quiescence [75].  
          ROS are generated in multiple compartments and by multiple enzymes within the 
cell. Although the vast majority (estimated at approximately 90%) of these harmful 
compounds is produced in mitochondria (Figure 1.1) [76 - 79], ROS are also generated 
by NADP/H oxidases and phagocytic oxidases in the plasma membrane [76 - 79], in 
several oxidative reactions that are catalyzed by amino acid oxidases, cyclooxygenases, 
lipid oxigenase and xanthine oxidase in the cytosol [76 - 79], and during lipid metabolism 
in peroxisomes [44, 80, 81]. The steady-state level of ROS within the cell is the result of 
a delicate balance that exists between the rates of ROS formation and of their 
detoxification in antioxidant scavenger reactions taking place in various cellular 
locations. The CuZnSOD (SOD1) subform of superoxide dismutase in the cytosol and the 
MnSOD (SOD2) subform of this enzyme in the mitochondrion convert superoxide 
radicals to a less toxic and more stable compound, namely hydrogen peroxide (Figure 
1.2) [76 - 79]. The subsequent detoxification of hydrogen peroxide depends on the 
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following enzymes (Figure 1.2) [76 - 79]: 1) glutathione peroxidases in the cytosol, 
mitochondria and peroxisomes; 2) catalases in the cytosol, mitochondria and 
peroxisomes; and 3) peroxiredoxins in the cytosol, mitochondria and peroxisomes. 
          
 
Figure 1.1. ROS are generated by numerous enzymes in multiple compartments within the cell, mostly (~ 
90%) within mitochondria. 
 
          Most of the known targets for the oxidative damage by ROS are mitochondrial 
proteins, DNA and lipids, including (Figure 1.3) [44, 76 - 79]: 1) aconitase, a [4Fe-4S] 
cluster enzyme of the tricarboxylic acid (TCA) cycle; 2) Lys4p, a [4Fe-4S] cluster 
enzyme of lysine biosynthesis that takes place in the mitochondrion; 3) succinate 
dehydrogenase (SDH), a [3Fe-3S] cluster- and heme-containing enzyme of the TCA that 
also functions as complex II of the electron transfer chain (ETC) in the mitochondrial 
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membrane; 4) cytochrome c, a heme-containing mobile component of the mitochondrial 
ETC; 5) cytochrome c oxidase, a heme-containing complex IV of the mitochondrial ETC; 
6) the mitochondrial DNA (mtDNA) nucleoid that, in contrast to chromatin in the 
nucleus, lacks histones; and 7) saturated fatty acids of membrane lipids.          
 
Figure 1.2. Detoxification of ROS occurs in antioxidant scavenger reactions confined to various cellular 
compartments.  
 
          While high intracellular and intraorganellar levels of ROS tend to cause oxidative 
damage to various cellular constituents, the low concentrations of these highly reactive 
chemical compounds promote a number of processes related to the protection of the 
cellular macromolecules from oxidative damage (Figure 1.4) [36, 44, 80 - 93]. In 
addition, the low intracellular and intraorganellar concentrations of ROS activate protein 
machinery that protects the cell from apoptosis, one of the forms of programmed cell 
death [44, 82 - 89, 91 - 93]. Such a protective function of ROS is initiated by ROS 
sensors present in the mitochondrion (i.e., protein kinases PKD1, PKCδ, Src, Abl, PI3 
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kinase and Akt), plasma membrane (i.e., the Ras protein), and cytosol (i.e., the PNC1 
protein) (Figure 1.4) [44, 76 - 79, 82 - 87, 91 - 93]. Some of these ROS sensors in the 
cytosol and mitochondrion interact with the cytosol-to-nucleus and mitochondrion-to-
nucleus shuttling proteins (i.e., p32 and Hsp27p, respectively), thereby promoting their 
relocation to the nucleus (Figure 1.4) [76 - 79, 84 - 87, 91 - 93]. In the nucleus, these two 
shuttling proteins activate a distinct group of transcriptional factors and cofactors (i.e., 
SIRT1, FOXO3, p53, NF-κB, DET1 and COP1), all of which function as global 
transcriptional activators of genes encoding oxidative stress-response and anti-apoptotic 
proteins (Figure 1.4) [76 - 79, 84, 86, 87, 91 - 93]. Moreover, some of the ROS sensors in 
the cytosol and mitochondrion phosphorylate and inactivate the pro-apoptotic factors Bad 
and JNK, thereby delaying the intrinsic, mitochondria-dependent apoptotic pathway of 
programmed cell death (Figure 1.4) [77 - 79, 85, 87, 91 - 93]. 
  
 
Figure 1.3. High levels of ROS cause oxidative damage to various cellular constituents. Most of the known 
targets for the oxidative damage by ROS are mitochondrial proteins, DNA and lipids. 
 
          The mitochondria-controlled, ROS-modulated intrinsic pathway of apoptosis also 
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depends on the delicate balance between mitochondrial fission and fusion (Figure 1.5) 
[94 - 98]. Mitochondrial fusion maintains a tubular mitochondrial network, thereby: 1) 
facilitating transfer of the mitochondrial membrane potential (i.e., energy) from O2-rich 
to O2-poor cellular regions; 2) complementing mtDNA mutations that accumulate with 
aging; and 3) hampering the intrinsic pathway of apoptosis (Figure 1.5) [94 - 99]. On the 
other hand, mitochondrial fission breaks down the mitochondrial network, thereby: 1) 
ensuring inheritance of mitochondria by newly formed daughter cells; 2) causing 
respiratory defects; 3) leading to loss or mutation of mtDNA that remains 
uncomplemented; and 4) promoting the intrinsic pathway of apoptosis (Figure 1.5) [94 - 
99].   
Figure 1.4. The sub-lethal concentrations of ROS promote a number of processes related to the protection 
of the cellular macromolecules from oxidative damage. 
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          Numerous recent findings have implicated the intrinsic, mitochondria-dependent 
apoptotic pathway of programmed cell death in aging of evolutionary distant organisms. 
Apoptosis has been well known for its fundamental role in human development and 
physiology [100]. The apoptotic pathway of programmed cell death also exists in other 
mammals and multicellular organisms [101]. 
 
Figure 1.5. A delicate balance between mitochondrial fission and fusion controls the intrinsic pathway of 
apoptosis and numerous other vital processes in a cell. 
 
          Until recently, it has been unknown whether apoptosis exists in unicellular 
organisms (such as yeast), and if it did what role it may serve. Recent data provided 
evidence that yeast cells can undergo apoptosis by showing characteristic apoptotic 
markers: DNA cleavage, chromatin condensation, externalization of phosphatidylserine 
to the outer leaflet of the plasma membrane, and cytochrome c release from the 
mitochondria [102]. The first proof for an apoptotic process operating in yeast cells came 
from the study that revealed an apoptotic phenotype caused by a mutation in the CDC48 
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gene [103]. ROS have been implicated as central regulators of yeast apoptosis, which 
leads to even more similarity towards apoptosis in metazoan organisms [104]. Recent 
discovery of several yeast orthologues of mammalian apoptotic regulators provided the 
final proof that yeast and metazoan apoptosis are two versions of the same cellular 
program. These key apoptotic regulators in yeast cells include: 1) the yeast metacaspase 
Yca1p [103]; 2) an HtrA2/Omi-like protein, the yeast apoptotic serine protease Nma111p 
[105]; 3) the yeast apoptosis inducing factor Aif1p [106]; 4) the yeast histone chaperone 
Asf1p [107]; and 5) the yeast mitochondrial fission protein Drp1p [108]. Recent finding 
that aged yeast cells die exhibiting markers of apoptosis [109] suggested that apoptosis 
plays a pivotal role in aging of this unicellular eukaryotic organism.   
          One of the major objectives of this thesis was to provide deep mechanistic insight 
into the essential roles for mitochondrial morphology, mitochondria-generated ROS and 
mitochondria-controlled apoptosis in defining longevity of chronologically aging yeast. 
 
1.5 A modular network regulates longevity of chronologically aging yeast 
          One way to look at the complexity of the aging process, in which a limited number 
of master regulators orchestrate numerous cellular processes in space and time (see 
above) [3, 4, 6, 17, 31, 33, 36], is to consider each of these processes as a functional 
module integrated with other modules into a longevity network [1, 6, 8, 31, 32]. The 
synergistic action of individual modules could establish the rate of aging. Furthermore, 
the relative impact of each module on the rate of aging in a particular organism or cell 
type could differ at various stages of its lifetime and could also vary in different 
organisms and cell types [1, 6, 8, 31, 32]. In this conceptual framework, the longevity 
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network could progress through a series of checkpoints. At each of these checkpoints, a 
distinct set of master regulators senses the functional states of critical modules 
comprising the network. Based on this information and considering the input of some 
environmental cues (such as dietary intake, environmental stresses, endocrine factors 
etc.), master regulators modulate certain processes within monitored modules in order to 
limit the age-related accumulation of molecular and cellular damage [31, 32]. The 
resulting changes in the dynamics of individual modules comprising the network and in 
its general configuration are critically important for specifying the rate of aging during 
late adulthood. 
          Recent studies in our laboratory not only provided evidence for the existence of a 
modular network regulating longevity of chronologically aging yeast but also revealed 
the spatio-temporal dynamics of this network and its remodeling under longevity-
extending CR conditions [32, 40, 44, 110]. To study the effect of CR on the 
chronological lifespan of yeast, we incubated the wild-type strain BY4742 in rich YP 
medium initially containing 0.2%, 0.5%, 1% or 2% glucose. YP medium was chosen for 
chronological aging studies because, in contrast to a synthetic medium, it is rich in amino 
acids, nucleotides, vitamins and other nutrients. We therefore expected that the reduction 
of glucose concentration in YP medium would lower the number of available calories 
without compromising the supply of essential nutrients [32], thereby modeling a 
traditional CR dietary regimen established in experiments with laboratory rodents [25, 
26]. An equally important reason for choosing rich YP medium for chronological aging 
studies was that the recent isolation of quiescent and nonquiescent cells from yeast 
stationary-phase cultures grown in this medium provided a novel, valuable system for 
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elucidating the mechanisms linking chronological aging to quiescence, the mitotic cell 
cycle and apoptosis [111, 112]. Our choice of the strain BY4742 was based on its 
relatively short chronological lifespan [113], thereby offering considerable time savings 
for chronological aging studies of yeast cultivated in rich YP medium. Importantly, this 
yeast strain serves as one of the two haploid genetic backgrounds of the widely used 
Yeast Knock-Out Collection available from Open Biosystems. We found that CR cells of 
wild-type grown on 0.2% or 0.5% glucose lived significantly longer than wild-type cells 
grown under non-CR conditions on 1% or 2% glucose [32, 40]. Importantly, ATP levels 
and the dynamics of their change during chronological aging were very similar for CR 
and non-CR yeast [32]. Thus, CR yeast are not starving. Based on this important 
conclusion, we suggested that: 1) CR yeast remodel their metabolism in order to match 
the level of ATP produced in non-CR yeast; and 2) such specific remodeling of 
metabolism in CR yeast prolongs their lifespan [32]. To define a specific pattern of 
metabolism that is responsible for the anti-aging effect of CR and to establish the 
mechanisms underlying such effect, we routinely monitor the age-dependent dynamics of 
proteomes, lipidomes and metabolomes in wild-type and numerous long- and short-lived 
mutant strains of yeast [32, 40, 44, 110, 114]. In our research on aging, we also assess the 
effect of a CR diet and various single-gene-deletion mutations on the age-related 
alterations in cell ultrastructure, stability of nuclear genome, telomere length, 
carbohydrate and lipid metabolism, concentration of ROS, mitochondrial morphology, 
essential processes in mitochondria, mitochondrial membrane lipids, frequency of 
mitochondrial DNA (mtDNA) mutations, composition of mitochondrial nucleoid, 
susceptibility to exogenously induced apoptosis, and stress resistance [32, 40, 44, 110, 
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114]. A strategy that we developed for elucidating the mechanisms of longevity 
regulation in yeast is outlined in Figure 1.6.  
 
Figure 1.6. A strategy that we developed for elucidating the mechanisms underlying longevity regulation 
in yeast. Abbreviations: CR, calorie restriction; EM, electron microscopy; ER, endoplasmic reticulum; FM, 
fluorescence microscopy; GC, gas chromatography; MS, mass spectrometry; mtDNA, mitochondrial DNA; 
ROS, reactive oxygen species; TLC, thin-layer chromatography. 
 
          Using this strategy, we provided evidence that, before yeast enter the non-
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proliferative stationary (ST) phase, they establish a diet- and genotype-specific pattern of 
metabolism and organelle dynamics during the preceeding diauxic (D) and post-diauxic 
(PD) growth phases [32, 40, 44, 110, 114]. Our findings imply that, by designing such 
specific pattern prior to entry into a non-proliferative state, yeast define their long-term 
viability. We therefore concluded that yeast longevity is programmed by the level of 
metabolic capacity and organelle organization they reached prior to reproductive 
maturation [32, 40, 44, 110, 114]. We found that yeast reach such a level by establishing 
a diet- and genotype-specific configuration of what we call “a modular longevity 
network” [32, 114] (Figure 1.7).  
 
Figure 1.7. A modular network regulates longevity of chronologically aging yeast. The network 
integrates a number of cellular processes, which we call modules (see this thesis and [32] for detailed 
description of individual modules). CR and non-CR yeast establish different configurations of the longevity 
network by altering the dynamics of individual modules that comprise the network. During diauxic (D) and 
 17
post-diauxic (PD) phases, yeast establish a particular configuration of their longevity network by setting up 
the rates of the processes that take place within each of the network’s modules. Different configurations of 
the network designed during D and PD phases define different rates of survival during the non-proliferative 
stationary (ST) phase. The different network’s configurations established by CR and non-CR yeast entering 
ST phase are shown. Note: The thickness of arrows correlates with the rates of the processes taking place 
within each of the network’s modules. The metabolites accumulated in bulk quantities and the processes 
accelerated to the highest extent are shown in bold. Abbreviations: Ac-CoA, acetyl-CoA; AcOH, acetic 
acid; CL, cardiolipins; CR, calorie restriction; DAG, diacylglycerols; EE, ethyl esters; ER, endoplasmic 
reticulum; EtOH, ethanol; FA-CoA, CoA esters of fatty acids; FFA, free fatty acids; LB, lipid bodies; PL, 
phospholipids; Prx1p, peroxiredoxin; Sod2, superoxide dismutase; TAG, triacylglycerols; TCA, the 
tricarboxylic acid cycle in mitochondria; ΔΨ, the mitochondrial membrane potential. 
 
Based on such analysis of the spatiotemporal dynamics of the network, we proposed that 
it integrates modules operating in 1) trehalose and glycogen metabolism; 2) glycolysis, 
glucose fermentation to ethanol, and gluconeogenesis; 3) lipid metabolism in the 
endoplasmic reticulum (ER), lipid bodies and peroxisomes; 4) various routes of 
interorganellar metabolic flow; 5) essential oxidation-reduction reactions in 
mitochondria; 6) maintenance of ROS homeostasis; 7) protection of mtDNA from 
oxidative damage; 8) maintenance of a tubular mitochondrial network; and 9) 
mitochondria-controlled apoptosis (Figure 1.7) [32, 40, 44, 110, 114]. By evaluating how 
various interventions alter the functional state of the network’s modules and affect 
lifespan, we inferred the logistics of integrating individual modules into the network and 
suggested a model for the spatiotemporal dynamics of the longevity network operating in 
chronologically aging yeast (Figure 1.8). This model envisions that 1) yeast establish a 
diet- and genotype-specific configuration of the network by setting up the rates of the  
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Figure 1.8. A model for the spatiotemporal dynamics of the longevity network operating in 
chronologically aging yeast. The specific configurations of the longevity network that have been 
differently designed by CR and non-CR yeast during diauxic (D) phase and that have differently evolved in 
these yeast during the subsequent post-diauxic (PD) phase, result in establishing different rates of survival 
during the non-proliferative stationary (ST) phase. Thus, by designing a specific configuration of the 
modular longevity network prior to reproductive maturation, yeast define their chronological life span. 
Note: The thickness of arrows correlates with the rates of the processes taking place within each of the 
network’s modules. The metabolites accumulated in bulk quantities and the processes accelerated to the 
highest extent are shown in bold. The metabolites produced and the processes occurred during the step of 
the aging process preceding the step that is displayed are shown in gray colour. T bars denote inhibition of 
the process. Abbreviations: Ac-CoA, acetyl-CoA; AcOH, acetic acid; CL, cardiolipins; CR, calorie 
restriction; DAG, diacylglycerols; EE, ethyl esters; ER, endoplasmic reticulum; EtOH, ethanol; FA-CoA, 
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CoA esters of fatty acids; FFA, free fatty acids; LB, lipid bodies; PL, phospholipids; Prx1p, peroxiredoxin; 
Sod2, superoxide dismutase; TAG, triacylglycerols; TCA, the tricarboxylic acid cycle in mitochondria; ΨΔ, 
the mitochondrial membrane potential. 
 
processes taking place within each of its modules; 2) the establishment of a network’s 
configuration occurs before yeast enter a non-proliferative state; and 3) different 
network’s configurations established prior to entry into a non-proliferative state define 
different rates of survival following such entry [32, 40, 44, 110, 114]. Thus, by designing 
a specific configuration of the modular longevity network prior to reproductive 
maturation, yeast define their chronological lifespan. We therefore concluded that the 
chronological aging of yeast is an ontogenetic program that progresses through at least 
two checkpoints before yeast enter the non-proliferative ST phase (Figure 1.8) [32, 44].  
          One of the major objectives of this thesis was to elucidate the molecular and 
cellular mechanisms by which several modules of the longevity network depicted in 
Figures 1.7 and 1.8 control the aging process in yeast. 
  
1.6 Five groups of novel anti-aging small molecules greatly extend longevity of 
chronologically aging yeast  
            In the model for the modular longevity network operating in chronologically yeast 
(Figures 1.7 and 1.8) [32, 44], lipid metabolism in the ER, peroxisomes and lipid bodies 
regulates longevity. Our laboratory provided evidence that the specific remodeling of 
lipid metabolism in CR yeast extends their lifespan by delaying lipoapoptosis (a lipid-
induced form of cell death) and by modulating some apoptosis- and stress response-
related processes in mitochondria (Figures 1.7 and 1.8) [32, 40, 44, 110, 114]. One of the 
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objectives of the research on mechanisms of longevity regulation in our laboratory is to 
identify chemical compounds that, by targeting longevity-defining cellular processes that 
integrate lipid metabolism and mitochondria-confined modules into the longevity 
network, can extend yeast lifespan. Our recent high-throughput chemical genetic screen 
of several commercially available compound libraries identified 24 compounds that 
greatly extend yeast chronological lifespan and belong to 5 chemically distinct groups 
[32]. Importantly, all of the compounds that we identified are structurally distinct from 
resveratrol, a constituent of red wine that extends the replicative lifespan of yeast [115] 
and the chronological lifespans of worms, flies and fishes [116 - 121] by activating so-
called sirtuins of the Sir2p protein family. Furthermore, all these compounds are 
structurally unrelated to several other small molecules that, similar to resveratrol, activate 
the sirtuin SIRT1, improve health and survival, and delay the onset of age-related 
diseases in rodent models [122 - 124]. Thus, it is conceivable that the novel anti-aging 
compounds that we identified target longevity-related cellular processes that are not 
modulated by resveratrol and other known activators of sirtuins. 
            The novel anti-aging small molecules that we identified can be used as research 
tools for studying mechanisms of longevity and as pharmaceutical agents for aging and 
age-related disorders. Recent studies in our laboratory revealed that at least one of them, 
a bile lithocholic acid (LCA), is also a potent and selective anti-tumor agent in cultured 
human neuroblastoma, glioma and breast cancer cells [125]. One of the objectives of this 
thesis was to establish the molecular and cellular mechanisms through which LCA 
extends yeast longevity by modulating age-related changes in mitochondrial morphology, 
mitochondrially-generated ROS and mitochondria-controlled apoptosis. 
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1.7 Autophagy and aging 
          Autophagy is a cellular process in which damaged and dysfunctional organelles or 
portions of cytoplasm are sequestered for degradation in lysosomes of mammalian cells 
or vacuoles of yeast cells [126]. Autophagic degradation is an essential cytoprotective 
mechanism that is vital for cell resistance to various stresses and mandatory for proper 
turnover of cellular organelles and macromolecules. Importantly, autophagy has been 
shown to be induced under longevity-extending CR conditions [127].  
 
 
Figure 1.9. Three fundamentally different modes of autophagy are macroautophagy, microautophagy and 
chaperone-mediated autophagy. From: Yen and Klionsky (2008). Physiology 23:248-262. 
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Three major modes of autophagy are known as macroautophagy, microautophagy and 
chaperone-mediated autophagy; each of them is known to have a distinct cellular function 
and underlying mechanism (Figure 1.9). Macroautophagy involves the sequestration of 
cellular components into double-membrane vesicles called autophagosomes and the 
subsequent targeting of these vesicles to lysosomes (vacuoles in yeast), where their entire 
content is degraded by proteases, lipases, nucleases and glucosidases [128].  In a so-
called non-selective macroautophagy pathway, an organelle or a portion of cytoplasm is 
first sequestered by a double membrane into a structure called autophagosome and then 
targeted for degradation in the lysosome/vacuole (Figures 1.10 and 1.11). In contrast,  
 
Figure 1.10. Macroautophagy is the major mode of autophagy involving the sequestration of organelles 
and cytosolic proteins by double-membrane vesicles (called autophagosomes) and their delivery to the 
lysosome/vacuole. From: Yen and Klionsky (2008). Physiology 23:248-262. 
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selective macroautophagy targets specific organelles or cellular components such as 
mitochondria (mitophagy), peroxisomes (macropexophagy) and endoplasmic reticulum 
(reticulophagy) (Figures 1.10 and 1.11) [126]. In either of these pathways, the underlying 
mechanisms are similar; they are initiated by pre-vesicle formation (phagophore 
nucleation) and expansion and are followed by vesicle completion (fusion of phagophore 
ends) around a cellular component or cytosolic fraction [126, 128]. This process is 
completed by the targeting of the autophagosome to a lysosome/vacuole, with which the 
autophagosome then fuses to form an autolysosome - thus releasing its contents for 







Figure 1.11. The macroautophagy pathways include 1) non-selective macroautophagy; 2) mitophagy (a 
cargo-specific, selective pathway); 3) macropexophagy (a cargo-specific, selective pathway); and 4) 
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cytoplasm-to-vacuole [Cvt] (a biosynthetic pathway). From: Yen and Klionsky (2008). Physiology 23:248-
262. 
 
            The recycling of dysfunctional organelles, misfolded proteins and other by-
products of cellular aging by macroautophagy is highly beneficial to survival. 
 
 
Figure 1.12. Macroautophagy plays an essential role in longevity regulation and has been implicated in the 
incidence of diverse age-related pathologies, including neurodegeneration and cancer. From: Mizushima et 
al (2008). Nature 451:1069-1075. 
 
Macroautophagy also plays a role in resisting starvation by providing cells with the 
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metabolic precursors and biosynthetic components when their environmental availability 
is low [129]. Gradual age-related reduction of autophagy efficacy results in the 
accumulation of dysfunctional organelles and other by-products of cellular aging [126], 
and has been implicated in the incidence of diverse age-related pathologies - including 
cancer, neurodegenerative diseases, infections and heart attacks [130] (Figure 1.12). Due 
to its important cytoprotective and organelle-renewing functions, macroautophagy is vital 
for longevity in non-dividing cells such as neurons, monocytes and liver cells [126, 128, 
129]. Indeed, the nervous-tissue specific knockout of autophagy related genes (Atg) in 
mice has been shown to cause motor deficits and abnormal reflexes [129]. Furthermore, 
macroautophagy is necessary for the clearance of protein aggregates associated with 
neurodegenerative conditions, such as Parkinson, Alzheimer and Huntingdon diseases 
[126, 128 - 130].  
            Because of their essential roles in mitigating the effects of disease, infection and 
aging, the regulatory pathways of autophagy are promising targets for the development of 
new therapeutic compounds [126, 128, 129]. Autophagy is known to be governed by 
several conserved autophagy-related (Atg) genes. The products of these genes are 
regulated transcriptionally and post-transcriptionally by a nutrient-sensing signaling 
network that has been implicated in longevity regulation in organism across phyla [126, 
130]. In yeast, this network is centered on the target of rapamycin complex 1 (TOR1), 
which has been shown to phosphorylate Atg1p, Atg13p and Atg17p that compose a 
macroautophagy induction protein complex [126, 128, 129]. This protein complex has 
been shown to drive the assembly of a pre-autophagosome structure (PAS). 
Phosphorylation of Atg13p by TOR1 is thought to inhibit the formation of the complex 
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and subsequent macroautophagy induction, thereby suppressing macroautophagy [131]. 
This complex is also a target of the cAMP/PKA pathway [130]. In a mechanism 
independent or parallel to TOR1, protein kinase A (PKA) inhibits the formation of the 
macroautophagy induction protein complex (Atg1p/Atg13p/Atg17p) by phosphorylating 
Atg1p and Atg13p [128, 130, 132]. Thus, the induction of macroautophagy in yeast is 
driven by a concerted action of the TOR1 and PKA signaling pathways of longevity 
regulation [132].  
            Atg1p, a key component of the macroautophagy pathway, is a serine-threonine 
kinase highly conserved in eukaryotes [126, 128, 130]. In response to conditions that 
induce autophagy, Atg1p is initially recruited by adaptor proteins to the PAS, and then 
activated by associating with Atg13p (Figure 1.13) [133, 134]. Although only some of its 
cellular protein targets have been identified, Atg1 has been shown to play a pivotal role in 
macroautophagy [135]. Indeed, the atg1 mutant yeast strain is known to be deficient in 
the formation of autophagosomes as well as in several downstream steps in 
macroautophagy [126, 128, 130]. The human homologs of yeast Atg1p, ULK1 and 
ULK2, are upregulated at the transcription level by the tumor suppressor p53 in response 
to DNA damage. As such, a number of human cancers are associated with ULK1/2 
suppression [136].  
            Atg 11p, on the other hand, is necessary only for the selective pathways of 
macroautophagy operating in yeast cells (Figure 1.13). It is an adaptor protein that 
interacts with Atg1p and several other autophagy-related proteins [128 - 130]. The 
localization of Atg1p, Atg8p and several other selective autophagy factors to the pre-
autophagosome structure has been shown to be dependent on Atg11p [137]. Atg11p has 
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been hypothesized to function similar to myosins, namely by guiding the associated 
autophagosomes on an actin filament [138]. This hypothesis is based on structural 
similarities between myosin motor proteins and Atg11p and on the demonstrated 
involvement of the actin cytoskeleton in selective macroautophagy, but not non-selective 























atg1Δ: [NSM]- [MTP]- [Cvt]-
atg11Δ: [NSM]+ [MTP]- [Cvt]-
atg19Δ: [NSM]+ [MTP]+ [Cvt]-
atg32Δ: [NSM]+ [MTP]- [Cvt]+
 
Figure 1.13. The molecular machinery of yeast macroautophagy and its regulation by longevity signaling 
pathways and anti-aging compounds. 
 
            One of the major objectives of this thesis was to explore the involvement of 
mitophagy, a selective pathway of autophagic degradation aimed at dysfunctional 
mitochondria, in regulating yeast longevity, maintaining functional  mitochondria and 
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protecting yeast from apoptotic and a recently discovered by our laboratory necrosis-like 
“lipoptotic” modes of age-related cell death. 
 
1.8 Thesis outline and contributions of colleagues 
          Chapter 2 of my thesis outlines the spectrum of mitochondria-confined processes 
affected by CR. We found that CR modulates oxidation-reduction processes and ROS 
production in yeast mitochondria, reduces the frequency of mtDNA mutations, and alters 
the abundance and mtDNA-binding activity of mitochondrial nucleoid-associated 
proteins. Findings described in Chapter 2 provide evidence that these mitochondrial 
processes play essential roles in regulating longevity of chronologically active yeast by 
defining their viability following cell entry into a quiescent state. Based on these 
findings, we propose a hypothesis that ROS, which are mostly generated as by-products 
of mitochondrial respiration, play a dual role in regulating longevity of chronologically 
aging yeast. On the one hand, if yeast mitochondria are unable (due to a dietary regimen) 
to maintain ROS concentration below a toxic threshold, ROS promote aging by 
oxidatively damaging certain mitochondrial proteins and mtDNA. On the other hand, if 
yeast mitochondria can (due to a dietary regimen) maintain ROS concentration at a 
certain “optimal” level, ROS delay chronological aging. We propose that this “optimal” 
level of ROS is insufficient to damage cellular macromolecules but can activate certain 
signaling networks that extend lifespan by increasing the abundance or activity of stress-
protecting and other anti-aging proteins. In addition, studies presented in Chapter 2 imply 
that mtDNA mutations do not contribute to longevity regulation in yeast grown under 
non-CR conditions but make important contribution to longevity regulation in yeast 
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placed on a CR diet. 
          Chapter 3 of my thesis describes the results of our examination of how single-gene-
deletion mutations affecting trehalose biosynthesis and degradation impact 1) the age-
related dynamics of changes in trehalose concentration; 2) yeast chronological lifespan 
under CR conditions; 3) the chronology of oxidative protein damage, intracellular ROS 
level and protein aggregation; and 4) the timeline of thermal inactivation of a protein in 
heat-shocked yeast cells and its subsequent reactivation in yeast returned to low 
temperature. Findings described in Chapter 3 provide evidence that CR extends yeast 
chronological lifespan in part by altering a pattern of age-related changes in trehalose 
concentration. We outline a model for molecular mechanisms underlying the essential 
role of trehalose in defining yeast longevity by modulating protein folding, misfolding, 
unfolding, refolding, oxidative damage, solubility and aggregation throughout lifespan. 
          Chapter 4 of my thesis describes the results of our evaluation of a potential role for 
glycogen metabolism in lifespan extension by CR. To attain this objective, in studies 
described in this chapter we monitored the dynamics of age-related changes in its 
intracellular level. We also assessed how various single-gene-deletion mutations that 
differently alter glycogen concentrations in pre-quiescent and quiescent yeast cells affect 
longevity of chronologically aging yeast under CR conditions. Our findings provide 
evidence that the maintenance of a proper balance between the biosynthesis and 
degradation of glycogen is mandatory for lifespan extension by CR. 
          Chapter 5 of my thesis describes the results of our evaluation of a role for ethanol 
metabolism in lifespan extension by CR. To attain this objective, in studies described in 
this chapter we monitored the dynamics of age-related changes in ethanol concentration 
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in chronologically aging yeast cultured under CR and non-CR conditions. We also 
assessed how single-gene-deletion mutations eliminating Adh1p (an enzyme that is 
required for ethanol synthesis) or Adh2p (an enzyme that catalyzes ethanol degradation) 
affect longevity of chronologically aging yeast under CR and non-CR conditions. 
Furthermore, we examined the effects of the adh1Δ and adh2Δ mutations on the 
intracellular levels of trehalose, glycogen, neutral lipids, free fatty acids (FFA) and 
diacylglycerols (DAG) in chronologically aging yeast under non-CR conditions. 
Moreover, we monitored how single-gene-deletion mutations eliminating Adh1p or 
Adh2p influence the abundance of Fox1p, Fox2p and Fox3p, all of which are the core 
enzymes of fatty acid β-oxidation in peroxisomes. Our findings provide evidence that 
ethanol accumulated in yeast placed on a calorie-rich diet represses the synthesis of 
Fox1p, Fox2p and Fox3p, thereby suppressing peroxisomal oxidation of FFA that 
originate from triacylglycerols synthesized in the endoplasmic reticulum (ER) and 
deposited within LBs. The resulting build-up of arrays of FFA (so-called gnarls) within 
LBs of non-CR yeast initiates several negative feedback loops regulating the metabolism 
of triacylglycerols. Due to the action of these negative feedback loops, chronologically 
aging non-CR yeast not only amass triacylglycerols in LBs but also accumulate DAG and 
FFA in the ER. The resulting remodeling of lipid dynamics in chronologically aging non-
CR yeast shortens their lifespan by causing their premature death due to 1) necrosis 
triggered by the inability of their peroxisomes to oxidize FFA; 2) lipoapoptosis initiated 
in response to the accumulation of DAG and FFA; and 3) the DAG-induced 
reorganization of the protein kinase C-dependent signal transduction network affecting 
multiple longevity-related cellular targets. 
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          Chapter 6 of my thesis describes studies that ultimately led us to the identification 
of small molecules increasing the chronological lifespan of yeast under CR conditions by 
targeting lipid metabolism and modulating “housekeeping” longevity assurance 
pathways. We predicted that such housekeeping pathways 1) modulate longevity 
irrespective of the organismal and intracellular nutrient and energy status; and 2) do not 
overlap (or only partially overlap) with the “adaptable” longevity pathways that are under 
the stringent control of calorie and/or nutrient availability. In studies presented in this 
chapter of my thesis, we found that in yeast grown under CR conditions the pex5Δ 
mutation not only remodels lipid metabolism but also causes the profound changes in 
longevity-defining processes in mitochondria, resistance to chronic (long-term) stresses, 
susceptibility to mitochondria-controlled apoptosis, and frequencies of mutations in 
mitochondrial and nuclear DNA. We therefore chose the single-gene-deletion mutant 
strain pex5Δ as a short-lived strain for carrying out a chemical genetic screen aimed at the 
identification of novel anti-aging compounds targeting housekeeping longevity assurance 
pathways. By screening the total of approximately 19,000 representative compounds 
from seven commercial libraries, our laboratory recently identified 24 small molecules 
that greatly extend the chronological lifespan of pex5Δ under CR conditions and belong 
to 5 chemical groups. One of these groups consisted of 6 bile acids, including lithocholic 
acid (LCA). Findings presented in this chapter of my thesis imply that LCA, a bile acid, 
modulates housekeeping longevity assurance pathways by 1) attenuating the pro-aging 
process of mitochondrial fragmentation, a hallmark event of age-related cell death; 2) 
altering oxidation-reduction processes in mitochondria - such as oxygen consumption, the 
maintenance of membrane potential and ROS production - known to be essential for 
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longevity regulation; 3) enhancing cell resistance to oxidative and thermal stresses, 
thereby activating the anti-aging process of stress response; 4) suppressing the pro-aging 
process of mitochondria-controlled apoptosis; and 5) enhancing stability of nuclear and 
mitochondrial DNA, thus activating the anti-aging process of genome maintenance. The 
observed pleiotropic effect of LCA on a compendium of housekeeping longevity 
assurance processes implies that this bile acid is a multi-target life-extending compound 
that increases chronological lifespan in yeast by modulating a network of the highly 
integrated cellular events that are not controlled by the adaptable AMP-activated protein 
kinase/target of rapamycin (AMPK/TOR) and cAMP/protein kinase A (cAMP/PKA) 
pathways. 
          Chapter 7 of my thesis describes studies that provided evidence for the existence of 
two critical periods when the addition of LCA to yeast grown under CR conditions on 
0.2% glucose can increase both their mean and maximum chronological lifespans. One of 
these two critical periods includes logarithmic and diauxic growth phases, whereas the 
other period exists in the early stationary (ST) phase of growth. In contrast, LCA does not 
cause a significant extension of the mean or maximum chronological lifespan of CR yeast 
if it is added in post-diauxic or late ST growth phases. Because aging of multicellular and 
unicellular eukaryotic organisms affects numerous anti- and pro-aging processes within 
cells [2, 3, 7, 9, 14, 17 - 21, 27 - 36], we hypothesized that the observed ability of LCA to 
delay chronological aging of yeast grown under CR conditions only if added at certain 
critical periods (checkpoints) of their lifespan could be due to its differential effects on 
certain anti- and pro-aging processes at different checkpoints. To test the validity of our 
hypothesis, in studies described in this chapter of my thesis we examined how the 
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addition of LCA at different periods of chronological lifespan in yeast grown under CR 
conditions influences anti- and pro-aging processes taking place during each of these 
periods. Our empirical validation of this hypothesis suggests a mechanism linking the 
ability of LCA to delay chronological aging of yeast only if added at certain periods 
(checkpoints) of their lifespan to the differential effects of this natural anti-aging 
compound on certain anti- and pro-aging processes at each of these checkpoints. 
          Chapter 8 of my thesis describes studies aimed at exploring possible roles of 
mitophagy - a selective macroautophagic removal of dysfunctional mitochondria - in 
regulating yeast longevity, maintaining functional mitochondria, and protecting yeast 
from apoptotic and a recently discovered by our laboratory necrosis-like “lipoptotic” 
modes of age-related cell death. We used a combination of functional genetic, chemical 
biological, cell biological and electron microscopical analyses to carry out comparative 
analyses of the single-gene-deletion mutant strain atg32Δ, which is impaired only in the 
mitophagic pathway of selective macroautophagy, and wild-type (WT) strain. atg32Δ is 
known to lack a mitochondrial outer membrane protein Atg32p whose binding to an 
adaptor protein Atg11p drives the recruitment of mitochondria to the phagophore 
assembly site, thereby initiating the mitophagy process. Our findings provide the first 
comprehensive evidence that mitophagy defines yeast longevity, facilitates yeast 
chronological lifespan extension by a recently discovered anti-aging natural compound, 
sustains functional mitochondria, and protects yeast from apoptotic and necrosis-like 
“lipoptotic” forms of cell death. 
          Most of the findings described in Chapter 2 have been published in Experimental 
Gerontology [Goldberg, A.A.*, Bourque, S.D.*, Kyryakov, P.*, Gregg, C., Boukh-Viner, 
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T., Beach, A., Burstein, M.T., Machkalyan, G., Richard, V., Rampersad, S., Cyr, D., 
Milijevic, S. and Titorenko, V.I. (2009). Effect of calorie restriction on the metabolic 
history of chronologically aging yeast. Exp. Gerontol. 44:555-571; * Equally contributed 
first co-authors] and in The Biochemical Society Transactions [Goldberg, A.A.*, 
Bourque, S.D.*, Kyryakov, P.*, Boukh-Viner, T., Gregg, C., Beach, A., Burstein, M.T., 
Machkalyan, G., Richard, V., Rampersad, S. and Titorenko, V.I. (2009). A novel function 
of lipid droplets in regulating longevity. Biochem. Soc. Trans. 37:1050-1055; * Equally 
contributed first co-authors]. I carried out and supervised more than 30% of all of the 
work described in each of these publications and prepared the first draft of sections 
relevant to my work. I am an equally contributed first co-author on both these 
publications. Dr. V. Titorenko provided intellectual leadership of these projects and 
edited both manuscripts.  
          All findings described in Chapter 3 have been published in Frontiers in Physiology 
[Kyryakov, P., Beach, A., Richard, V.R., Burstein, M.T., Leonov, A., Levy, S., and 
Titorenko, V.I. (2012). Caloric restriction extends yeast chronological lifespan by altering 
a pattern of age-related changes in trehalose concentration. Front. Physiol.; in press]. I 
carried out and supervised more than 50% of the work described in this publication and 
prepared the first draft of the entire manuscript. Dr. V. Titorenko provided intellectual 
leadership of these projects and edited both manuscripts. 
          Some of the findings described in Chapter 4 have been published in Experimental 
Gerontology [Goldberg, A.A.*, Bourque, S.D.*, Kyryakov, P.*, Gregg, C., Boukh-Viner, 
T., Beach, A., Burstein, M.T., Machkalyan, G., Richard, V., Rampersad, S., Cyr, D., 
Milijevic, S. and Titorenko, V.I. (2009). Effect of calorie restriction on the metabolic 
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history of chronologically aging yeast. Exp. Gerontol. 44:555-571; * Equally contributed 
first co-authors]. I carried out and supervised more than 30% of the work described in 
this publication and prepared the first draft of sections relevant to my work. I am an 
equally contributed first co-author on this publication. Dr. V. Titorenko provided 
intellectual leadership of this project and edited the manuscript. Furthermore, some of the 
findings described in Chapter 4 are presented in the manuscript of a paper [Kyryakov, P., 
Beach, A., Burstein, M.T., Richard, V.R. and Titorenko, V.I. The maintenance of a 
proper balance between the biosynthesis and degradation of glycogen in chronologically 
aging yeast is mandatory for lifespan extension by caloric restriction] that is currently in 
preparation for submission to Aging Cell. I expect this manuscript to be submitted for 
publication in September or October 2012. I carried out and supervised more than 60% of 
the work described in this publication and prepared the first draft of sections relevant to 
my work. Dr. V. Titorenko provided intellectual leadership of this project and will be 
editing the first draft of the manuscript. 
          Some of the findings described in Chapter 5 have been published in Experimental 
Gerontology [Goldberg, A.A.*, Bourque, S.D.*, Kyryakov, P.*, Gregg, C., Boukh-Viner, 
T., Beach, A., Burstein, M.T., Machkalyan, G., Richard, V., Rampersad, S., Cyr, D., 
Milijevic, S. and Titorenko, V.I. (2009). Effect of calorie restriction on the metabolic 
history of chronologically aging yeast. Exp. Gerontol. 44:555-571; * Equally contributed 
first co-authors] and in The Biochemical Society Transactions [Goldberg, A.A.*, 
Bourque, S.D.*, Kyryakov, P.*, Boukh-Viner, T., Gregg, C., Beach, A., Burstein, M.T., 
Machkalyan, G., Richard, V., Rampersad, S. and Titorenko, V.I. (2009). A novel function 
of lipid droplets in regulating longevity. Biochem. Soc. Trans. 37:1050-1055; * Equally 
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contributed first co-authors]. I carried out and supervised more than 30% of all of the 
work described in each of these publications and prepared the first draft of sections 
relevant to my work. I am an equally contributed first co-author on both these 
publications. Dr. V. Titorenko provided intellectual leadership of these projects and 
edited both manuscripts. Furthermore, some of the findings described in Chapter 5 are 
presented in the manuscript of a paper [Kyryakov, P., Beach, A., Burstein, M.T., Richard, 
V.R. and Titorenko, V.I. Lipid droplets function as a hub in a regulatory network that 
defines the chronological lifespan of yeast by modulating lipid metabolism in the 
endoplasmic reticulum and peroxisomes] that is currently in preparation for submission 
to Cell Metabolism. I expect this manuscript to be submitted for publication in October or 
November 2012. I carried out and supervised more than 40% of the work described in 
this publication and prepared the first draft of sections relevant to my work. Dr. V. 
Titorenko provided intellectual leadership of this project and will be editing the first draft 
of the manuscript. 
          Most of the findings described in Chapter 6 have been published in Aging 
[Goldberg, A.A.*, Richard, V.R.*, Kyryakov, P.*, Bourque, S.D.*, Beach, A., Burstein, 
M.T., Glebov, A., Koupaki, O., Boukh-Viner, T., Gregg, C., Juneau, M., English, A.M., 
Thomas, D.Y., and Titorenko, V.I. (2010). Chemical genetic screen identifies lithocholic 
acid as an anti-aging compound that extends yeast chronological life span in a TOR-
independent manner, by modulating housekeeping longevity assurance processes. Aging 
2:393-414; * Equally contributed first co-authors]. I carried out and supervised about 
25% of the work described in this publication and prepared the first draft of sections 
relevant to my work. I am an equally contributed first co-author on this publication. Dr. 
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V. Titorenko provided intellectual leadership of this project and edited the manuscript. 
Furthermore, some of the findings described in Chapter 6 are presented in the manuscript 
of a paper [Kyryakov, P., Beach, A., Burstein, M.T., Richard, V.R. and Titorenko, V.I. 
Lipid droplets function as a hub in a regulatory network that defines the chronological 
lifespan of yeast by modulating lipid metabolism in the endoplasmic reticulum and 
peroxisomes] that is currently in preparation for submission to Cell Metabolism. I expect 
this manuscript to be submitted for publication in October or November 2012. I carried 
out and supervised more than 40% of the work described in this publication and prepared 
the first draft of sections relevant to my work. Dr. V. Titorenko provided intellectual 
leadership of this project and will be editing the first draft of the manuscript. 
          All findings described in Chapter 7 are presented in the manuscript of a paper 
[Kyryakov, P., Beach, A., Burstein, M.T., Richard, V.R., Gomez-Perez, A. and 
Titorenko, V.I. Lithocholic acid, a natural anti-aging compound, extends longevity of 
chronologically aging yeast only if added at certain critical periods of their lifespan] that 
is currently in preparation for submission to Cell Cycle. I expect this manuscript to be 
submitted for publication in August 2012. I carried out and supervised more than 50% of 
the work described in this publication and prepared the first draft of sections relevant to 
my work. Dr. V. Titorenko provided intellectual leadership of this project and is currently 
editing the first draft of the manuscript. 
            All findings described in Chapter 8 are presented in the manuscripts of two papers 
[1. Kyryakov, P., Gomez-Perez, A., Koupaki, O., Beach, A., Burstein, M.T., Richard, 
V.R., Leonov, A. and Titorenko, V.I. Mitophagy is a longevity assurance process that in 
chronologically aging yeast sustains functional mitochondria and maintains lipid 
 38
homeostasis. 2. Kyryakov, P., Sheibani, S., Mattie, S., Gomez-Perez, A., Beach, A., 
Burstein, M.T., Richard, V.R., Leonov, A., Vali, H. and Titorenko, V.I. Mitophagy 
protects yeast from a necrosis-like “lipoptotic” mode of cell death triggered by exposure 
to palmitoleic fatty acid] that are currently in preparation for submission to Autophagy 
and Cell Death and Differentiation, respectively. I expect these manuscripts to be 
submitted for publication in August 2012 and October 2012, respectively. I carried out 
and supervised more than 50% of the work described in each of these two manuscripts 
and prepared the first drafts of sections relevant to my work. Dr. V. Titorenko provided 
intellectual leadership of this project and is currently editing the first drafts of the 
manuscripts. 
            All abbreviations, citations, and the numbering of figures and tables that have 
been used in the published papers and in the manuscripts in preparation have been 
changed to the format of this thesis. 
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2 Caloric restriction (CR) modulates oxidation-reduction processes and ROS 
production in yeast mitochondria, reduces the frequency of mitochondrial 
DNA (mtDNA) mutations, and alters the abundance and mtDNA-binding 
activity of mitochondrial nucleoid-associated proteins 
 
2.1 Abstract 
            To make a first step towards the use of high-throughput empirical data on cell 
metabolic history of chronologically aging yeast for defining the molecular causes of 
cellular aging, we recently conducted the mass spectrometry-based identification and 
quantitation of proteins recovered from purified mitochondria of CR and non-CR yeast 
[32]. Our comparative analysis of mitochondrial proteomes of these yeast revealed that 
CR altered the levels of numerous proteins that function in essential processes confined 
to mitochondria. This chapter of my thesis describes the spectrum of mitochondria-
confined processes affected by CR. We found that CR modulates oxidation-reduction 
processes and ROS production in yeast mitochondria, reduces the frequency of mtDNA 
mutations, and alters the abundance and mtDNA-binding activity of mitochondrial 
nucleoid-associated proteins. Findings described here provide evidence that these 
mitochondrial processes play essential roles in regulating longevity of chronologically 
active yeast by defining their viability following cell entry into a quiescent state. Based 
on these findings, we propose a hypothesis that ROS, which are mostly generated as by-
products of mitochondrial respiration, play a dual role in regulating longevity of 
chronologically aging yeast. On the one hand, if yeast mitochondria are unable (due to a 
dietary regimen) to maintain ROS concentration below a toxic threshold, ROS promote 
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aging by oxidatively damaging certain mitochondrial proteins and mtDNA. On the other 
hand, if yeast mitochondria can (due to a dietary regimen) maintain ROS concentration at 
a certain “optimal” level, ROS delay chronological aging. We propose that this “optimal” 
level of ROS is insufficient to damage cellular macromolecules but can activate certain 
signaling networks that extend lifespan by increasing the abundance or activity of stress-
protecting and other anti-aging proteins. In addition, studies presented in this chapter of 
my thesis imply that mtDNA mutations do not contribute to longevity regulation in yeast 
grown under non-CR conditions but make important contribution to longevity regulation 
in yeast placed on a CR diet. 
 
2.2 Introduction 
          Because longevity signaling pathways and mechanisms underlying their 
modulation by genetic, dietary and pharmacological interventions are evolutionarily 
conserved, the budding yeast S. cerevisiae is a valuable model system in aging research 
[13 - 20]. Our laboratory uses S. cerevisiae as a model organism for unveiling the 
molecular and cellular mechanisms underlying longevity regulation and extension by 
genetic, dietary and pharmacological interventions. To address the inherent complexity of 
aging from a systems perspective and to build an integrative model of aging process, we 
recently investigated the effect of caloric restriction (CR), a low-calorie dietary regimen, 
on longevity and metabolic history of chronologically aging yeast [32, 40, 110, 114]. The 
full growth cycle of yeast cultured in complete YP medium (1% yeast extract, 2% 
peptone) initially containing 0.2%, 0.5%, 1% or 2% glucose began with logarithmic (L) 
phase and progressed through diauxic (D) and post-diauxic (PD) phases to stationary  
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Figure 2.1. CR extends the chronological lifespan of yeast. (A and B) Kinetics of growth (A) and glucose 
consumption (B) for the WT strain BY4742. Each plot shows a representative experiment repeated 4-6 
times in triplicate with similar results. (C) Survival of chronologically aging WT cells. Data are presented 
as mean ± SEM (n = 16-28). p < 0.001 at days 10 to 33 for cells grown on 0.2% or 0.5% glucose vs. cells 
grown on 2% glucose. (D) The mean chronological lifespans of WT cells. Data are presented as mean ± 
SEM (n = 16-28); *p < 0.01, **p < 0.001. (E) ATP levels in chronologically aging WT cells. Data are 
presented as mean ± SEM (n = 3-5). (A-E) Cells were cultured in YP medium containing 0.2%, 0.5%, 1% 
or 2% glucose. Abbreviations: Diauxic (D), logarithmic (L), post-diauxic (PD) or stationary (ST) phase. 
From [32], with permission. 
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(ST) phase (Figure 2.1A). The rates of growth (Figure 2.1A) and glucose consumption 
(Figure 2.1B) in L phase were similar for cells cultured in any of the four media, whereas 
the maximum cell density in ST-phase cultures varied within a 28-% range and correlated 
with the initial glucose concentration (Figure 2.1A). CR cells grown on 0.2% or 
0.5%glucose lived significantly longer than cells grown under non-CR conditions on 1% 
or 2% glucose (Figure 2.1C). In fact, the mean chronological lifespan of cells grown on 
0.2% glucose was extended by more than 60% and that of cells grown on 0.5% glucose 
was extended by almost 2-fold, as compared to the mean chronological lifespan of cells 
grown on 2% glucose (Figure 2.1D).  Importantly, ATP levels and the dynamics of their 
change during chronological aging were very similar for CR and non-CR yeast (Figure 
2.1E). Thus, CR yeast are not starving. Based on this important conclusion, our 
laboratory put forward a hypothesis that: 1) CR yeast remodel their metabolism in order 
to match the level of ATP produced in non-CR yeast; and 2) such specific remodeling of 
metabolism in CR yeast prolongs their lifespan [32, 114]. 
          It has been recently predicted that the application of the concepts and 
methodologies of so-called metabolic control analysis (MCA) to the analysis of empirical 
data on the cell metabolic histories of model organisms will enable to 1) infer the relative 
contributions of various cellular processes to aging; and 2) define how interventions such 
as dietary restriction delay aging by modulating these processes [31, 151]. To make a first 
step towards the use of MCA for defining the molecular causes of cellular aging by 
elucidating the effect of CR on the metabolic history of chronologically aging yeast, our 
laboratory recently carried out the mass spectrometry-based identification and 
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Figure 2.2. CR alters the abundance of a distinct set of proteins in mitochondria of chronologically aging 
yeast. Relative levels (fold difference relative to that on 2% glucose) of proteins recovered in purified yeast 
mitochondria. Proteins were identified and quantitated using mass spectrometry. The complete list of 
proteins and their relative levels are provided in Tables 2.1 and 2.2, respectively. From the data of 
proteomic analysis, I inferred an outline of mitochondria-confined processes that were activated (red 
arrows) or inhibited (green arrows) by CR prior to entry of yeast into the non-proliferative ST phase. 
Abbreviations: Ac-CoA, acetyl-CoA; ETC, the mitochondrial electron transport chain; mtDNA, 
mitochondrial DNA; mtDNA-bp, mitochondrial DNA-binding proteins; PDH, the mutienzyme pyruvate 
dehydrogenase complex; ROS, reactive oxygen species; TCA, the tricarboxylic acid cycle in mitochondria. 
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CR and non-CR cells [32]. Our comparative analysis of mitochondrial proteomes of CR 
and non-CR yeast revealed that CR altered the levels of numerous proteins that function 
in essential processes confined to mitochondria (Figure 2.2). 
          In studies described in this chapter of the thesis, we investigated the spectrum of 
mitochondrial processes affected by CR. These studies revealed that CR modulates 
oxidation-reduction processes and ROS production in yeast mitochondria, reduces the 
frequency of mtDNA mutations, and alters the abundance and mtDNA-binding activity of 
mitochondrial nucleoid-associated proteins. Our findings provide evidence that these 
mitochondria-confined processes play essential roles in regulating longevity of 
chronologically active yeast by defining their viability during ST growth phase, following 
cell entry into a quiescent state.   
 
2.3 Materials and Methods 
Strains and media  
The wild-type strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) was grown in YP 
medium (1% yeast extract, 2% peptone) containing 0.2%, 0.5%, 1% or 2% glucose as 
carbon source. Cells were cultured at 30oC with rotational shaking at 200 rpm in 
Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1. 
 
Oxygen consumption assay 
The rate of oxygen consumption by yeast cells recovered at various time points was 
measured continuously in a 2-ml stirred chamber using a custom-designed biological 
oxygen monitor (Science Technical Center of Concordia University) equipped with a 
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Clark-type oxygen electrode. 1 ml of YP medium supplemented with 0.2% glucose was 
added to the electrode for approximately 5 minutes to obtain a baseline. Cultured cells of 
a known titre were spun down at 3,000 × g for 5 minutes. The resulting pellet was 
resuspended in YP medium supplemented with 0.2% glucose and then added to the 
electrode with the medium that was used to obtain a baseline. The resulting slope was 
used to calculate the rate of oxygen consumption in O2% x min-1 × 109 cells. 
 
Monitoring the formation of ROS  
Cells grown in YP medium containing 0.2%, 0.5%, 1% or 2% glucose as carbon source 
were tested microscopically for the production of ROS by incubation with 
dihydrorhodamine 123 (DHR). In the cell, this nonfluorescent compound can be oxidized 
to the fluorescent chromophore rhodamine 123 by ROS. Cells were also probed with a 
fluorescent counterstain Calcofluor White M2R (CW), which stains the yeast cell walls 
fluorescent blue. CW was added to each sample in order to label all cells for their proper 
visualization. DHR was stored in the dark at –20oC as 50 μl aliquots of a 1 mg/ml 
solution in ethanol. CW was stored in the dark at –20oC as the 5 mM stock solution in 
anhydrous DMSO (dimethylsulfoxide). 
          The concurrent staining of cells with DHR and CW was carried out as follows. The 
required amounts of the 50 μl DHR aliquots (1 mg/ml) and of the 5 mM stock solution of 
CW were taken out of the freezer and warmed to room temperature. The solutions of 
DHR and CW were then centrifuged at 21,000 × g for 5 min in order to clear them of any 
aggregates of fluorophores. For cell cultures with a titre of ~ 107 cells/ml, 100 μl was 
taken out of the culture to be treated. If the cell titre was lower, proportionally larger 
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volumes were used. 6 μl of the 1 mg/ml DHR and 1 μl of the 5 mM CW solutions were 
added to each 100 μl aliquot of culture. After a 2-h incubation in the dark at room 
temperature, the samples were centrifuged at 21,000 × g for 5 min. Pellets were 
resuspended in 10 μl of PBS buffer (20 mM KH2PO4/KOH, pH 7.5, and 150 mM NaCl). 
Each sample was then supplemented with 5 μl of mounting medium, added to a 
microscope slide, covered with a coverslip, and sealed using nail polish. Once the slides 
were prepared, they were visualized under the Zeiss Axioplan fluorescence microscope 
mounted with a SPOT Insight 2 megapixel color mosaic digital camera. Several pictures 
of the cells on each slide were taken, with two pictures taken of each frame. One of the 
two pictures was of the cells seen through a rhodamine filter in order to detect cells dyed 
with DHR. The second picture was of the cells seen through a DAPI filter in order to 
visualize CW, and therefore all the cells present in the frame. 
          For evaluating the percentage of DHR-positive cells, the UTHSCSA Image Tool 
(Version 3.0) software was used to calculate both the total number of cells and the 
number of stained cells. Fluorescence of individual DHR-positive cells in arbitrary units 
was determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3-
5 independent experiments, the value of median fluorescence was calculated by analyzing 
at least 800-1000 cells that were collected at each time point. The median fluorescence 
values were plotted as a function of the number of days cells were cultured. 
 
Monitoring the mitochondrial membrane potrential  
The mitochondrial membrane potential (ΔΨ) was measured in live yeast by fluorescence 
microscopy of Rhodamine 123 (R123) staining. For R123 staining, 5 Ì 106 cells were 
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harvested by centrifugation for 1 min at 21,000 Ì g at room temperature and then 
resuspended in 100 μl of 50 mM sodium citrate buffer (pH 5.0) containing 2% glucose. 
R123 (Invitrogen) was added to a final concentration of 10 μM. Following incubation in 
the dark for 30 min at room temperature, the cells were washed twice in 50 mM sodium 
citrate buffer (pH 5.0) containing 2% glucose and then analyzed by fluorescence 
microscopy. Images were collected with a Zeiss Axioplan fluorescence microscope 
(Zeiss) mounted with a SPOT Insight 2 megapixel color mosaic digital camera (Spot 
Diagnostic Instruments). For evaluating the percentage of R123-positive cells or cells 
with fragmented nucleus the UTHSCSA Image Tool (Version 3.0) software was used to 
calculate both the total number of cells and the number of stained cells or cells with 
fragmented nucleus. Fluorescence of individual R123-positive cells in arbitrary units was 
determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3-6 
independent experiments, the value of median fluorescence was calculated by analyzing 
at least 800-1000 cells that were collected at each time-point. The median fluorescence 
values were plotted as a function of the number of days cells were cultured. 
 
Measurement of mitochondrial mutations and nuclear mutations affecting 
mitochondrial components 
The frequency of spontaneous single-gene (mit- and syn-) and deletion (rho- and rhoo) 
mutations in mtDNA and spontaneous single-gene nuclear mutations (pet-) affecting 
essential mitochondrial components was evaluated by measuring the fraction of 
respiratory-competent (rho+) yeast cells remaining in their aging population. rho+ cells 
maintained intact their mtDNA and their nuclear genes encoding essential mitochondrial 
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components. Therefore, rho+ cells were able to grow on glycerol, a non-fermentable 
carbon source. In contrast, mutant cells deficient in mitochondrial respiration were unable 
to grow on glycerol. Most of these mutant cells carried mutations in mtDNA (including 
single-gene mit- and syn- mutations or large deletions rho-) or completely lacked this 
DNA (rhoo mutants), whereas some of them carried so-called pet- mutations in nuclear 
genes that code for essential mitochondrial components [140]. Serial dilutions of cell 
samples removed from different phases of growth were plated in duplicate onto YP plates 
containing either 2% glucose or 3% glycerol as carbon source. Plates were incubated at 
30oC. The number of CFU on YP plates containing 2% glucose was counted after 2 d of 
incubation, whereas the number of CFU on YP plates containing 3% glycerol was 
counted after 6 d of incubation. For each culture, the percentage of respiratory-deficient 
(mit-, syn-, rho-, rhoo and pet-) cells was calculated as follows: 100 - [(number of CFU per 
ml on YP plates containing 3% glycerol/number of CFU per ml on YP plates containing 
2% glucose) × 100]. The frequency of spontaneous point mutations in the rib2 and rib3 
loci of mtDNA was evaluated by measuring the frequency of mtDNA mutations that 
caused resistance to the antibiotic erythromycin [141]. These mutations impair only 
mtDNA [142, 143]. In each of the seven independent experiments performed, ten 
individual yeast cultures were grown in YP medium containing 0.2%, 0.5%, 1% or 2% 
glucose as carbon source. A sample of cells was removed from each culture at various 
time-points. Cells were plated in duplicate onto YP plates containing 3% glycerol and 
erythromycin (1 mg/ml). In addition, serial dilutions of each sample were plated in 
duplicate onto YP plates containing 3% glycerol as carbon source for measuring the 
number of respiratory-competent (rho+) cells. The number of CFU was counted after 6 d 
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of incubation at 30oC. For each culture, the frequency of mutations that caused resistance 
to erythromycin was calculated as follows: number of CFU per ml on YP plates 
containing 3% glycerol and erythromycin/number of CFU per ml on YP plates containing 
3% glycerol.  
 
Isolation of the crude mitochondrial fraction 
The crude mitochondrial fraction was isolated as we described previously [144]. Yeast 
cells were pelleted at 3,000 × g for 5 min at room temperature, washed twice with 
distilled water, resuspended in DTT buffer (100 mM Tris-H2SO4, pH 9.4, 10 mM 
dithiothreitol [DTT]), and incubated for 20 min at 30oC to weaken the cell wall. The cells 
were then washed with Zymolyase buffer (1.2 M sorbitol, 20 mM potassium phosphate, 
pH 7.4), centrifuged at 3,000 × g for 5 min at room temperature, and incubated with 3 
mg/g (wet wt) of Zymolyase-100T in 7 ml/g (wet wt) Zymolyase buffer for 45 min at 
30°C.  Following an 8-min centrifugation at 2,200 × g at 4oC, the isolated spheroplasts 
were washed in ice-cold homogenization buffer (5 ml/g) (0.6 M sorbitol, 10 mM Tris-
HCl, pH7.4, 1 mM EDTA, 0.2% (w/v) BSA) and then centrifuged at 2,200 × g for 8 min 
at 4oC. Washed spheroplasts were homogenized in ice-cold homogenization buffer using 
15 strokes. The cell debris was removed by centrifuging the resulting homogenates at 
1,500 × g for 5 min at 4°C. The supernatant was further centrifuged at 3,000 × g for 5 
min at 4°C to remove residual cell debris. The resulting supernatant was then centrifuged 
at 12,000 × g for 15 min at 4°C to pellet mitochondria. The remnant cell debris was 
removed by centrifuging the mitochondrial fraction at 3,000 × g for 5 min at 4°C. The 
resulting supernatant was then centrifuged at 12,000 × g for 15 min at 4°C to obtain the 
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crude mitochondrial pellet, which was then resuspended in 3 ml of SEM Buffer (250 mM 
sucrose, 1 mM EDTA, 10 mM MOPS, pH 7.2) and used for the purification of 
mitochondria as described below. 
 
Purification of mitochondria devoid of microsomal and cytosolic contaminations 
Mitochondria devoid of microsomal and cytosolic contaminations were purified as we 
described previously [144]. A sucrose gradient was made by carefully overlaying 1.5 ml 
of 60% sucrose with 4 ml of 32% sucrose, 1.5 ml of 23% sucrose, and then 1.5 ml of 
15% sucrose (all in EM buffer; 1 mM EDTA, 10 mM MOPS, pH 7.2). Finally, a 3-ml 
aliquot of the crude mitochondrial fraction in SEM buffer was applied to the gradient and 
centrifuged at 134,000 × g (33,000 rpm) overnight at 4°C in vacuum (Rotor SW50Ti, 
Beckman). The purified mitochondria found at the 60%/32% sucrose interface were 
carefully removed and stored at - 80°C. 
 
Purification of proteins that bind to mitochondrial DNA (mtDNA)  
Purification of in organello formaldehyde-fixed proteins that bind to mtDNA was 
performed as previously described [145, 146]. Purified mitochondria were diluted in 
FB15 buffer (10 mM Tricine/KOH, pH 7.5, 0.1 mM EDTA, 50 mM NaCl, 15% sucrose) 
and pelleted by centrifugation at 40,000 × g at 4oC for 1.5 h. The sedimented 
mitochondria were resuspended (10 mg/ml) in FB15, adjusted to 40 mM Tris/HCl, pH 
8.0, 2.5 mM MgCl2 and treated with DNase I (1 unit/50 μg) for 1 h on ice. The reaction 
was terminated with 5 mM EDTA, pH 8.0; the mitochondria were pelleted, washed with 
RB buffer (20 mM HEPES, pH 7.6, 2 mM EDTA, 1 mM EGTA, 0.5 M sucrose), and 
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diluted to 2 mg/ml in CB buffer (RB buffer plus 50 mM Hepes, 50 mM NaCl, 7 mM β-
mercaptoethanol, 1 mM PMSF, 1 mM spermidine, 1× Protease Inhibitor mixture from 
Roche Molecular Biochemicals). Formaldehyde was added to the final concentration of 
1%, and the mitochondria were incubated at 4°C for 16 h with slow mixing. The reaction 
was quenched with 125 mM glycine, pH 7.0, and the mitochondria were pelleted, 
resuspended in CB buffer plus 50 mM glycine, and lysed with 0.5% NP-40. The lysate 
was diluted 3-fold, and the mtDNA-enriched pellet was collected by centrifugation 
(110,000 × g, 4oC, 1 h) through 20% sucrose (in 50 mM HEPES, pH 7.6, 50 mM NaCl, 
0.5% NP-40). The pellet was resuspended in CB buffer using a dounce homogenizer and 
treated with 1% sarkosyl and RNase A (50 μg/ml) for 1 h at room temperature. The 
mixture was adjusted to RI = 1.365 with CsCl (in TE, 1% sarkosyl), and 5 mg of the 
purified mitochondria was loaded into 11-ml tubes. Gradients were centrifuged (260,000 
× g, 25°C, 16 h) in a fixed angle rotor and fractionated into 0.5-ml fractions.  
 
Miscellaneous procedures 
SDS-PAGE and immunoblotting using a Trans-Blot SD semi-dry electrophoretic transfer 
system (Bio-Rad) were performed as previously described [147]. Blots were decorated 
with polyclonal antisera raised against Aco1p (kind gift of the late Dr. Ronald A. Butow, 
University of Texas Southwestern Medical Center). Antigen-antibody complexes were 
detected by enhanced chemiluminescence using an Amersham ECL Western blotting 
detection reagents (GE Healthcare). Enzymatic activities of cytochrome c oxidase [148], 





2.4.1 In chronologically aging yeast, CR modulates oxidation-reduction processes 
in mitochondria and alters the age-related dynamics of mitochondrially 
produced ROS 
            Because our comparative analysis of mitochondrial proteomes of CR and non-CR 
yeast revealed that CR altered the levels of numerous proteins that function in essential 
processes confined to mitochondria (Figure 2.2) [32], we sought to define the spectrum of 
mitochondrial processes affected by CR. We found that, through D, PD and ST phases, 
mitochondria of CR yeast maintained the amplified rate of oxygen consumption, elevated 
the mitochondrial membrane potential (ΔΨ), and increased enzymatic activities of 
cytochrome c oxidase (CCO), succinate dehydrogenase (SDH) and aconitase (ACO), as 
compared to mitochondria of non-CR yeast (Figure 2.3). The observed amplification of 
these essential mitochondrial processes in CR yeast can be adequately explained by the 
CR-promoted rise in the levels of mitochondrial proteins that serve the formation of 
acetyl-CoA from pyruvate and its subsequent oxidation via the tricarboxylic acid (TCA) 
cycle, electron transport, and ATP-producing oxidative phosphorylation (Figure 2.2).    
            Despite the elevated levels of cytosolic and mitochondrial ROS scavenging 
proteins in CR yeast (Figure 2.2), CR elevated the level of intracellular ROS (Figure 
2.3E). ROS are mostly generated as by-products of mitochondrial respiration [152 - 154]. 
Thus, it is conceivable that, by promoting electron flow through the mitochondrial 
electron transport chain (ETC), CR enhanced the ROS-generating transfer of a single 
electron to oxygen in mitochondria. 
 53
            We also found that the degree of CR influenced essential mitochondrial processes 
and activities such as oxygen consumption and ROS production, the establishment and 
maintenance of ΔΨ, and enzymatic activities of CCO, SDH and ACO. In fact, in CR 
yeast grown on 0.2% glucose, a glucose concentration providing only a moderate CR-
dependent lifespan extension, the efficiencies of all these processes and enzymatic 
activities were 1) greatly amplified when yeast entered D phase; and 2) sharply declined 
through the following PD and ST phases (Figure 2.3). Of note, the sharply declined 
activity of ACO recovered from CR yeast grown on 0.2% glucose could be substantially 
increased in vitro by incubation of cell lysate with Fe3+ and S2- (Figure 2.3F), which are 
able to restore the oxidation-dependent loss of one iron from the [4Fe-4S] cluster of ACO 
[155]. As we found, in CR yeast grown on 0.5% glucose, a glucose concentration that 
provides the maximal benefit of CR for longevity, the efficiencies of all these 
mitochondrial processes and enzymatic activities were 1) amplified to a much lesser 
extent during D phase than they were amplified in yeast grown on 0.2% glucose; and 2) 
reached a plateau in PD phase and remained mainly unchanged during the following ST 
phase (Figure 2.3). During the non-proliferative ST phase, the efficiencies and activities 
of all monitored mitochondrial processes and enzymes in CR yeast grown on 0.5% 
glucose exceeded those seen in CR yeast grown on 0.2% glucose.  
            Altogether, these findings suggest that the observed early spike in oxygen 
consumption by mitochondria of yeast grown on 0.2% glucose, which exceeded the 
modest increase seen in yeast grown on 0.5% glucose, resulted in a greatly elevated level 
of mitochondrial ROS. This, in turn, led to the oxidative damage and inactivation of 
CCO, SDH, ACO and, perhaps, some other components of the mitochondrial ETC and 
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TCA cycle. Late in ST phase, the resulting decline in the rate of electron flow through the 
mitochondrial ETC of yeast grown on 0.2% glucose substantially decreased 
mitochondrial ROS below the level observed in mitochondria of yeast grown on 0.5% 









































































































ACO, - Fe3+ - S2-
ACO, + Fe3+ + S2-
0.2% glucose:
ACO, - Fe3+ - S2-
ACO, + Fe3+ + S2-
2.0% glucose:
Figure 2.3. CR influences oxidation-reduction processes in mitochondria and modulates the level of 
mitochondrially produced ROS. (A) The dynamics of age-dependent changes in the rate of oxygen 
consumption by cells. Data are presented as mean ± SEM (n = 15-19). (B) The dynamics of age-dependent 
changes in the mitochondrial membrane potential (ΔΨ) during chronological aging of yeast. ΔΨ was 
visualized using R123. At least 800 cells were used for quantitation of R123 staining for each of 3 
independent experiments. Data are presented as mean ± SEM (n = 15-19). (C and D) Enzymatic activities 
of CCO (C) and SDH (D) in purified mitochondria. Data are presented as mean ± SEM (n = 6-10). (E) The 
dynamics of age-dependent changes in the intracellular levels of ROS during chronological aging of yeast. 
ROS were visualized using DHR. At least 800 cells were used for quantitation of DHR staining for each of 
5 independent experiments. Data are presented as mean ± SEM (n = 8-13). (F) Enzymatic activities of ACO 
in total cell lysates. The ACO activity was measured with or without the reactivation agents Fe3+ and Na2S. 
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Data are presented as mean ± SEM (n = 5). (A-E) Cells were cultured in YP media initially containing four 
different concentrations of glucose. (F) Cells were cultured in YP medium initially containing 0.2% or 2% 
glucose. 
 
2.4.2  CR influences the frequency of mitochondrial DNA (mtDNA) mutations and 
modulates the abundance and mtDNA-binding activity of mitochondrial 
nucleoid-associated proteins 
            Our data imply that the observed during D and PD phases spike in ROS 
production by mitochondria of CR yeast grown on 0.2% glucose can oxidatively damage 
their mtDNA, eventually (i.e., during ST phase) introducing deletions and point 
mutations into it. In fact, during ST phase, the population of these CR cells accumulated 
an increasing fraction of respiratory-deficient mutants (Figure 2.4A). Most of these 
mutants are known to carry mutations in mtDNA (including single-gene mit- and syn- 
mutations or large deletions rho-) or completely lack mtDNA (rhoo mutants), whereas 
some of them carry so-called pet- mutations in nuclear genes that code for essential 
mitochondrial components [156, 157]. We also found that only cells under CR at 0.2% 
glucose exhibited an increased frequency of mtDNA mutations that caused resistance to 
erythromycin (Figure 2.4B). Resistance to this antibiotic can be acquired only through a 
distinct set of point mutations in the mitochondrial rib2 and rib3 genes that encode two 
different rRNAs confined to mitochondria [158 - 160]. Noteworthy, the highest 
amplitude of the early spike in ROS production by yeast under CR at 0.2% glucose 
(Figure 2.4E) correlated with their elevated frequencies of mtDNA mutations (Figures 
2.4A and 2.4B) and shortened lifespan (Figures 2.1C and 2.1D), as compared to yeast 
under CR at 0.5% glucose. Thus, it is conceivable that the frequency of ROS-induced 
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deletions and point mutations in mtDNA influence yeast longevity under CR conditions. 
This hypothesis could satisfactorily explain my observation that yeast under CR at 0.5% 
glucose live longer than yeast under CR at 0.2% glucose. Conversely, it seems that the 
frequency of mtDNA deletions and point mutations does not affect the longevity of 
chronologically aging yeast grown on 1% or 2% glucose, i.e. under non-CR conditions. 
In fact, we found that, despite these yeast had much lower frequencies of mtDNA 
mutations than CR yeast grown on 0.2% glucose (Figures 2.4A and 2.4B), they lived a 
shorter life (Figures 2.1C and 2.1D). 
 
Figure 2.4. CR modulates the frequency of mtDNA mutations and influences the efficiency of aconitase 
binding to mtDNA. (A) The percentage of respiratory-deficient cells that were unable to grow in medium 
containing 3% glycerol because they carried large mtDNA deletions (rho-) or lacked mtDNA (rhoo). Data 
are presented as mean ± SEM (n = 7). (B) Relative frequencies (fold difference relative to that on 2% 
glucose) of mtDNA point mutations that caused resistance to erythromycin. Data are presented as mean ± 
SEM (n = 70); *p < 0.01, **p < 0.001. (C) Western blot analysis of aconitase (Aco1p) recovery in fractions 
of a CsCl gradient that was used for the purification of mitochondrial nucleoids. The peak fraction for the 
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mitochondrial Aco1p-DNA complex (arrow) is indicated. (A and B) Cells were cultured in YP media 
initially containing four different concentrations of glucose. (C) Cells were cultured in YP medium initially 
containing 0.2% glucose. 
 
            It should be emphasized that the observed elevated frequencies of mtDNA 
deletions and point mutations in CR yeast grown on 0.2% glucose occurred despite an 
effort that these yeast have made to protect the stability of mtDNA by remodeling 
mitochondrial nucleoids early in their life. In fact, during D and PD phases, these CR 
yeast induced the synthesis of a distinct set of mtDNA-binding proteins (Figure 2.2) 
known for their essential role in maintaining mtDNA and protecting it from oxidative 
damage [157]. One of these proteins, the TCA-cycle enzyme aconitase (Aco1p) known 
for its ability to interact with mtDNA and to maintain its integrity when cells are shifted 
to respiratory conditions [161], associated with mtDNA of aging CR yeast grown on 
0.2% glucose (Figure 2.4C). As we found, the efficiency of such Aco1p binding to 
mtDNA at different stages of the aging process (Figure 2.4C) correlated with the 
concentration of ROS generated by mitochondria of these CR yeast (Figure 2.3E). Of 
note, CR decreased the levels of mitochondrial Abf2p and Ilv5p (Figure 2.2), the two 
mtDNA-binding proteins that associate with mitochondrial nucleoids under conditions of 
low respiration or amino-acid starvation, respectively [157]. Therefore, we suggest the 
following scenario for metabolic remodeling of mitochondrial nucleoids in 
chronologically aging CR yeast. In response to the early spike in oxygen consumption 
and ROS generation by their mitochondria, CR yeast induce the synthesis of Aco1p and 
other bifunctional mitochondrial proteins that, in addition to their essential role in 
respiratory metabolism, are able to interact specifically with mtDNA. Concomitantly, CR 
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yeast repress the synthesis of both Abf2p and Ilv5p. Because of their increased 
concentrations and due to their partial oxidation by mitochondrial ROS, Aco1p and other 
mtDNA-binding proteins bind to mtDNA in order to protect it from oxidative damage. 
Such binding of Aco1p and other respiratory-metabolism sensing proteins to mtDNA 
may substitute for Abf2p and Ilv5p, thereby remodeling mitochondrial nucleoids by 
converting them into the conformation that is more resistant to oxidative damage. 
Noteworthy, the level of Aco1p in yeast cells is known to be modulated by the 
mitochondrial retrograde (RTG) signaling pathway. This pathway activates transcription 
of the ACO1 gene in response to a decline in mitochondrial respiratory function caused 
by mtDNA damage [162, 163]. It is conceivable therefore that chronologically aging CR 
yeast respond to the partial oxidative damage of their mtDNA by turning on the RTG 
pathway. By activating transcription of ACO1 and, perhaps, other genes encoding 
bifunctional mtDNA-binding proteins known to maintain the integrity of mtDNA in yeast 
shifted to respiratory conditions [161, 162], this signaling pathway may govern the 
resulting conversion of mitochondrial nucleoids into the conformation that is more 
resistant to oxidative damage. 
 
2.5 Discussion 
          Findings described in this chapter of my thesis suggest a hypothesis that ROS, 
which are mostly generated as by-products of mitochondrial respiration [152 - 154], play 
a dual role in regulating longevity of chronologically aging yeast. First, if yeast 
mitochondria are unable (due to a dietary regimen) to maintain ROS concentration below 
a toxic threshold, ROS promote aging by oxidatively damaging certain mitochondrial 
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proteins (such as CCO, SDH and ACO) and mtDNA. In fact, we found that the highest 
amplitude of the early spike in ROS production in CR yeast entering D phase on 0.2% 
glucose (Figure 2.3E) correlated with their 1) shortened (as compared to CR yeast grown 
on 0.5% glucose) lifespan (Figures 2.1C and 2.1D); 2) sharply declined activities of 
CCO, SDH and ACO through the following PD and ST phases (Figures 2.3C, 2.3D and 
2.3F); and 3) elevated frequencies of mtDNA deletions and point mutations, as compared 
to yeast under CR at 0.5% glucose (Figures 2.4A and 2.4B). Second, if yeast 
mitochondria can (due to a dietary regimen) maintain ROS concentration at a certain 
“optimal” level, ROS delay chronological aging. We propose that this “optimal” level of 
ROS is insufficient to damage cellular macromolecules but can activate certain signaling 
networks [152 - 154, 164] that extend lifespan by increasing the abundance or activity of 
stress-protecting and other anti-aging proteins; the term “mitohormesis” has been coined 
for such anti-aging role of mitochondrially produced ROS [165]. Indeed, we found that 
elevated (as compared to non-CR yeast) ROS concentrations in CR yeast (Figure 2.3E) 
correlated with their extended chronological longevity (Figures 2.1C and 2.1D), 
increased abundance of numerous mitochondrial and cytosolic anti-stress chaperones and 
mtDNA-binding proteins (Figure 2.2), and augmented resistance to chronic thermal and 
oxidative stresses [32]. Moreover, although the low concentration of ROS seen in non-
CR yeast could play a key role in protecting their mtDNA from “spontaneous” 
mutagenesis (Figures 2.4A and 2.4B), the inability of these yeast to generate ROS in 
sufficiently high, “optimal” quantities could contribute to their lowered (as compared to 
CR yeast) levels of cytosolic and mitochondrial stress-protecting proteins (Figure 2.2) 
and reduced resistance to chronic thermal and oxidative stresses [32]. Noteworthy, the 
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view that mitochondrially produced ROS in “optimal” concentrations contribute to 
extension of yeast lifespan by promoting “mitohormesis” is controversial [166, 167]. 
          Studies presented in this chapter of my thesis also imply that mtDNA mutations do 
not contribute to longevity regulation in non-CR yeast grown on 1% or 2% glucose. In 
fact, despite these yeast lived a shorter life than CR yeast grown on 0.2% glucose 
(Figures 2.1C and 2.1D), they had much lower frequencies of mtDNA deletions and point 
mutations, as compared to yeast under CR at 0.2% glucose (Figures 2.4A and 2.4B). In 
contrast, it seems that the frequency of mtDNA mutations is an important contributing 
factor to yeast longevity under CR conditions. Indeed, the elevated frequencies of 
mtDNA mutations in yeast under CR at 0.2% glucose (Figures 2.4A and 2.4B) correlated 
with their shortened lifespan, as compared to yeast under CR at 0.5% glucose (Figures 
2.1C and 2.1D). 
 
2.6 Conclusions 
          As the reported here investigation of the spectrum of mitochondrial processes 
affected by CR revealed, the low-calorie diet modulates oxidation-reduction processes 
and ROS production in yeast mitochondria, reduces the frequency of mtDNA mutations, 
and alters the abundance and mtDNA-binding activity of mitochondrial nucleoid-
associated proteins. These findings provide evidence that these mitochondria-confined 
processes play essential roles in regulating longevity of chronologically active yeast by 
defining cell viability following entry into a quiescent state.  A challenge for the future 
will be to examine whether the pattern established in yeast cells grown under CR 
conditions can be reversed upon their transfer to calorie-rich medium. Another challenge 
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for the future will be to test the validity of the proposed here hypothesis that 
chronologically aging CR yeast protect their mitochondrial nucleoids from oxidative 
damage by turning on the RTG signaling pathway, which then activates transcription of 
ACO1 and other genes encoding bifunctional mtDNA-binding proteins known to 
maintain the integrity of mtDNA under respiratory conditions. It is conceivable that this 
knowledge will be instrumental for designing high-throughput screens aimed at 
discovering novel anti-aging drugs and natural compounds that can increase lifespan by 









3 Caloric restriction (CR) extends yeast chronological lifespan by altering a 
pattern of age-related changes in trehalose concentration 
 
3.1 Abstract 
            The nonreducing disaccharide trehalose has been long considered only as a 
reserve carbohydrate. However, recent studies in yeast suggested that this osmolyte can 
protect cells and cellular proteins from oxidative damage elicited by exogenously added 
reactive oxygen species (ROS). Trehalose has been also shown to affect stability, folding 
and aggregation of bacterial and firefly proteins heterologously expressed in heat-
shocked yeast cells. Our recent investigation of how a lifespan-extending caloric 
restriction (CR) diet alters the metabolic history of chronologically aging yeast suggested 
that their longevity is programmed by the level of metabolic capacity - including 
trehalose biosynthesis and degradation - that yeast cells developed prior to entry into 
quiescence [32]. To investigate whether trehalose homeostasis in chronologically aging 
yeast may play a role in longevity extension by CR, in studies described in this chapter of 
my thesis we examined how single-gene-deletion mutations affecting trehalose 
biosynthesis and degradation impact 1) the age-related dynamics of changes in trehalose 
concentration; 2) yeast chronological lifespan under CR conditions; 3) the chronology of 
oxidative protein damage, intracellular ROS level and protein aggregation; and 4) the 
timeline of thermal inactivation of a protein in heat-shocked yeast cells and its 
subsequent reactivation in yeast returned to low temperature. Our data imply that CR 
extends yeast chronological lifespan in part by altering a pattern of age-related changes in 
trehalose concentration. We outline a model for molecular mechanisms underlying the 
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essential role of trehalose in defining yeast longevity by modulating protein folding, 




          CR, a dietary regimen in which only calorie intake is reduced but the supply of 
amino acids, vitamins and other nutrients is not compromised, is known to have the most 
profound longevity-extending effect across phyla and to improve overall health by 
delaying the onset of age-related diseases [3, 9, 47 - 49, 168]. The longevity benefit 
associated with CR is mediated by a signaling network that integrates the insulin/insulin-
like growth factor 1 (IGF-1), AMP-activated protein kinase/target of rapamycin 
(AMPK/TOR) and cAMP/protein kinase A (cAMP/PKA) longevity regulation pathways 
and governs a distinct group of cellular processes [3, 9, 30, 33, 36, 40]. Our recent 
investigation of how CR alters the metabolic history of chronologically aging yeast 
suggested that trehalose metabolism is one of these longevity-defining processes [32]. 
Trehalose is a nonreducing disaccharide that until recently has been considered only as a 
reserve carbohydrate [169]. However, the demonstrated abilities of this osmolyte to 
protect yeast cells and cellular proteins from oxidative damage caused by exogenously 
added ROS [170] and to impact stability, folding and aggregation of bacterial and firefly 
proteins heterologously expressed in heat-shocked yeast [171, 172] suggested that 
trehalose may exhibit similar effects on endogenous proteins in cells of yeast and other 
organisms [171 - 174]. It is conceivable therefore that trehalose may be involved in 
modulating cellular protein homeostasis (proteostasis). By maintaining proper synthesis, 
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post-translational modifications, folding, trafficking, degradation and turnover of proteins 
within a cell, an evolutionarily conserved proteostasis network governs various cellular 
activities, influences diverse age-related pathologies, and defines organismal healthspan 
and longevity [175, 176]. 
          To evaluate a potential role of trehalose in lifespan extension by CR, in studies 
described in this chapter of the thesis we monitored how single-gene-deletion mutations 
that alter trehalose concentrations in pre-quiescent and quiescent yeast cells affect 
longevity of chronologically aging yeast under CR conditions. We also elucidated how 
these mutations influence the chronology of oxidative protein carbonylation, intracellular 
ROS, protein aggregation, thermal inactivation of a protein in heat-shocked yeast cells 
and a subsequent reactivation of this protein in yeast shifted to low temperature. Our 
findings provide evidence that the longevity-extending effect of a CR diet in 
chronologically aging yeast is due in part to a specific pattern of age-related changes in 
trehalose concentration elicited by CR. Based on these findings, we propose a model for 
molecular mechanisms by which trehalose modulates cellular proteostasis throughout 
lifespan, thereby defining yeast longevity.           
 
3.3 Materials and Methods 
Yeast strains and growth conditions 
The wild-type (WT) strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) and single-
gene-deletion mutant strains in the BY4742 genetic background (all from Open 
Biosystems) were grown in YP medium (1% yeast extract, 2% peptone) containing 0.2% 
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glucose as carbon source. Cells were cultured at 30oC with rotational shaking at 200 rpm 
in Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1. 
 
Chronological lifespan assay 
A sample of cells was taken from a culture at a certain time-point. A fraction of the 
sample was diluted in order to determine the total number of cells using a 
hemacytometer. Another fraction of the cell sample was diluted and serial dilutions of 
cells were plated in duplicate onto YP plates containing 2% glucose as carbon source. 
After 2 d of incubation at 30oC, the number of colony forming units (CFU) per plate was 
counted. The number of CFU was defined as the number of viable cells in a sample. For 
each culture, the percentage of viable cells was calculated as follows: (number of viable 
cells per ml/total number of cells per ml) × 100. The percentage of viable cells in mid-
logarithmic phase was set at 100%. The lifespan curves were validated using a 
LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's instructions. 
 
Trehalose concentration measurement 
Preparation of alkali cellular extract and a microanalytic biochemical assay for measuring 
trehalose concentration were performed as previously described [177]. To prepare an 
alkali cellular extract, 2 × 109 cells were harvested by centrifugation for 1 min at 21,000 
× g at 4oC. The cells were washed three times in ice-cold PBS (20 mM KH2PO4/KOH, 
pH 7.5, and 150 mM NaCl). The cell pellet was quickly resuspended in 200 μl of ice-cold 
SHE solution (50 mM NaOH, and 1 mM EDTA), and 800 μl of ice-cold SHE solution 
were added to the cell suspension. The resulting alkali extract was incubated at 60oC for 
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30 min to destroy endogenous enzyme activities and pyridine nucleotides. The extract 
was neutralized by adding 500 μl of THA solution (100 mM Tris/HCl, pH 8.1, and 50 
mM HCl), divided into 150-μl aliquots, quickly frozen in liquid nitrogen, and stored at - 
80oC prior to use. To measure trehalose concentration, 50 μl of alkali extract (recovered 
from the total of 6.5 × 107 cells) were added to 150 μl of trehalose reagent (25 mM 
KH2PO4/KOH, pH 7.5, and 0.02% BSA; with or without 15 mU trehalase (Sigma)). The 
mixture was incubated for 60 min at 37oC. 800 μl of glucose reagent (100 mM Tris/HCl, 
pH 8.1, 2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM NADP+, and mixture of 
hexokinase (7 U) and glucose-6-phosphate dehydrogenase (8 U) (Sigma)) was added and 
the mixture incubated for 30 min at 25oC. The NADPH generated from NADP+ was 
measured fluorimetrically (excitation at 365 nm, emission monitored at 460 nm).  
 
Hexokinase activity measurement  
Preparation of cellular lysate and a microanalytic biochemical assay for measuring 
hexokinase enzymatic activity were performed as previously described [177]. To prepare 
a cellular lysate, 2 × 107 cells were harvested by centrifugation for 1 min at 21,000 × g at 
4oC. The cells were washed three times in ice-cold PBS (20 mM KH2PO4/KOH, pH 7.5, 
and 150 mM NaCl). The cell pellet was quickly resuspended in 800 μl of EB buffer (20 
mM KH2PO4/KOH, pH 7.5, 0.02% BSA, 0.5 mM EDTA, 5 mM β-mercaptoethanol, 25% 
glycerol, and 0.5% Triton X-100) and incubated for 5 min at 25oC. The resulting lysate 
was divided into 40-μl aliquots and stored at - 80oC prior to use. To measure hexokinase 
activity, 4 μl of cellular lysate (recovered from the total of 1 × 105 cells) were added to 
996 μl of hexokinase reagent (100 mM Tris/HCl, pH 8.1, 0.05% BSA, 7 mM MgCl2, 5 
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mM ATP, 5 mM glucose, 0.5 mM DTT, 100 μM NADP+, 0.5% Triton X-100, and 2 U 
glucose-6-phosphate dehydrogenase (Sigma)). The mixture was incubated for 1 h at 
25oC. The NADPH generated from NADP+ was measured fluorimetrically (excitation at 
365 nm, emission monitored at 460 nm). To monitor the extent of thermal inactivation of 
hexokinase in heat-shocked yeast cells and the efficacy of its reactivation during 
subsequent incubation of these cells at low temperature, yeast were grown at 29oC and 
recovered upon entry into a quiescent state at day 7 or following such an entry at day 13. 
These cells were treated with cycloheximide for 5 min at 29oC, heat shocked for 60 min 
at 43oC, then shifted to 29oC and incubated for 60 min. Hexokinase enzymatic activity 
was measured every 15 min of heat shock treatment and every 15 min of the following 
incubation at 29oC. 
 
Immunodetection of carbonyl groups in oxidatively damaged cellular proteins  
Total cell lysates were made by vortexing the cells in ice-cold TCL buffer (25 mM 
MOPS/KOH, pH 7.2, 150 mM NaCl, 50 mM DTT, and 1% CHAPS) with glass beads 
three times for 1 min. Lysates were then centrifuged for 5 min at 21,000 × g at 4oC, and 
the supernatants of total cell lysates were collected. The carbonyl groups of proteins 
recovered in total cell lysates were derivatized to 2,4-dinitrophenylhydrazones using the 
OxyBlotTM Protein Oxidation Detection Kit (Chemicon), according to the manufacturer’s 
instructions. Briefly, total cellular proteins were denatured by adding 12% SDS to an 
equal volume of the total cell lysate containing 10 μg of protein. Denatured proteins were 
incubated with 2,4-dinitrophenylhydrazine for 15 min at room temperature. Proteins were 
separated by 12.5% SDS-PAGE. Immunoblotting using a Trans-Blot SD semi-dry 
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electrophoretic transfer system (Bio-Rad) was performed as described [178]. The 
derivatized carbonyl groups were detected with a 2,4-dinitrophenyl-specific antibody 
(Chemicon) and the Amersham ECL Western Blotting System (GE Healthcare). 
 
ROS measurement 
ROS were measured in live yeast by fluorescence microscopy of Dihydrorhodamine 123 
(DHR) staining according to established procedures [32, 179]. Briefly, 5 Ì 106 cells were 
harvested by centrifugation for 1 min at 21,000 Ì g at room temperature and then 
resuspended in 100 μl of PBS. DHR (Sigma) was added to a final concentration of 10 
μM. Following incubation in the dark for 60 min at room temperature, the cells were 
washed in PBS and then analyzed by fluorescence microscopy. Images were collected 
with a Zeiss Axioplan fluorescence microscope (Zeiss) mounted with a SPOT Insight 2 
megapixel color mosaic digital camera (Spot Diagnostic Instruments). Fluorescence of 
individual DHR-positive cells in arbitrary units was determined by using the UTHSCSA 
Image Tool software (Version 3.0). In each of 3-6 independent experiments, the value of 
median fluorescence was calculated by analyzing at least 800-1000 cells that were 
collected at each time-point. The median fluorescence values were plotted as a function 
of the number of days cells were cultured. 
 
Recovery of insoluble aggregates of denatured proteins 
Insoluble aggregates of denatured proteins were recovered according to established 
procedures [180, 181], with the following modifications. Total cell lysates were made by 
vortexing the cells in ice-cold MBS buffer (25 mM MOPS/KOH, pH 7.2, and 150 mM 
 69
NaCl) with glass beads four times for 1 min. Unbroken cells and cell debris were 
removed by centrifugation for 3 min at 1,000 × g at 4oC. The supernatants of total cell 
lysates were collected and normalized by dilution to a final concentration of 1 mg/ml. 
Equal aliquots of the total cell lysates were supplemented with 3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS; Sigma) to a final 
concentration of 10 mM. CHAPS is a zwitterionic, non-denaturing and electrically 
neutral detergent; although it protects a native state of soluble proteins and efficiently 
solubilizes intrinsic membrane proteins (including proteins associated with lipid raft 
membrane domains), it is unable to solubilize aggregates of denatured proteins [181 - 
184]. After incubation on ice for 30 min, samples were subjected to centrifugation at 
100,000 × g for 30 min at 4oC. The pellet fractions of insoluble aggregates of denatured 




3.4.1 Lifespan extension by CR requires a specific pattern of age-related changes 
in trehalose concentration 
            To evaluate the effect of trehalose on lifespan extension by CR, we incubated WT 
strain and several mutant strains, each carrying a single-gene-deletion mutation affecting 
trehalose biosynthesis or degradation [169], 2001), in YP medium initially containing 
0.2% glucose. We monitored the chronological lifespans of all these strains and assessed 




Figure 3.1. The chronological lifespan of yeast grown under CR conditions can be extended by mutations 
that simultaneously increase trehalose concentration prior to quiescence and reduce trehalose concentration 
following entry into a quiescent state. (A) Outline of metabolic pathways of trehalose biosynthesis and 
degradation. (B, C) The dynamics of age-dependent changes in the intracellular levels of trehalose during 
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chronological aging of wild-type (wt) and mutant strains. (D-G) Survival (D, E) and the mean lifespans (F, 
G) of chronologically aging wt and mutant strains. Each mutant carried a single-gene-deletion mutation that 
affects trehalose biosynthesis or degradation. Cells were cultured in YP medium initially containing 0.2% 
glucose. Data are presented as mean ± SEM (n = 5-6); *p < 0.01 (relative to the mean lifespan of wt strain). 
Abbreviations: D, diauxic growth phase; L, logarithmic growth phase; PD, post-diauxic growth phase; ST, 
stationary growth phase. 
 
            The tps1Δ and tps2Δ mutations, which eliminate two different catalytic subunits 
of the trehalose synthase complex (Figure 3.1A), substantially decreased trehalose 
concentration in yeast cells grown under CR conditions and shortened their lifespans 
(Figures 3.1B and 3.1D). CR yeast whose trehalose level was significantly increased 
before they have entered the non-proliferative stationary (ST) growth phase and remained 
significantly elevated during ST phase - as it was observed in mutant cells lacking the 
Nth1p isozyme of neutral trehalase - were short-lived (Figures 3.1C and 3.1E). Moreover, 
even if trehalose concentration exceeded the level seen in WT only after CR yeast have 
entered ST phase - as it occurred in mutant cells lacking the Nth2p isozyme of neutral 
trehalase - cells had shortened lifespan (Figure 3.1C and 3.1E). 
            Importantly, some genetic manipulations altering trehalose concentration 
extended the lifespan of CR yeast. Specifically, in long-lived mutants lacking the Tsl1p 
or Tps3p regulatory subunit of the trehalose synthase complex, trehalose concentration 
exceeded that in WT until the end of post-diauxic (PD) growth phase, but then in ST 
phase reached a plateau at the level that was 50-70% of that seen in WT (Figures 3.1B 
and 3.1D). Similar dynamics of age-related changes in trehalose concentration was 
observed in the long-lived mutant ath1Δ lacking acid trehalase (Figures 3.1C and 3.1E). 
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            Altogether, these findings imply that the extended chronological lifespan of CR 
yeast (as compared to that of non-CR yeast) can be further prolonged by genetic 
manipulations that simultaneously 1) increase trehalose concentration by 70-160% during 
PD phase, prior to entry into a quiescent state; and 2) reduce trehalose concentration by 
60-80% during ST phase, following entry into quiescence. Thus, lifespan extension by a 
low calorie diet requires a specific pattern of age-related changes in the intracellular level 
of trehalose. 
 
3.4.2 Mutations that increase trehalose concentration prior to entry into 
quiescence reduce oxidative damage to cellular proteins throughout lifespan, 
irrespective of their effects on longevity 
            Trehalose accumulation in exponentially grown yeast cells exposed to elevated 
temperature or to a proteasome inhibitor has been shown to increase their ability to 
survive a subsequent treatment with exogenous ROS and to protect cellular proteins from 
oxidative carbonylation caused by such a treatment [170]. According to the mitochondrial 
free radical theory of aging, the gradual accumulation of macromolecular damage caused 
by mitochondrially produced ROS throughout lifespan accelerates cellular dysfunction 
and later in life leads to a functional decline and increased mortality [185, 186]. Although 
a body of evidence does not validate the core statement of this theory on a casual role of 
ROS generation in aging, the importance of ROS in mediating a stress response to age-
related cellular damage is supported by numerous findings [187 - 192]. To evaluate a 
potential role of trehalose in linking a ROS-dependent oxidative macromolecular damage 
to lifespan extension by CR, we assessed how the tsl1Δ and nth1Δ mutations influence 
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the dynamics of age-related changes in protein carbonylation and ROS in yeast grown 
under CR conditions. 
            Both the tsl1Δ and nth1Δ mutations elevated trehalose concentration (Figures 
3.1B and 3.1C) and reduced oxidative carbonylation of cellular proteins (Figure 3.2A) 
during PD phase, prior to entry into a quiescent state under CR conditions. None of these 
mutations altered ROS levels in pre-quiescent cells limited in calories (Figure 3.2B). 
Thus, it is unlikely that the observed reduction of oxidative damage to cellular proteins in 
pre-quiescent tsl1Δ and nth1Δ cells was due to the previously proposed by Benaroudj et 
al. [170] ability of trehalose, a nonreducing disaccharide, to quench ROS. It is 
conceivable therefore that prior to quiescence trehalose protects cellular proteins from 
oxidative carbonylation (Figure 3.2A) by interacting with their carbonylation-prone 
misfolded and unfolded species. These aberrantly folded protein species are known to be 
much more sensitive to oxidative carbonylation than their properly folded counterparts 
[193, 194]. Several mechanisms responsible for protein stabilization by trehalose 
molecules have been recently proposed [173, 174]. 
            The extent of protein carbonylation reached prior to entry into a quiescent state 
was not significantly altered in tsl1Δ and nth1Δ cells following entry into quiescence 
(Figure 3.2A), likely due to greatly diminished ROS levels observed in quiescent tsl1Δ 
and nth1Δ cells under CR conditions (Figure 3.2B). Trehalose concentration in quiescent 
tsl1Δ cells was substantially lower than that seen in quiescent WT cells (Figure 3.1B). In 
contract, the concentration of trehalose in quiescent nth1Δ cells exceeded the level 
detected in quiescent WT cells (Figure 3.1C). We therefore concluded that genetic 
manipulations that increase trehalose concentration prior to entry into a quiescent state  
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Figure 3.2. Although mutations that in yeast grown under CR conditions increase trehalose concentration 
prior to entry into quiescence do not alter ROS levels, they reduce oxidative damage to cellular proteins 
throughout lifespan. (A) Immunodetection of carbonyl groups in oxidatively damaged cellular proteins in 
chronologically aging wt and mutant strains. (B) The dynamics of age-related changes in intracellular ROS 
levels during chronological aging of wt and mutant strains. wt, tsl1Δ and nth1Δ cells were cultured in YP 
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medium initially containing 0.2% glucose. Data are presented as mean ± SEM (n = 3-4). Abbreviations: D, 
diauxic growth phase; PD, post-diauxic growth phase; ST, stationary growth phase. 
 
reduce oxidative damage to cellular proteins throughout lifespan, regardless of their 
effects on the intracellular concentration of this nonreducing disaccharide following entry 
into quiescence.     
            Although both the tsl1Δ and nth1Δ mutations reduced oxidative carbonylation of 
cellular proteins throughout lifespan (Figure 3.2A), their effects on longevity differed. 
The tsl1Δ mutation extended the chronological lifespan of CR yeast, whereas the nth1Δ 
mutations shortened it (Figures 3.1D – 3.1G). Hence, it is unlikely that the observed 
ability of these genetic manipulations to protect cellular proteins from oxidative damage 
plays a role in defining longevity of chronologically aging yeast under CR conditions. 
 
3.4.3 A pattern of age-related changes in trehalose concentration defines the 
dynamics of protein aggregation throughout lifespan 
            Trehalose has been shown to 1) stabilize bacterial and firefly luciferases in their 
native (folded) states in heat-shocked yeast cells; 2) prevent aggregation and maintain 
non-native (misfolded or partially folded) states of these two luciferases, as well as of 
firefly rhodanese, following their guanidinium-induced denaturation in vitro and in yeast 
cells briefly exposed to elevated temperature; and 3) inhibit the refolding and reactivation 
of these pre-denatured bacterial and firefly proteins in vitro and in yeast cells by 
interfering with chaperone-assisted folding of their non-native (misfolded or partially 
folded) species [171]. It has been predicted that trehalose may exhibit similar effects on 
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the stability, folding and aggregation of endogenous proteins in cells of yeast and other 
organisms [171 – 174]. 
            Furthermore, our investigation of how a CR diet affects the metabolic history of 
chronologically aging yeast suggested that the elevated level of trehalose observed prior 
to entry into quiescence in slowly aging CR yeast (as compared to that seen in rapidly 
aging non-CR yeast) protects from aggregation proteins that have been completely or 
partially unfolded and/or oxidatively carbonylated due to their exposure to intracellular 
ROS [32]. We hypothesized that such protective effect of high trehalose concentrations 
could contribute to the enhanced survival of CR yeast (as compared to survival of non-
CR yeast) following their entry into quiescence [32]. 
            Moreover, we also hypothesized that a dietary or genetic intervention providing 
yeast with the ability to maintain trehalose concentration at a certain ‘‘optimal” level 
prior and following entry into a quiescent state would extend their longevity [32]. We 
predicted that at such an “optimal” level trehalose concentration is 1) sufficiently high 
prior to entry into quiescence to allow this osmolyte to prevent aggregation of proteins 
that have been completely or partially unfolded and/or oxidatively carbonylated; and 2) 
sufficiently low following entry into quiescence to reduce the efficiency with which 
trehalose inhibits the refolding and reactivation of partially unfolded and/or oxidatively 
carbonylated proteins [32]. 
            To test the validity of our hypothesis, we assessed how the tsl1Δ and nth1Δ 
mutations influence the dynamics of age-related changes in the extent of protein 
aggregation in yeast limited in calories. We found that both these mutations, which we 
demonstrated to elevate trehalose concentration (Figures 3.1B and 3.1C) and to decrease  
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Figure 3.3. In yeast grown under CR conditions, a pattern of age-related changes in trehalose concentration 
defines the dynamics of protein aggregation throughout lifespan. Total cell lysates were made by vortexing 
the cells in ice-cold buffer with glass beads. Unbroken cells and cell debris were removed by centrifugation 
for 3 min at 1,000 × g at 4oC. The supernatants of total cell lysates were collected and normalized by 
dilution to a final concentration of 1 mg/ml. Equal aliquots of the total cell lysates were supplemented with 
CHAPS, a zwitterionic, non-denaturing and electrically neutral detergent that protects a native state of 
soluble proteins and efficiently solubilizes membrane proteins, but is unable to solubilize aggregates of 
denatured proteins. After incubation on ice for 30 min, samples were subjected to centrifugation at 100,000 
× g for 30 min at 4oC. The pellet fractions of insoluble aggregates of denatured proteins were analyzed by 
12.5% SDS-PAGE, followed by silver staining. wt, tsl1Δ and nth1Δ cells were cultured in YP medium 
initially containing 0.2% glucose. Abbreviations: D, diauxic growth phase; PD, post-diauxic growth phase; 
ST, stationary growth phase. 
 
oxidative protein carbonylation (Figure 3.2A) during PD phase under CR conditions, 
significantly reduce the extent of aggregation of cellular proteins during this growth 
phase preceding entry into a quiescent state (Figure 3.3). Following entry into 
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quiescence, the extent of protein aggregation in tsl1Δ cells was substantially lower than 
that seen in quiescent WT cells and especially in quiescent nth1Δ cells (Figure 3.3). As 
we mentioned above, trehalose concentration in quiescent tsl1Δ cells was significantly 
reduced as compared to that in WT (Figure 3.1B) and especially in nth1Δ (Figure 3.1C) 
cells reached reproductive maturation. Furthermore, both the concentration of trehalose 
(Figures 3.1B and 3.1C) and the extent of protein aggregation (Figure 3.3) in quiescent 
nth1Δ cells were significantly higher than that observed in WT cells and especially in 
tsl1Δ cells entered a quiescent state. 
          In sum, these findings validate our hypothesis in which a genetic intervention will 
extend longevity of calorically restricted yeast if it 1) elevates trehalose concentration 
prior to entry into quiescence to allow this osmolytic disaccharide to prevent aggregation 
of completely or partially unfolded and/or oxidatively carbonylated cellular proteins; and 
2) reduces the concentration of  trehalose following entry into quiescence to limit its 
inhibitory effect on the refolding and reactivation of partially unfolded and/or oxidatively 
carbonylated proteins. 
 
3.4.4 Trehalose concentration in yeast cells defines the sensitivity of an endogenous 
enzyme to thermal inactivation and the extent of its subsequent reactivation 
at low temperature 
            To use a complementary experimental approach for validating our hypothesis on a 
longevity-defining role of trehalose concentration in maintaining biological activities of 
proteins in chronologically aging yeast under CR conditions, we assessed how the tsl1Δ 
and nth1Δ mutations influence 1) the extent of thermal inactivation of hexokinase, an 
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endogenous enzyme protein, in heat-shocked yeast cells; and 2) the efficacy of its 
reactivation during subsequent incubation of these cells at low temperature. In these 
experiments, yeast grown at 29oC  and recovered upon entry into a quiescent state or 
following such an entry were treated with cycloheximide for 5 min at 29oC, heat shocked 
for 60 min at 43oC, then shifted to 29oC and incubated for 60 min (Figure 3.4).        
            In tsl1Δ and nth1Δ cells recovered at day 7, upon entry into a quiescent state, the 
activity of hexokinase synthesized prior to a cycloheximide-induced inhibition of protein 
synthesis at 29oC was significantly less susceptible to thermal inactivation at 43oC than in 
identically treated and chronologically aged WT cells (Figure 3.4C). Under these 
conditions, trehalose concentrations in both tsl1Δ and nth1Δ cells significantly exceeded 
that in WT cells of the same chronological age (Figure 3.4A). If cells were recovered at 
day 13, following entry into a quiescent state, hexokinase activity in tsl1Δ cells having a 
lower trehalose concentration than WT cells (Figure 3.4B) was more susceptible to the 
thermal inactivation at 43oC then in WT cells (Figure 3.4D). In contrast, in nth1Δ cells 
recovered at day 13 and having a higher trehalose concentration then WT cells of the 
same chronological age (Figure 3.4B) hexokinase activity was less susceptible to such 
thermal inactivation then in WT cells (Figure 3.4D). These findings imply that in 
calorically restricted pre-quiescent yeast trehalose preserves biological activities of 
partially inactivated cellular proteins, perhaps by stabilizing their native (folded) state, 
preventing their unfolding and/or inhibiting their subsequent aggregation.       
            In tsl1Δ and nth1Δ cells recovered at day 7, upon entry into quiescence, the 
reactivation of thermally inactivated hexokinase during the subsequent incubation at low 
temperature occurred significantly less efficient then in WT cells of the same  
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Figure 3.4. In yeast grown under CR conditions, trehalose concentration defines the sensitivity of 
hexokinase, an endogenous enzyme, to thermal inactivation and the extent of its subsequent reactivation at 
low temperature. Yeast cells grown at 29oC were recovered upon entry into a quiescent state at day 7 or 
following such an entry at day 13. The cells were treated with cycloheximide for 5 min at 29oC to inhibit 
protein synthesis, heat shocked for 60 min at 43oC, then shifted to 29oC and incubated for 60 min. (A, B) 
The intracellular levels of trehalose prior to cell treatment with cycloheximide. (C, D) Changes in 
hexokinase enzymatic activity following cell exposure to cycloheximide, during heat shock treatment for 
60 min at 43oC and subsequent incubation for 60 min at 29oC.  wt, tsl1Δ and nth1Δ cells were cultured in 
YP medium initially containing 0.2% glucose. Data are presented as mean ± SEM (n = 3-5). Abbreviations: 
CHX, cycloheximide; PD, post-diauxic growth phase; ST, stationary growth phase. 
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chronological age (Figure 3.4C). Noteworthy, the efficacy of such hexokinase 
reactivation was inversely proportional to trehalose concentration in yeast cells that 
reached a transition to a quiescent state (Figures 3.4A and 3.4C). If cells were recovered 
at day 13, following entry into a quiescent state, the reactivation of thermally inactivated 
hexokinase during the subsequent incubation at low temperature occurred only in tsl1Δ 
cells having significantly lower trehalose concentration as compared to WT and 
especially to nth11Δ cells of the same chronological age (Figures 3.4B and 3.4D). In 
nth1Δ cells recovered at day 13 and having a higher trehalose concentration then WT 
cells of the same chronological age (Figure 3.4B), thermally inactivated hexokinase was 
further inactivated during the subsequent incubation at low temperature with the 
efficiency exceeding that in WT cells (Figure 3.4D).  These findings imply that in 
calorically restricted quiescent yeast trehalose inhibits the reactivation of inactivated 
cellular proteins, perhaps by interfering with chaperone-assisted folding of their non-
native (misfolded or partially folded) species. 
 
3.5 Discussion  
            To investigate whether trehalose homeostasis in yeast cells may play a role in 
longevity extension by CR, we assessed how single-gene-deletion mutations that in 
chronologically aging yeast alter trehalose concentrations prior to quiescence and 
following entry into a quiescent state impact lifespan. We also examined the effects of 
these mutations on the chronology of oxidative protein carbonylation, intracellular ROS, 
protein aggregation, thermal inactivation of a protein in heat-shocked yeast cells and a 
subsequent reactivation of this protein in yeast shifted to low temperature. Our findings 
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provide evidence that CR extends yeast chronological lifespan in part by altering a 
pattern of age-related changes in trehalose concentration. Based on our data, we propose 
a model for molecular mechanisms underlying the essential role of trehalose in defining 
yeast longevity by modulating cellular proteostasis throughout lifespan (Figure 3.5). This 
outlined below model adequately explains how genetic interventions altering a pattern of 
age-related changes in trehalose concentration influence a longevity-defining balance 
between protein folding, misfolding, unfolding, refolding, oxidative damage, solubility 
and aggregation. 
            Pre-quiescent WT cells proliferating under CR conditions cope with a flow of 
misfolded, partially folded and unfolded protein species in the non-native folding state 
(Figure 3.5A, process 1). The continuous formation of these protein species within a 
proliferating cell is due to a number of factors, including 1) macromolecular crowding, 
which is caused by the very high intracellular protein concentration and leads to 
inappropriate intermolecular contacts; 2) stochastic fluctuations in protein structure; 3) 
transcriptional errors; 4) inherited genetic polymorphisms, including gene copy number 
variations; 5) intrinsic errors in gene expression that may create an excess of 
unassembled subunits of oligomeric protein complexes; 6) errors in protein translation – 
such as missense incorporation of amino acids, frame-shifting, stop-codon readthrough 
and premature termination; 7) defects in posttranslational protein modifications and 
turnover; and 8) inefficient translocation of secretory and mitochondrial precursor 
proteins across membranes of their target organelles [195 - 197]. In pre-quiescent WT 
cells, trehalose stabilizes the native state of proteins and thereby reduces the formation of 
their aberrantly folded species (Figure 3.5A, process 2). The promoted by trehalose shift  
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Figure 3.5. A model for molecular mechanisms underlying the essential role of trehalose in defining yeast 
longevity by modulating cellular proteostasis throughout lifespan. The outlined model adequately explains 
how the tsl1Δ and nth1Δ mutations altering a pattern of age-related changes in trehalose concentration 
influence a longevity-defining balance between protein folding, misfolding, unfolding, refolding, oxidative 
damage, solubility and aggregation. See text for details. The thickness of arrows and T bars correlates with 
the rates of the processes taking place in chronologically aging yeast prior to entry into a quiescent state 
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and following such an entry under CR conditions. T bars denote inhibition of the process. Abbreviation: 
ROS, reactive oxygen species. 
 
of a balance between native and non-native protein folding states towards properly folded 
protein species is amplified by the tsl1Δ and nth1Δ mutations, both of which significantly 
elevate trehalose concentration prior to entry into a quiescent state (Figures 3.5B and 
3.5C, process 2). Our finding that the enzymatic activity of an endogenous hexokinase 
synthesized prior to a cycloheximide-induced inhibition of protein synthesis at 29oC in 
pre-quiescent tsl1Δ and nth1Δ cells is significantly less susceptible to thermal inactivation 
at 43oC than in identically treated and chronologically aged WT cells (Figure 3.4C) 
supports the role of trehalose in stabilizing the native state of cellular proteins. Moreover, 
a previously demonstrated ability of trehalose to stabilize bacterial and firefly luciferases 
in their native states in heat-shocked yeast cells [171] provides additional support for the 
validity of our conclusion on the essential role of this osmolyte in shifting a balance 
between native and non-native protein folding states towards native folding structures. It 
is conceivable that trehalose may stabilize the native state of proteins in pre-quiescent 
yeast cells via any of the three recently proposed mechanisms [173, 174]. 
            In pre-quiescent WT cells, the aberrantly folded protein species that have not been 
refolded into functional three-dimensional native conformations or degraded within an 
elaborate network of molecular chaperones and protein degradation factors [195 - 197] 
form insoluble aggregates (Figure 3.5A, process 3). In these cells, trehalose reduces the 
formation of such protein aggregates, perhaps by shielding the contiguous exposed 
hydrophobic side chains of amino acids that are abundant in misfolded, partially folded 
and unfolded protein species and promote their aggregation (Figure 3.5A, process 4). Our 
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finding that the tsl1Δ and nth1Δ mutations, both of which elevate trehalose concentration 
prior to entry into quiescence (Figures 3.1B and 3.1C), significantly reduce the extent of 
protein aggregation in pre-quiescent cells (Figure 3.3) supports the essential role of 
trehalose in preventing the formation of insoluble protein aggregates in these 
proliferation-competent cells (Figures 3.5B and 3.5C, process 4). Moreover, a previously 
demonstrated ability of trehalose to prevent aggregation and maintain non-native states of 
bacterial and firefly luciferases, as well as of firefly rhodanese, following their 
guanidinium-induced denaturation in vitro and in heat-shocked yeast cells [171] further 
validates our conclusion that trehalose inhibits aggregation of the aberrantly folded 
protein species accumulating in pre-quiescent yeast.  
            The misfolded, partially folded and unfolded protein species present in pre-
quiescent WT cells are known to be more sensitive to ROS-driven oxidative 
carbonylation than their properly folded counterparts [193, 194]. These cells accumulate 
substantial levels of ROS (Figure 3.2B), which oxidatively damage a pool of the 
aberrantly folded and unfolded proteins (Figure 3.2A) prior to entry into a quiescent state 
(Figure 3.5A, process 5). Prior to quiescence, trehalose protects cellular proteins from 
oxidative carbonylation by interacting with their carbonylation-prone misfolded and 
unfolded species (Figure 3.5A, process 4) but not by quenching ROS (as it has been 
previously proposed by Benaroudj et al. [170]. In support of this mechanism for the 
protection of proteins from ROS-elicited oxidative damage by trehalose, we found that in 
pre-quiescent cells the tsl1Δ and nth1Δ mutations reduce oxidative carbonylation of 
cellular proteins (Figure 3.2A) but do not alter ROS levels (Figure 3.2B; Figures 3.5B 
and 3.5C, process 5). 
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            The oxidatively carbonylated protein species present in pre-quiescent WT cells 
are known to have a tendency to form insoluble aggregates that escape degradation and 
can compromise the cellular proteostasis network by inhibiting the proteasomal protein 
degradation machinery [193, 194, 198]. By protecting cellular proteins from oxidative 
carbonylation (Figure 3.5A, process 5; see above), trehalose reduces the formation of 
insoluble protein aggregates prior to entry into senescence (Figure 3.5A, process 6). This 
indirect inhibitory effect of trehalose on protein aggregation supplements its direct 
inhibition by trehalose (Figure 3.5A, process 3; see above), which could shield the 
patches of exposed hydrophobic side chains of amino acids tending to promote 
aggregation of aberrantly folded and unfolded protein species (Figure 3.5A, process 4; 
see above).   
            Following entry into a quiescent state, a network of molecular chaperones in WT 
cells promotes a refolding of misfolded, partially folded and unfolded protein species, 
either soluble or extracted from protein aggregates accumulated in pre-quiescent cells 
(Figure 3.5A, processes 7 and 8). This chaperone-assisted refolding of aberrantly folded 
protein species is the essential anti-aging process [195, 197 - 199]. By shielding the 
contiguous exposed hydrophobic side chains of amino acids that are abundant in 
misfolded, partially folded and unfolded protein species, trehalose in quiescent WT cells 
competes with molecular chaperones for binding with these patches of hydrophobic 
amino acid residues (Figure 3.5A, processes 9 and 10) known to be mandatory for 
enabling the chaperone-assisted refolding of aberrantly folded protein species [195, 197 - 
199]. By interfering with this essential anti-aging process in quiescent WT cells, trehalose 
operates as a pro-aging compound (Figure 3.5A). In support of our hypothesis that this 
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mechanism underlies the essential role of trehalose homeostasis in defining longevity of 
chronologically aging yeast under CR conditions (Figures 3.5B and 3.5C, processes 9 and 
10) we found that 1) the tsl1Δ mutation reduces trehalose concentration following entry 
into quiescence (Figure 3.1B), decreases the extent of protein aggregation in quiescent 
cells (Figure 3.3) and extends yeast chronological lifespan (Figure 3.1D); and 2) the 
nth1Δ mutation elevates trehalose concentration following entry into quiescence (Figure 
3.1C), increases the extent of protein aggregation in quiescent cells (Figure 3.3) and 
shortens yeast chronological lifespan (Figure 3.1E). 
            The major challenge now is to get a greater insight into the proposed mechanism 
underlying the essential role of trehalose homeostasis in defining longevity of 
chronologically aging yeast under lifespan-extending CR conditions. To address this 
challenge, many important questions need to be answered. What are the identities of 
oxidatively damaged proteins whose accumulation in pre-quiescent WT cells 
proliferating under CR conditions is reduced by genetic manipulations that elevate 
trehalose concentration prior to entry into quiescence (Figure 3.2A)? Are these proteins 
known for their essential role in defining longevity? Will genetic manipulations 
eliminating any of these proteins or altering their levels affect the chronological lifespan 
of yeast? What kind of proteins form insoluble aggregates that accumulate, in a trehalose-
dependent fashion, in WT cells prior to and/or following entry into a quiescent state 
(Figure 3.3)? Are they known to be modifiers of lifespan in yeast? How will genetic 
manipulations eliminating any of these proteins or altering their levels influence 
longevity of chronologically aging yeast? Do oxidatively damaged and/or aggregated 
protein species concentrate in certain protein quality control compartments, such as the 
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juxtanuclear quality control compartment, the insoluble protein deposit compartment 
and/or aggresome [195, 200, 201], or are they randomly distributed throughout a cell 
prior to and/or following entry into quiescence? Does trehalose reside, permanently or 
temporarily, in any of these protein quality control compartments or is this osmolyte 
dispersed within a cell before and/or after it enters a quiescent state? What molecular 
chaperones constitute the proteostasis machinery whose ability to refold aberrantly folded 
proteins is compromised by trehalose in quiescent cells? We shall have to answer these 
important questions if we want to understand the complexity of the proteostasis network 




            Findings presented in this chapter of my thesis provide evidence that CR extends 
yeast chronological lifespan in part by altering a pattern of age-related changes in 
trehalose concentration. Based on these findings, we propose a model for molecular 
mechanisms underlying the essential role of trehalose in defining yeast longevity by 
modulating cellular proteostasis throughout lifespan. A challenge now is to get a greater 
insight into these mechanisms. To name just some of the many important questions 
needed to be answered to address this challenge, we need to 1) identify the oxidatively 
damaged proteins whose accumulation in pre-quiescent yeast cells proliferating under CR 
conditions is reduced by genetic manipulations that elevate trehalose concentration prior 
to entry into quiescence; 2) establish the identities of proteins forming insoluble 
aggregates that accumulate in yeast cells prior to and/or following entry into a quiescent 
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state; and 3) define molecular chaperones constituting the proteostasis machinery whose 
ability to refold aberrantly folded proteins is compromised by trehalose in quiescent cells. 
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4 A proper balance between the biosynthesis and degradation of glycogen is 
obligatory for lifespan extension by caloric restriction (CR) 
 
4.1 Abstract 
            Our recent comparative analysis of cellular proteomes of CR and non-CR yeast  
revealed that the administration of a low-calorie diet increased the levels of key enzymes  
involved in the biosynthesis of glycogen [32], known to be the major glucose store in  
yeast [169]. Moreover, CR reduced the levels of key enzymes catalyzing the degradation  
of glycogen in chronologically aging yeast [32]. To evaluate a potential role of glycogen 
metabolism in lifespan extension by CR, in studies described in this chapter of the thesis 
we monitored the dynamics of age-related changes in its intracellular level. We also 
assessed how various single-gene-deletion mutations that differently alter glycogen 
concentrations in pre-quiescent and quiescent yeast cells affect longevity of  
chronologically aging yeast under CR conditions. Our findings provide evidence that a 
proper balance between the biosynthesis and degradation of glycogen is obligatory for 
lifespan extension by CR. 
 
4.2 Introduction 
            To make another step towards the use of metabolic control analysis (MCA) for 
defining the molecular causes of cellular aging by elucidating the effect of CR on the 
metabolic history of chronologically aging yeast, our laboratory recently carried out the 
mass spectrometry-based identification and quantitation of proteins recovered in total cell 
lysates of aging CR and non-CR cells [32]. Our comparative analysis of cellular 
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proteomes of CR and non-CR yeast revealed that CR altered the levels of numerous 
proteins that function in various processes (Figure 4.1). Noteworthy, CR increased the 
levels of key enzymes involved in the biosynthesis of glycogen (Figure 4.1), known to be 
the major glucose store in yeast [169]. Moreover, the administration of this low-calorie 
dietary regimen resulted in a reduction of the levels of key enzymes catalyzing the 
degradation of glycogen (Figure 4.1).     
            To evaluate a potential role of glycogen metabolism in lifespan extension by CR, 
in studies described in this chapter of the thesis we monitored the dynamics of age-related 
changes in its intracellular level. We also assessed how various single-gene-deletion 
mutations that differently alter glycogen concentrations in pre-quiescent and quiescent 
yeast cells affect longevity of chronologically aging yeast under CR conditions. Our 
findings provide evidence that a proper balance between the biosynthesis and degradation 
of glycogen is obligatory for lifespan extension by CR.  
 
4.3 Materials and Methods 
Strains and media  
The wild-type strain Saccharomyces cerevisiae BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0) and mutant strains glg2Δ (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 
glg2Δ::kanMX4), glc3Δ (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 glc3Δ::kanMX4), gsy2Δ 
(MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 gsy2Δ::kanMX4), pig1Δ (MATα his3Δ1 leu2Δ0 
lys2Δ0 ura3Δ0 pig1Δ::kanMX4), pcl8Δ (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 
pcl8Δ::kanMX4), gph1Δ (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 gph1Δ::kanMX4), gdb1Δ 




Figure 4.1. In chronologically aging yeast cells, CR alters the abundance of proteins that function in 
carbohydrate and lipid metabolism, stress protection, ROS detoxification, and essential processes confined 
to mitochondria. Relative levels (fold difference relative to that on 2% glucose) of proteins recovered in 
total lysates of yeast cells are shown. Proteins were identified and quantitated using mass spectrometry. The 
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complete list of proteins and their relative levels are provided in [32] (Tables S1 and S2, respectively). 
From the data of proteomic analysis, we inferred an outline of metabolic pathways and interorganellar 
communications that were activated (red arrows) or inhibited (green arrows) by CR prior to entry of yeast 
into the non-proliferative ST phase. Abbreviations: Ac-CoA, acetyl-CoA; AcOH, acetic acid; DAG, 
diacylglycerols; EE, ethyl esters; ER, endoplasmic reticulum; ERG, ergosterol; EtOH, ethanol; FA-CoA, 
CoA esters of fatty acids; FFA, free fatty acids; LB, lipid bodies; PL, phospholipids; ROS, reactive oxygen 
species; TAG, triacylglycerols; TCA, the tricarboxylic acid cycle in mitochondria. 
 
lys2Δ0 ura3Δ0 snf1Δ::kanMX4) and tpk1Δ (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 
tpk1Δ::kanMX4) (all from Open Biosystems) were grown in YP medium (1% yeast 
extract, 2% peptone) containing 0.2%, 0.5%, 1% or 2% glucose as carbon source. Cells 
were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask 
volume/medium volume” ratio of 5:1. 
 
Chronological lifespan assay 
A sample of cells was taken from a culture at a certain time-point. A fraction of the 
sample was diluted in order to determine the total number of cells using a 
hemacytometer. Another fraction of the cell sample was diluted and serial dilutions of 
cells were plated in duplicate onto YP plates containing 2% glucose as carbon source. 
After 2 d of incubation at 30oC, the number of colony forming units (CFU) per plate was 
counted. The number of CFU was defined as the number of viable cells in a sample. For 
each culture, the percentage of viable cells was calculated as follows: (number of viable 
cells per ml/total number of cells per ml) × 100. The percentage of viable cells in mid-
logarithmic phase was set at 100%. The lifespan curves were validated using a 
LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's instructions. 
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Glycogen concentration measurement 
Preparation of alkali cellular extract and a microanalytic biochemical assay for measuring 
glycogen concentration were performed as previously described [177]. To prepare an 
alkali cellular extract, 2 × 109 cells were harvested by centrifugation for 1 min at 21,000 
× g at 4oC. The cells were washed three times in ice-cold PBS (20 mM KH2PO4/KOH, 
pH 7.5, and 150 mM NaCl). The cell pellet was quickly resuspended in 200 μl of ice-cold 
SHE solution (50 mM NaOH, and 1 mM EDTA), and 800 μl of ice-cold SHE solution 
were added to the cell suspension. The resulting alkali extract was incubated at 60oC for 
30 min to destroy endogenous enzyme activities and pyridine nucleotides. The extract 
was neutralized by adding 500 μl of THA solution (100 mM Tris/HCl, pH 8.1, and 50 
mM HCl), divided into 150-μl aliquots, quickly frozen in liquid nitrogen, and stored at - 
80oC prior to use. To measure glycogen concentration, 50 μl of alkali extract (recovered 
from the total of 6.5 × 107 cells) were added to 500 μl of glycogen reagent [50 mM 
sodium acetate, pH 4.6, 0.02% BSA; with or without 5 μg/ml amyloglucosidase (14 
U/mg; Roche)]. The mixture was incubated for 30 min at 25oC. 500 μl of glucose reagent 
[100 mM Tris/HCl, pH 8.1, 2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM NADP+, 5 
μg/ml glucose-6-phosphate dehydrogenase (Sigma), 20 μg/ml hexokinase (450 U/mg; 
Roche) was added and the mixture incubated for 30 min at 25oC. The NADPH generated 








Figure 4.2. CR remodels glycogen metabolism. (A) Outline of metabolic pathways and interorganellar 
communications operating in chronologically aging yeast. (B, C) The dynamics of age-dependent changes 
in the intracellular levels of glycogen during chronological aging of yeast. Cells were cultured in YP 
medium initially containing 0.2%, 0.5%, 1% or 2% glucose. Data are presented as mean ± SEM (n = 4-6). 
For glycogen levels, p < 0.001 at days 3 to 21 for cells grown on 0.2% or 0.5% glucose versus cells grown 
on 2% glucose. Abbreviations: Ac-CoA, acetyl-CoA; AcOH, acetic acid; DAG, diacylglycerols; EE, ethyl 
esters; ER, endoplasmic reticulum; ERG, ergosterol; EtOH, ethanol; FA-CoA, CoA esters of fatty acids; 
FFA, free fatty acids; LB, lipid bodies; PL, phospholipids; TAG, triacylglycerols; TCA, the tricarboxylic 





4.4.1    CR remodels glycogen metabolism  
            Our monitoring of the dynamics of age-related changes in glycogen concentration 
revealed that the intracellular levels of this major reserve carbohydrate in yeast [169] 
increased sharply in L phase, regardless of initial glucose concentration in the medium 
(Figure 4.2B). During the subsequent D and PD phases, CR yeast continued to 
accumulate glycogen, whereas non-CR yeast rapidly consumed it (Figure 4.2C). In 
contrast to non-CR yeast, yeast under CR began to degrade their reserved glycogen only 
when they entered ST phase (Figure 4.2C). Of note, the degree of CR influenced both 
glycogen storage and its consumption. In fact, CR yeast grown on 0.5% glucose reserved 
more glycogen by the end of PD phase and then consumed it in ST phase somewhat 
faster, as compared to CR yeast grown on 0.2% glucose (Figure 4.2C).  
 
4.4.2 The maintenance of a proper balance between the biosynthesis and 
degradation of glycogen is mandatory for lifespan extension by CR  
            We next used a collection of mutants, each lacking a single protein that functions 
in glycogen biosynthesis or degradation (Figure 4.3A) [169], for functional analysis of 
the role for age-dependent glycogen dynamics in lifespan extension by CR. We found 
that any genetic manipulation that substantially reduced glycogen concentration in CR 
cells entering ST phase of growth on 0.2% glucose shortened their chronological lifespan. 
This pattern was seen in mutants that lacked 1) the Glg2p isoform of self-glucosylating 
glycogenin glucosyltransferase; 2) the Gsy2p isoform of glycogen synthase; 3) Gac1p, 
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Pig1p or Snf1p, all of which promote the dephosphorylation and activation of Gsy2p; or 
4) the glycogen branching enzyme Glc3p (Figures 4.3B – 4.3D). Our findings also 
revealed that the chronological lifespan of CR yeast could be prolonged only by a genetic 
manipulation that simultaneously accelerates 1) glycogen biosynthesis during growth 
phases preceding ST phase; and 2) glycogen degradation during ST phase. In fact, lack of 
some proteins, although accelerated glycogen biosynthesis during growth phases 
preceding ST phase, impaired glycogen degradation during ST phase and resulted in a 
shortened lifespan. We observed this pattern in mutants that lacked 1) the Pcl8p or 
Pho85p, each promoting the phosphorylation and inactivation of Gsy2p; or 2) the Gph1p 
isoform of glycogen phosphorylase (Figures 4.3B – 4.3D). Only in the tpk1Δ mutant,  
 
Figure 4.3. CR extends lifespan in part by maintaining a proper balance between the biosynthesis and 
degradation of glycogen. (A) Outline of metabolic pathways of glycogen biosynthesis and degradation. (B) 
The mean lifespans of WT and mutant strains. Each mutant lacked a single enzyme that functions in 
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glycogen biosynthesis or degradation. Each plot represents the average of 2-3 experiments; error bars show 
SEM. (C, D) Glycogen concentrations in cells of a WT strain and mutant strains. Each mutant carried a 
single-gene-deletion mutation that affects glycogen biosynthesis or degradation. Each plot shows a 
representative experiment repeated 2-3 times with similar results. (B-D) Cells were cultured in YP medium 
initially containing 0.2% glucose. 
 
which lacked the catalytic subunit Tpk1p of cAMP-dependent protein kinase, the 
acceleration of both glycogen biosynthesis prior to ST phase and glycogen degradation 
during ST phase led to a substantially extended lifespan (Figures 4.3B and 4.3D). Of 
note, we found that lifespan was not affected by any of the single-gene-deletion 
mutations that, by eliminating a low-abundance redundant component functioning in 
glycogen biosynthesis or degradation, did not have an effect on concentration of this 
major reserve carbohydrate. This pattern was seen in mutants that lacked 1) the Glg1p 
isoform of self-glucosylating glycogenin glucosyltransferase; 2) the Gsy1p isoform of 
glycogen synthase; or 3) the Gdb1p glycogen debranching enzyme (Figures 4.3B and 
4.3D).  
 
4.5 Discussion  
            Along with other data from our laboratory on the molecular mechanism 
underlying the ability of CR to extend longevity of chronologically aging yeast [32, 40, 
110, 114], findings presented in this chapter of my thesis imply that, by activating the 
synthesis of enzymes catalyzing the biosynthesis of glycogen and by suppressing the 
synthesis of enzymes required for its degradation, CR promotes the accumulation of this 
major reserve carbohydrate. Our functional analysis of the role for age-dependent 
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glycogen dynamics in lifespan extension by CR with the help of a collection of mutants, 
each lacking a single protein that functions in glycogen biosynthesis or degradation, 
provides evidence that lifespan extension by CR relies in part on the establishment of a 
proper balance between the biosynthesis and degradation of glycogen. Current studies in 
our laboratory are aimed at establishing molecular mechanisms underlying the longevity-
defining role of such balance in chronologically aging yeast.  
 
4.6 Conclusions 
            Findings presented in this chapter of my thesis provide conclusive evidence that 
lifespan extension by CR in chronologically aging yeast relies in part on the 
establishment of a proper balance between the biosynthesis and degradation of glycogen, 









            In studies described in this chapter of the thesis, we monitored the dynamics of 
age-related changes in ethanol concentration in chronologically aging yeast cultured 
under CR and non-CR conditions. We also assessed how single-gene-deletion mutations 
eliminating Adh1p (an enzyme that is required for ethanol synthesis) or Adh2p (an 
enzyme that catalyzes ethanol degradation) affect longevity of chronologically aging 
yeast under CR and non-CR conditions. Furthermore, we examined the effects of the 
adh1Δ and adh2Δ mutations on the intracellular levels of trehalose, glycogen, neutral 
lipids, free fatty acids (FFA) and diacylglycerols (DAG) in chronologically aging yeast 
under non-CR conditions. Moreover, we monitored how single-gene-deletion mutations 
eliminating Adh1p or Adh2p influence the abundance of Fox1p, Fox2p and Fox3p, all of 
which are the core enzymes of fatty acid β-oxidation in peroxisomes. Our findings 
provide evidence that ethanol accumulated in yeast placed on a calorie-rich diet represses 
the synthesis of Fox1p, Fox2p and Fox3p, thereby suppressing peroxisomal oxidation of 
FFA that originate from triacylglycerols synthesized in the endoplasmic reticulum (ER) 
and deposited within LBs. The resulting build-up of arrays of FFA (so-called gnarls) 
within LBs of non-CR yeast initiates several negative feedback loops regulating the 
metabolism of triacylglycerols. Due to the action of these negative feedback loops, 
chronologically aging non-CR yeast not only amass triacylglycerols in LBs but also 
accumulate DAG and FFA in the ER. The resulting remodeling of lipid dynamics in 
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chronologically aging non-CR yeast shortens their lifespan by causing their premature 
death due to 1) necrosis triggered by the inability of their peroxisomes to oxidize FFA; 2) 
lipoapoptosis initiated in response to the accumulation of DAG and FFA; and 3) the 
DAG-induced reorganization of the protein kinase C-dependent signal transduction 
network affecting multiple longevity-related cellular targets. 
 
5.2 Introduction 
          Our recent mass spectrometry-based identification and quantitation of proteins 
recovered in total cell lysates of chronologically aging CR and non-CR yeast revealed 
that CR alters the levels of numerous proteins that function in various processes (Figure 
4.1) [32]. Of note, the administration of this low-calorie dietary regimen reduced the level 
of Adh1p (an enzyme that is required for ethanol synthesis) and elevated the level of 
Adh2p (an enzyme that catalyzes ethanol degradation) (Figure 4.1) [32]. 
          To evaluate a potential role of ethanol metabolism in lifespan extension by CR, in 
studies described in this chapter of the thesis we monitored the dynamics of age-related 
changes in its intracellular level. We also assessed how single-gene-deletion mutations 
eliminating Adh1p or Adh2p affect longevity of chronologically aging yeast under CR 
and non-CR conditions. In addition, we examined the effects of the adh1∆ and adh2∆ 
mutations on the intracellular levels of trehalose, glycogen, neutral lipids, free fatty acids 
and diacylglycerols in chronologically aging yeast under non-CR conditions. Moreover, 
we monitored how single-gene-deletion mutations eliminating Adh1p or Adh2p influence 
the abundance of Fox1p, Fox2p and Fox3p, all of which are the core enzymes of fatty 
acid β-oxidation in peroxisomes. Our findings provide evidence that CR extends yeast 
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chronological lifespan by reducing ethanol concentration, thereby causing a remodeling 
of carbohydrate and lipid metabolism. 
 
5.3 Materials and Methods 
Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0) and mutant strains adh1Δ (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 
adh1Δ::kanMX4) and adh2Δ (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 adh2Δ::kanMX4) 
were grown in YP medium (1% yeast extract, 2% peptone) containing 0.2%, 0.5%, 1% or 
2% glucose as carbon source. Cells were cultured at 30oC with rotational shaking at 200 
rpm in Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1. 
 
Chronological lifespan assay 
A sample of cells was taken from a culture at a certain time-point. A fraction of the 
sample was diluted in order to determine the total number of cells using a 
hemacytometer. Another fraction of the cell sample was diluted and serial dilutions of 
cells were plated in duplicate onto YP plates containing 2% glucose as carbon source. 
After 2 d of incubation at 30oC, the number of colony forming units (CFU) per plate was 
counted. The number of CFU was defined as the number of viable cells in a sample. For 
each culture, the percentage of viable cells was calculated as follows: (number of viable 
cells per ml/total number of cells per ml) × 100. The percentage of viable cells in mid-
logarithmic phase was set at 100%. The lifespan curves were validated using a 
LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's instructions. 
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Visualization of intracellular lipid bodies (LBs) 
Wild-type and mutant cells grown in YP supplemented with 0.2% glucose were tested 
microscopically for the presence of intracellular LBs by incubation with BODIPY 
493/503. Cells were also probed with a fluorescent counterstain Calcofluor White M2R 
(CW) in order to visualize all cells in the population. BODIPY 493/503 was stored in the 
dark at –20oC as 100 μl aliquots of a 1 mM solution in ethanol. CW was stored in the 
dark at –20oC as the 5 mM stock solution in anhydrous DMSO. 
The concurrent staining of cells with BODIPY 493/503 and CW was carried out as 
follows. The required amounts of the 100 μl BODIPY 493/503 aliquots (1 mM) and of 
the 5 mM stock solution of CW were taken out of the freezer and warmed to room 
temperature. The solutions of DHR and CW were then centrifuged at 21,000 × g for 5 
min in order to clear them of any aggregates of fluorophores. For cell cultures with a titre 
of ~ 107 cells/ml, 100 μl was taken out of the culture to be treated. If the cell titre was 
lower, proportionally larger volumes were used. The samples were then centrifuged at 
21,000 × g for 1 min, and pelleted cells were resuspended in 100 μl of TNT buffer (25 
mM Tris/HCl (pH 7.5), 150 mM NaCl and 0.2 % Triton X-100). After a 10-min 
incubation at room temperature, the samples were centrifuged at 21,000 × g for 1 min. 
Pellets were then resuspended in 100 μl of TN buffer (25 mM Tris/HCl (pH 7.5), 150 
mM NaCl), and the samples were subjected to centrifugation at 21,000 × g for 1 min. 
Pelleted cells were finally resuspended in 100 μl of TN buffer. Each 100 μl aliquot of 
cells was then supplemented with 1 μl of the 1 mM BODIPY 493/503 and 1 μl of the 5 
mM CW solutions. After a 15-min incubation in the dark at room temperature, the 
samples were centrifuged at 21,000 × g for 5 min. Pellets were resuspended in 100 μl of 
 104
TN buffer. The samples were centrifuged again at 21,000 × g for 5 min, and pellets were 
resuspended in 100 μl of TN buffer. 10 μl of the BODIPY 493/503- and CW-treated cell 
suspension was then added to a microscope slide and covered with a coverslip. The slides 
were then sealed using nail polish. Once the slides were prepared, they were visualized 
under the Zeiss Axioplan fluorescence microscope mounted with a SPOT Insight 2 
megapixel color mosaic digital camera.  Several pictures of the cells on each slide were 
taken, with two pictures taken of each frame. One of the two pictures was of the cells 
seen through a fluorescein filter in order to detect cells dyed with BODIPY 493/503. The 
second picture was of the cells seen through a DAPI filter in order to visualize CW, and 
therefore all the cells present in the frame. For evaluating the percentage of BODIPY 
493/503-positive cells, the UTHSCSA Image Tool (Version 3.0) software was used to 
calculate both the total number of cells and the number of stained cells. 
 
Trehalose concentration measurement 
Preparation of alkali cellular extract and a microanalytic biochemical assay for measuring 
trehalose concentration were performed as previously described [177]. To prepare an 
alkali cellular extract, 2 × 109 cells were harvested by centrifugation for 1 min at 21,000 
× g at 4oC. The cells were washed three times in ice-cold PBS (20 mM KH2PO4/KOH, 
pH 7.5, and 150 mM NaCl). The cell pellet was quickly resuspended in 200 μl of ice-cold 
SHE solution (50 mM NaOH, and 1 mM EDTA), and 800 μl of ice-cold SHE solution 
were added to the cell suspension. The resulting alkali extract was incubated at 60oC for 
30 min to destroy endogenous enzyme activities and pyridine nucleotides. The extract 
was neutralized by adding 500 μl of THA solution (100 mM Tris/HCl, pH 8.1, and 50 
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mM HCl), divided into 150-μl aliquots, quickly frozen in liquid nitrogen, and stored at - 
80oC prior to use. To measure trehalose concentration, 50 μl of alkali extract (recovered 
from the total of 6.5 × 107 cells) were added to 150 μl of trehalose reagent (25 mM 
KH2PO4/KOH, pH 7.5, and 0.02% BSA; with or without 15 mU trehalase (Sigma)). The 
mixture was incubated for 60 min at 37oC. 800 μl of glucose reagent (100 mM Tris/HCl, 
pH 8.1, 2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM NADP+, and mixture of 
hexokinase (7 U) and glucose-6-phosphate dehydrogenase (8 U) (Sigma)) was added and 
the mixture incubated for 30 min at 25oC. The NADPH generated from NADP+ was 
measured fluorimetrically (excitation at 365 nm, emission monitored at 460 nm). 
 
Glycogen concentration measurement 
Preparation of alkali cellular extract and a microanalytic biochemical assay for measuring 
glycogen concentration were performed as previously described [177]. To prepare an 
alkali cellular extract, 2 × 109 cells were harvested by centrifugation for 1 min at 21,000 
× g at 4oC. The cells were washed three times in ice-cold PBS (20 mM KH2PO4/KOH, 
pH 7.5, and 150 mM NaCl). The cell pellet was quickly resuspended in 200 μl of ice-cold 
SHE solution (50 mM NaOH, and 1 mM EDTA), and 800 μl of ice-cold SHE solution 
were added to the cell suspension. The resulting alkali extract was incubated at 60oC for 
30 min to destroy endogenous enzyme activities and pyridine nucleotides. The extract 
was neutralized by adding 500 μl of THA solution (100 mM Tris/HCl, pH 8.1, and 50 
mM HCl), divided into 150-μl aliquots, quickly frozen in liquid nitrogen, and stored at - 
80oC prior to use. To measure glycogen concentration, 50 μl of alkali extract (recovered 
from the total of 6.5 × 107 cells) were added to 500 μl of glycogen reagent [50 mM 
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sodium acetate, pH 4.6, 0.02% BSA; with or without 5 μg/ml amyloglucosidase (14 
U/mg; Roche)]. The mixture was incubated for 30 min at 25oC. 500 μl of glucose reagent 
[100 mM Tris/HCl, pH 8.1, 2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM NADP+, 5 
μg/ml glucose-6-phosphate dehydrogenase (Sigma), 20 μg/ml hexokinase (450 U/mg; 
Roche) was added and the mixture incubated for 30 min at 25oC. The NADPH generated 
from NADP+ was measured fluorimetrically (excitation at 365 nm, emission monitored at 
460 nm). 
 
Preparation of total cell lysates 
An aliquot containing 1 × 109 cells was centrifuged for 7 min at 3,000 rpm at room 
temperature. Pelleted cells were washed twice with distilled water and further centrifuged 
for 3 min at 16,000 × g at room temperature. The recovered cell pellet was then 
resuspended in 500 μl of 4% CHAPS in 25 mM Tris/HCl buffer (pH 8.5) and centrifuged 
for 15 sec at 16,000 × g at room temperature. The cells were then washed again, first by 
resuspending them in 500 μl of 4% CHAPS in 25 mM Tris/HCl buffer (pH 8.5) and then 
by centrifuging for 15 sec at 16,000 × g at room temperature. The pellet of washed cells 
was then resuspended in 1 ml of ice-cold 4% CHAPS in 25 mM Tris/HCl buffer (pH 8.5), 
divided into 5 equal aliquots of 200 μl each and placed in Eppendorf tubes kept on ice. 
Each 200 μl aliquot was supplemented with ~100 μl of glass beads and vortexed three 
times for 1 minute. Apart from the vortexing steps, the samples were kept on ice at all 
times. Glass beads and cell debris were then pelleted by 5 min centrifugation at 16,000 × 
g at 4oC.  The resulting supernatant of the glass bead lysate was immediately transferred 
into a pre-chilled Eppendorf tube and stored at -20oC for further analysis. 
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Protein precipitation, SDS-PAGE and immunoblotting 
Protein concentration was determined using the RC DC protein assay kit (Bio-Rad) 
according to the manufacturer's instructions. Proteins were precipitated by adding 
trichloroacetic acid (TCA) to the final concentration of 10%, incubated on ice for 30 min, 
pelleted by centrifugation, and then washed with ice-cold 80% acetone. Dried protein 
pellets were then resuspended in the SDS-PAGE sample buffer and the pH was adjusted 
to neutral using 2 M Tris/HCl (pH 8.8). The samples were boiled for 5 min at 63°C, 
centrifuged for 30 sec at 16,000 x g, loaded onto a 12.5% gel and resolved by SDS-
PAGE. Immunoblotting using a Trans-Blot SD semi-dry electrophoretic transfer system 
(Bio-Rad) were performed as previously described [202]. Blots were decorated with 
monoclonal antibodies raised against actin (Abcam), Fox1p, Fox2p or Fox3p (kind gift of 
Dr. Richard A. Rachubinski, University of Alberta). Antigen-antibody complexes were 
detected by enhanced chemiluminescence using an Amersham ECL Western blotting 
detection reagents (GE Healthcare). 
 
Ethanol and acetic acid concentrations measurement 
1-ml aliquots of yeast cultures were centrifuged for 1 min at 16,000 × g at 4oC and 
supernatants frozen at -80oC. The supernatants were subjected to gas chromatography 
using an Agilent 6890 Networked GC system equipped with a Supelco Equity-1 (0.32 
mm × 30 cm) column and FID detector. Ethanol and acetic acid concentrations were 





Protocols for lipid extraction, separation by TLC, visualization by 5% phosphomolybdic 
acid in ethanol, and quantitation by densitometric analysis of TLC plates have been 




5.4.1 Concentration of ethanol is one of the key factors influencing chronological 
aging 
            As one can expect judging from the reduced level of Adh1p (an enzyme that is 
required for ethanol synthesis) and elevated level of Adh2p (an enzyme that catalyzes 
ethanol degradation) in yeast grown under CR conditions (Figure 4.1), the administration 
of this low-calorie dietary regimen by cell culturing on 0.2% or 0.5% glucose accelerated 
the depletion of ethanol from yeast cells (Figure 5.1B). Thus, the steady-state level of 
ethanol depends on a balance of enzymatic activities of the Adh1p and Adh2p isozymes 
of alcohol dehydrogenase (Figure 5.2A). 
            To evaluate the effect of endogenously produced ethanol on longevity, we 
incubated WT, adh1Δ and adh2Δ strains in media containing different glucose 
concentrations. We monitored the chronological lifespans of these strains and assessed 
the dynamics of changes in ethanol concentration during their aging. When yeast were 
placed on the CR diet by incubating them on 0.2% or 0.5% glucose, lack of Adh1p or 
Adh2p did not affect ethanol concentration (Figures 5.2B and 5.2C) or chronological 
lifespan (Figures 5.2F and 5.2G). Conversely, lack of Adh1p substantially decreased  
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Figure 5.1. CR accelerates ethanol catabolism. (A) Outline of metabolic pathways and interorganellar 
communications operating in chronologically aging yeast. (B) The dynamics of age-dependent changes in 
the extracellular concentrations of ethanol during chronological aging of wild-type yeast strain. Cells were 
cultured in rich YP medium initially containing 0.2%, 0.5%, 1% or 2% glucose. Data are presented as mean 
± SEM (n = 3-5). For ethanol levels, p < 0.001 at days 1 to 9 for cells grown on 0.2% or 0.5% glucose 
versus cells grown on 2% glucose. Abbreviations: Ac-CoA, acetyl-CoA; AcOH, acetic acid; CL, 
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cardiolipins; DAG, diacylglycerols; EE, ethyl esters; ER, endoplasmic reticulum; EtOH, ethanol; FA-CoA, 
CoA esters of fatty acids; FFA, free fatty acids; LB, lipid bodies; PL, phospholipids; TAG, triacylglycerols. 
 
ethanol concentration when yeast were grown on 1% or 2% glucose (Figures 5.2D and 
5.2E), prolonging their lifespan (Figures 5.2F and 5.2G). Furthermore, lack of Adh2p led 
to a considerable rise of ethanol concentration in non-CR yeast grown on 1% or 2% 
glucose (Figures 5.2D and 5.2E), shortening their lifespan (Figures 5.2F and 5.2G). By 
extending lifespan of non-CR yeast, adh1Δ to a great extent abolished the positive effect 
of CR on longevity (Figures 5.2H and 5.2I). Alternatively, by shortening lifespan of non-
CR yeast, adh2Δ enhanced the benefit of CR for longevity (Figures 5.2H and 5.2I). We 
therefore concluded that a genetic or dietary intervention that lowers ethanol 
concentration will extend yeast longevity. 
 
5.4.2 Ethanol remodels metabolism of trehalose, glycogen and several lipid species 
in chronologically aging yeast 
            We found that in chronologically aging yeast ethanol modulates the age-related 
dynamics of changes in concentrations of trehalose, glycogen and several lipid species. In 
fact, by decreasing ethanol concentration in non-CR yeast, adh1Δ remodelled the 
metabolism of these key for longevity compounds (see Chapters 3 and 4 of this thesis, as 
well as [32, 40, 110, 114]) in non-CR yeast by making it similar to the metabolic design 
of CR yeast. Specifically, the adh1Δ mutation 1) increased the level of trehalose 
(Figure5.3B); 2) redesigned glycogen metabolism by promoting glycogen accumulation 
in PD phase and delaying its consumption until ST phase (Figure 5.3C); 3) accelerated 





Figure 5.2. Ethanol is one of the key factors regulating longevity. (A) Outline of metabolic pathways and 
interorganellar communications operating in chronologically aging yeast cells. (B-E) The dynamics of age-
dependent changes in the extracellular concentration of ethanol for WT, adh1Δ and adh2Δ. Data are 
presented as mean ± SEM (n = 3-5). (F and G) Survival (F) and the mean chronological lifespans (G) of 
WT, adh1Δ and adh2Δ. Data are presented as mean ± SEM (n = 3-5); *p < 0.05, **p < 0.005. (H and I) A 
dose-response relationship between the mean chronological lifespan and the degree of CR for WT, adh1Δ 
and adh2Δ. Data are presented as mean ± SEM (n = 3-5). (B-I) Cells were cultured in YP medium initially 
containing 0.2%, 0.5%, 1% or 2% glucose. 
 
5.3D - 5.3F), the two major neutral lipids that in yeast are synthesized in the endoplasmic 
reticulum (ER) and then deposited in lipid bodies (LBs) (204); and 4) accelerated the 
consumption of free fatty acids (FFA) and diacylglycerols (DAG) during late PD and 
early ST phases (Figures 5.3G and 5.3H). In contrast, by elevating ethanol level in non-
CR yeast, adh2Δ enhanced the negative effect of a calorie-rich diet on longevity by 
further decreasing trehalose concentration, accelerating glycogen consumption, slowing 
down neutral lipids lipolysis, and decelerating FFA and DAG consumption (Figure 5.3). 
In sum, based on the findings presented in Chapters 5.4.1 and 5.4.2, we concluded that 
ethanol is one of the key factors regulating longevity by specifically modulating the 
metabolism of trehalose, glycogen, neutral lipids, FFA and DAG in chronologically aging 
yeast.  
 
5.4.3 Ethanol decelerates fatty acid oxidation in peroxisomes of chronologically 
aging yeast 
            We sought to define a mechanism by which ethanol modulates the dynamics of  
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Figure 5.3. In chronologically aging yeast, ethanol modulates the dynamics of trehalose, glycogen, neutral 
lipids, FFA and DAG. (A) Outline of metabolic pathways and interorganellar communications operating in 
chronologically aging yeast. (B, C, E-H) The dynamics of age-dependent changes in the levels of trehalose 
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(B), glycogen (C), TAG (E), EE (F), FFA (G) and DAG (H) during chronological aging of WT, adh1Δ and 
adh2Δ. Data are presented as mean ± SEM (n = 3-4). (D) Percent of WT, adh1Δ and adh2Δ cells that 
contain lipid bodies. Data are presented as mean ± SEM (n = 4). (B-H) Cells were cultured in rich YP 
medium initially containing 2% glucose. Abbreviations: Ac-CoA, acetyl-CoA; AcOH, acetic acid; DAG, 
diacylglycerols; EE, ethyl esters; ER, endoplasmic reticulum; FA-CoA, CoA esters of fatty acids; FFA, free 
fatty acids; LB, lipid bodies; PL, phospholipids; TAG, triacylglycerols. 
 
neutral lipids, FFA and DAG in chronologically aging yeast. Importantly, we found that 
the observed rapid depletion of ethanol seen in CR yeast (Figure 5.1B) coincides with 1) 
elevated levels of Fox1p, Fox2p and Fox3p (Figure 4.1), all of which are the core 
enzymes of peroxisomal fatty acid β-oxidation [205]; and 2) rapid consumption of FFA 
during PD phase [32]. Noteworthy, it has been previously shown that in the yeast species 
that need peroxisomes to utilize methanol as a sole carbon source for growth, ethanol 
suppresses the synthesis of peroxisomal enzymes catalyzing methanol oxidation [206]. 
Based on these findings, we hypothesized that the accumulation of ethanol in non-CR 
yeast cultures (Figure 5.1B) suppresses peroxisomal oxidation of FFA by repressing the 
synthesis of Fox1p, Fox2p and Fox3p, thereby causing the accumulation of FFA during 
PD phase (Figure 5.3G). This hypothesis was confirmed by our finding that a premature 
depletion of ethanol from non-CR cells of adh1Δ (Figures 5.2D and 5.2E) led to an early 
synthesis of Fox1p, Fox2p and Fox3p in PD phase (Figure 5.4B) and promoted FFA 
consumption (Figure 5.3G). In addition, we found that a postponed depletion of ethanol 
from non-CR cells of adh2Δ (Figures 5.2D and 5.2E) delays the synthesis of Fox1p, 




Figure 5.4. Ethanol suppresses the synthesis of Fox1p, Fox2p and Fox3p, all of which are the core 
enzymes of peroxisomal fatty acid β-oxidation. (A) Outline of metabolic pathways and interorganellar 
communications operating in chronologically aging yeast cells. (B) Western blot analysis of Fox1p, Fox2p, 
Fox3p and actin in aging WT, adh1Δ and adh2Δ cultured in YP medium initially containing 0.2%, 0.5%, 
1% or 2% glucose. Protein recovered in total cell lysates were resolved by SDS-PAGE and detected by 
immunoblotting. A representative of 3 independent experiments is shown.  
 
            How exactly ethanol modulates the dynamics of neutral lipids in chronologically 
aging yeast? By substantially decreasing ethanol concentration in non-CR yeast, adh1Δ 
accelerated not only the consumption of FFA but also the lipolysis of neutral lipids 
deposited in LBs (Figures 5.3D-5.3G). Moreover, by elevating ethanol level in non-CR 
yeast, adh2Δ decelerated both these processes (Figures 5.3D-5.3G). These findings 
strongly suggest that a diet or genetic manipulation that decelerates peroxisomal 
oxidation of FFA by Fox1p, Fox2p and/or Fox3p could also slow down the lipolysis of 
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neutral lipids in LBs, perhaps due to a feedback inhibition of the lipolysis by the 
concentrations of FFA or FA-CoA exceeding a critical level. 
 
5.5 Discussion 
            Findings described in this chapter of my thesis imply that the accumulation of 
ethanol in non-CR yeast suppresses peroxisomal oxidation of FFA by repressing the 
synthesis of Fox1p, Fox2p and Fox3p, thereby causing the build-up of FFA. Of note, it 
has been shown that the β-oxidation of FFA in yeast peroxisomes is facilitated by their 
physical association with LBs. The extensive physical contact existing between 
peroxisomes and LBs stimulates the lipolysis of neutral lipids within LBs, thereby 
initiating the conversion of newly formed free fatty acids to their CoA esters that then get 
imported and oxidized by peroxisomes [207]. The LBs-peroxisome association can lead 
to peroxisome invasion into the lipid core of LBs, thereby generating the so-called 
pexopodia that exist as individual peroxisomes or as their extensions penetrating the core 
of LBs [207]. Importantly, pexopodia of yeast mutants that were unable to oxidize FFA 
due to the absence of Fox1p, Fox2p or Fox3p caused the accumulation of the so-called 
gnarls within the core of LBs [207]. Gnarls represent electron-dense arrays of free fatty 
acids accumulated in excessive amounts within LBs of fox1Δ, fox2Δ and fox3Δ mutants 
[207]. In addition, lack of Fox1p, Fox2p or Fox3p resulted in the build-up of 
triacylglycerols within the core of LBs [207]. By extending these observations to lipid 
dynamics in LBs and peroxisomes of chronologically aging non-CR yeast, one could 
expect that the accumulation of ethanol in non-CR yeast and the resulting repression of 




Figure 5.5. A possible mechanism linking longevity and lipid dynamics in the endoplasmic reticulum 
(ER), lipid bodies (LBs) and peroxisomes of yeast placed on a calorie-rich diet. LBs in yeast cells 
function as a hub in a regulatory network that modulates neutral lipids synthesis in the ER and fatty acid 
oxidation in peroxisomes. The LBs-peroxisome association leads to peroxisome invasion into the lipid core 
of LBs, thereby generating the so-called pexopodium. Ethanol accumulated in yeast placed on a calorie-rich 
diet represses the synthesis of Fox1p, Fox2p and Fox3p, thereby suppressing peroxisomal oxidation of free 
fatty acids (FFA) that originate from triacylglycerols (TAG) synthesized in the ER and deposited within 
LBs. The resulting build-up of arrays of FFA (gnarls) within LBs of these yeast initiates several negative 
feedback loops regulating the metabolism of TAG. Due to the action of these negative feedback loops, 
chronologically aging yeast placed on a calorie-rich diet not only amass TAG in LBs but also accumulate 
 118
diacylglycerol (DAG) and FFA in the ER. The resulting remodeling of lipid dynamics in these yeast 
shortens their lifespan by causing their premature death due to 1) necrosis triggered by the inability of their 
peroxisomes to oxidize FFA; 2) lipoapoptosis initiated in response to the accumulation of DAG and FFA; 
and 3) a DAG-induced reorganization of the protein kinase C (PKC)-dependent signal transduction network 
affecting multiple stress response- and longevity-related processes. Other abbreviations: FFA-CoA, CoA 
esters of fatty acids. 
 
and triacylglycerols within the core of their LBs. 
            Taken together, these findings suggest a mechanism linking yeast longevity and 
lipid dynamics in the ER, LBs and peroxisomes (Figure 5.5). In this mechanism, LBs in 
yeast cells function as a hub in a regulatory network that modulates neutral lipids 
synthesis in the ER and FFA oxidation in peroxisomes. As we found, ethanol 
accumulated in yeast placed on a calorie-rich diet represses the synthesis of Fox1p, 
Fox2p and Fox3p, thereby suppressing peroxisomal oxidation of FFA that originate from 
triacylglycerols synthesized in the ER and deposited within LBs (Figures 5.3G, 5.3H and 
5.4B). In our hypothesis, the resulting build-up of arrays of FFA (gnarls) within LBs of 
non-CR yeast initiates several negative feedback loops regulating the metabolism of 
triacylglycerols (Figure 5.5). Due to the action of these negative feedback loops, 
chronologically aging non-CR yeast not only amass triacylglycerols in LBs but also 
accumulate DAG and FFA in the ER (Figures 5.3G and 5.3H) [32]. Of note, it has been 
recently revealed that 1) loss of peroxisome function triggers necrosis [208, 209]; 2) both 
FFA and DAG induce lipoapoptosis (a caspase- and mitochondria-independent form of 
programmed cell death) [210]; and 3) the accumulation of DAG triggers a protein kinase 
C-dependent signal transduction network affecting multiple stress response- and 
longevity-related processes [211, 212]. We therefore hypothesize that the proposed 
remodeling of lipid dynamics in chronologically aging non-CR yeast shortens their 
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lifespan by causing their premature death due to 1) necrosis triggered by the inability of 
their peroxisomes to oxidize FFA; 2) lipoapoptosis initiated in response to the 
accumulation of DAG and FFA; and 3) the DAG-induced reorganization of the protein 
kinase C-dependent signal transduction network affecting multiple longevity-related 
cellular targets (Figure 5.5). 
            Recently, we assessed the effect of CR on the dynamics of age-related changes in 
the proteomes and lipidomes of ER, LBs and peroxisomes in chronologically aging yeast 
(Kyryakov, P. et al., manuscript in preparation). We also examined how mutations that 
extend yeast longevity by impairing lipid metabolism in these organelles influence their 
morphologies, abundance, association with each other, and protein and lipid 
compositions during chronological aging (Kyryakov, P. et al., manuscript in preparation). 
Our findings support the proposed here model (Figure 5.5) for a mechanism in which 
LBs function as a hub in a regulatory network that defines the chronological lifespan of 
yeast by modulating both neutral lipids synthesis in the ER and FFA oxidation in 
peroxisomes. By orchestrating several negative feedback loops that coordinate lipid 
dynamics in a diet- and genotype-dependent fashion, this network controls age-related 
necrotic cell death and multiple stress response-related processes (Kyryakov, P. et al., 
manuscript in preparation). Implementing our understanding of the mechanism linking 
longevity and age-related dynamics of LBs, we developed a lifespan assay that was used 
for a high-throughput screening of extensive libraries of small molecules [40]. We 
identified five groups of novel anti-aging natural compounds that significantly delay 
yeast aging by remodeling lipid metabolism in the ER, LBs and peroxisomes and by 
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activating a distinct set of stress response-related processes in mitochondria (see next 
chapter of this thesis). 
 
5.6 Conclusions 
            Findings presented in this chapter of my thesis provide conclusive evidence that 
CR extends yeast chronological lifespan by reducing ethanol concentration, thereby 
causing a remodeling of carbohydrate and lipid metabolism. Our data suggest that the 
remodeling of lipid dynamics in chronologically aging non-CR yeast shortens their 
lifespan by causing their premature death due to 1) necrosis triggered by the inability of 
their peroxisomes to oxidize FFA; 2) lipoapoptosis initiated in response to the 
accumulation of DAG and FFA; and 3) the DAG-induced reorganization of the protein 
kinase C-dependent signal transduction network affecting multiple longevity-related 
cellular targets. 
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6 Lithocholic acid (LCA), a novel anti-aging compound, alters mitochondrial 
structure and function, reduces cell susceptibility to mitochondria-controlled 
apoptosis, and increases cell resistance to oxidative and thermal stresses 
 
6.1 Abstract 
            We sought to identify small molecules that increase the chronological lifespan of 
yeast under caloric restriction (CR) conditions by targeting lipid metabolism and 
modulating “housekeeping” longevity assurance pathways. We predicted that such 
housekeeping pathways 1) modulate longevity irrespective of the organismal and 
intracellular nutrient and energy status; and 2) do not overlap (or only partially overlap) 
with the “adaptable” longevity pathways that are under the stringent control of calorie 
and/or nutrient availability. In studies presented in this chapter of my thesis, we found 
that in yeast grown under CR conditions the pex5Δ mutation not only remodels lipid 
metabolism but also causes the profound changes in longevity-defining processes in 
mitochondria, resistance to chronic (long-term) stresses, susceptibility to mitochondria-
controlled apoptosis, and frequencies of mutations in mitochondrial and nuclear DNA. 
We therefore chose the single-gene-deletion mutant strain pex5Δ as a short-lived strain 
for carrying out a chemical genetic screen aimed at the identification of novel anti-aging 
compounds targeting housekeeping longevity assurance pathways. By screening the total 
of approximately 19,000 representative compounds from seven commercial libraries, our 
laboratory recently identified 24 small molecules that greatly extend the chronological 
lifespan of pex5Δ under CR conditions and belong to 5 chemical groups. One of these 
groups consisted of 6 bile acids, including LCA. Findings presented in this chapter of my 
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thesis imply that LCA modulates housekeeping longevity assurance pathways by 1) 
attenuating the pro-aging process of mitochondrial fragmentation, a hallmark event of 
age-related cell death; 2) altering oxidation-reduction processes in mitochondria - such as 
oxygen consumption, the maintenance of membrane potential and ROS production - 
known to be essential for longevity regulation; 3) enhancing cell resistance to oxidative 
and thermal stresses, thereby activating the anti-aging process of stress response; 4) 
suppressing the pro-aging process of mitochondria-controlled apoptosis; and 5) 
enhancing stability of nuclear and mitochondrial DNA, thus activating the anti-aging 
process of genome maintenance. The observed pleiotropic effect of LCA on a 
compendium of housekeeping longevity assurance processes implies that this bile acid is 
a multi-target life-extending compound that increases chronological lifespan in yeast by 
modulating a network of the highly integrated cellular events that are not controlled by 
the adaptable AMP-activated protein kinase/target of rapamycin (AMPK/TOR) and 
cAMP/protein kinase A (cAMP/PKA) pathways. 
 
6.2 Introduction 
          Longevity in evolutionarily distant organisms, from yeast to primates, can be 
extended by administering the following dietary and pharmacological interventions: 1) 
caloric restriction (CR),  a diet in which only calorie intake is reduced but the supply of 
amino acids, vitamins and other nutrients is not compromised [3, 7, 9, 16, 24 - 26, 213 - 
216]; 2) dietary restriction (DR), in which the intake of nutrients (but not necessarily of 
calories) is reduced by limiting food supply without causing malnutrition [3, 7, 9, 213 - 
221]; and 3) a limited set of anti-aging compounds, including resveratrol, rapamycin, 
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spermidine, caffeine and metformin [3, 16, 24, 28, 40, 49, 222 - 224]. All these 
longevity-extending interventions target a limited number of nutrient- and energy-sensing 
longevity signaling pathways that are conserved across phyla and include the 
insulin/insulin-like growth factor 1 (IGF-1), AMP-activated protein kinase/target of 
rapamycin (AMPK/TOR) and cAMP/protein kinase A (cAMP/PKA) pathways [3, 9, 16, 
27, 30, 36, 40, 43, 44]. The commonly accepted paradigm of longevity regulation posits 
that most, if not all, longevity signaling pathways are “adaptable” by nature - i.e., that all 
these pathways modulate longevity only in response to certain changes in the 
extracellular and intracellular nutrient and energy status of an organism [3, 9, 16, 27, 30, 
33, 40, 226 - 231]. However, Li+ in worms and rapamycin in fruits flies extend lifespan 
even under DR conditions, in which all adaptable pro-aging pathways are fully 
suppressed and all adaptable anti-aging pathways are fully activated [232, 233]. 
Therefore, our laboratory suggested that some longevity pathways could be “constitutive” 
or “housekeeping” by nature, i.e., that they: 1) modulate longevity irrespective of the 
organismal and intracellular nutrient and energy status; and 2) do not overlap (or only 
partially overlap) with the adaptable longevity pathways that are under the stringent 
control of calorie and/or nutrient availability [40]. A challenge of identifying such 
housekeeping longevity pathways could be met by conducting a chemical screen for 
compounds that can extend longevity even under CR or DR conditions. Because under 
such conditions the adaptable pro-aging pathways are fully suppressed and the adaptable 
anti-aging pathways are fully activated, a compound that can increase lifespan is 
expected to target the housekeeping longevity pathways [40].  
          Of note, lipid metabolism has been shown to be involved in longevity regulation in 
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yeast [32, 110, 114], worms [20, 234 - 236], fruit flies [20, 237] and mice [20, 238 - 242]. 
Recently, we proposed a mechanism linking yeast longevity and lipid dynamics in the 
endoplasmic reticulum, lipid bodies and peroxisomes (see Chapter 5 of this thesis). In 
this mechanism, a CR diet extends yeast chronological lifespan by activating fatty acid 
oxidation in peroxisomes (see Figure 5.5 of this thesis). It is conceivable that the 
identification of small molecules targeting this mechanism could yield novel anti-aging 
compounds. Such compounds can be used as research tools for defining the roles for 
different longevity pathways in modulating lipid metabolism and in integrating lipid 
dynamics with other longevity-related processes. Furthermore, the availability of such 
compounds would enable a quest for housekeeping longevity assurance pathways that do 
not overlap (or only partially overlap) with the adaptable pathways. Moreover, such 
compounds would have a potential to be used as pharmaceutical agents for increasing 
lifespan and promoting healthy aging by delaying the onset of age-related diseases, 
regardless of an organism’s dietary regimen. 
          To identify small molecules that increase the chronological lifespan of yeast under 
CR conditions by targeting lipid metabolism and modulating housekeeping longevity 
assurance pathways, in studies described in this chapter of the thesis we first chose the 
single-gene-deletion mutant strain pex5Δ as a short-lived strain for carrying out a 
chemical genetic screen aimed at the identification of such anti-aging molecules. We 
found that the pex5Δ mutation causes the profound changes not only in lipid metabolism 
but also in mitochondrial structure and function, cell susceptibility to mitochondria-
controlled apoptosis, and resistance to oxidative, thermal and osmotic stresses.  By 
screening the total of approximately 19,000 representative compounds from seven 
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commercial libraries, we identified 24 small molecules that greatly extend the 
chronological lifespan of pex5Δ under CR and belong to 5 chemical groups [40]. One of 
these groups consisted of 6 bile acids, including lithocholic acid (LCA) [40]. To define a 
compendium of cellular processes affected by LCA in wild-type yeast, in studies 
described in this chapter of the thesis we examined the effect of this bile acid on 
longevity-defining processes confined to mitochondria. Here, we demonstrate that LCA 
extends longevity of chronologically aging yeast by altering mitochondrial structure and 
function, reducing cell susceptibility to mitochondria-controlled apoptosis, and increasing 
cell resistance to oxidative and thermal stresses.       
 
6.3 Materials and Methods 
Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0) and mutant strain pex5Δ (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 pex5Δ::kanMX4) 
were grown in YP medium (1% yeast extract, 2% peptone) containing 0.2%, 0.5%, 1% or 
2% glucose as carbon source. Cells were cultured at 30oC with rotational shaking at 200 
rpm in Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1. 
 
Chronological lifespan (CLS) assay 
A sample of cells was taken from a culture at a certain time-point. A fraction of the 
sample was diluted in order to determine the total number of cells using a 
hemacytometer. Another fraction of the cell sample was diluted and serial dilutions of 
cells were plated in duplicate onto YP plates containing 2% glucose as carbon source. 
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After 2 d of incubation at 30oC, the number of colony forming units (CFU) per plate was 
counted. The number of CFU was defined as the number of viable cells in a sample. For 
each culture, the percentage of viable cells was calculated as follows: (number of viable 
cells per ml/total number of cells per ml) × 100. The percentage of viable cells in mid-
logarithmic phase was set at 100%. The lifespan curves were validated using a 
LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's instructions. 
 
Plating assays for the analysis of resistance to various stresses 
For the analysis of hydrogen peroxide resistance, serial dilutions (1:100 to 1:105) of wild-
type and mutant cells removed from mid-logarithmic phase (day 1) and from diauxic 
phase (days 2 and 3) in YP medium containing 0.2% glucose were spotted onto two sets 
of plates. One set of plates contained YP medium with 2% glucose alone, whereas the 
other set contained YP medium with 2% glucose supplemented with 5 mM hydrogen 
peroxide. Pictures were taken after a 3-day incubation at 30oC. 
          For the analysis of oxidative stress resistance, serial dilutions (1:100 to 1:105) of 
wild-type and mutant cells removed from mid-logarithmic phase (day 1) and from 
diauxic phase (days 2 and 3) in YP medium with 0.2% glucose were spotted onto two 
sets of plates. One set of plates contained YP medium with 2% glucose alone, whereas 
the other set contained YP medium with 2% glucose supplemented with 2.5 mM of the 
superoxide/hydrogen peroxide-generating agent paraquat. Pictures were taken after a 3-
day incubation at 30oC. 
          For the analysis of heat-shock resistance, serial dilutions (1:100 to 1:105) of wild-
type and mutant cells removed from mid-logarithmic phase (day 1) and from diauxic 
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phase (days 2 and 3) in YP medium with 0.2% glucose were spotted onto two sets of YP 
medium with 2% glucose plates. One set of plates was incubated at 30oC. The other set of 
plates was initially incubated at 55oC for 30 min, and was then transferred to 30oC. 
Pictures were taken after a 3-day incubation at 30oC. 
          For the analysis of salt stress resistance, serial dilutions (1:100 to 1:105) of wild-
type and mutant cells removed from mid-logarithmic phase (day 1) and from diauxic 
phase (days 2 and 3) in YP medium with 0.2% glucose were spotted onto two sets of 
plates. One set of plates contained YP medium with 2% glucose alone, whereas the other 
set contained YP medium with 2% glucose supplemented with 0.5 M NaCl. Pictures were 
taken after a 3-day incubation at 30oC. 
          For the analysis of osmotic stress resistance, serial dilutions (1:100 to 1:105) of 
wild-type and mutant cells removed from mid-logarithmic phase (day 1) and from 
diauxic phase (days 2 and 3) in YP medium contained 0.2% glucose were spotted onto 
two sets of plates. One set of plates contained YP medium with 2% glucose alone, 
whereas the other set contained YP medium with 2% glucose supplemented with 1 M 
sorbitol. Pictures were taken after a 3-day incubation at 30oC. 
 
Pharmacological manipulation of CLS 
CLS analysis was performed as described above in this section. The lithocholic (LCA; 
L6250) bile acid was from Sigma. Their stock solution of LCA in DMSO was made on 
the day of adding this compound to cell cultures. LCA was added to growth medium at 
the indicated concentration immediately following cell inoculation. The final 
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concentration of DMSO in yeast cultures supplemented with LCA (and in the 
corresponding control cultures supplemented with drug vehicle) was 1% (v/v). 
 
Monitoring the formation of reactive oxygen species (ROS)  
Cells grown in YP medium containing 0.2%, 0.5%, 1% or 2% glucose as carbon source 
were tested microscopically for the production of ROS by incubation with 
dihydrorhodamine 123 (DHR). In the cell, this nonfluorescent compound can be oxidized 
to the fluorescent chromophore rhodamine 123 by ROS. Cells were also probed with a 
fluorescent counterstain Calcofluor White M2R (CW), which stains the yeast cell walls 
fluorescent blue. CW was added to each sample in order to label all cells for their proper 
visualization. DHR was stored in the dark at –20oC as 50 μl aliquots of a 1 mg/ml 
solution in ethanol. CW was stored in the dark at –20oC as the 5 mM stock solution in 
anhydrous DMSO (dimethylsulfoxide). 
          The concurrent staining of cells with DHR and CW was carried out as follows. The 
required amounts of the 50 μl DHR aliquots (1 mg/ml) and of the 5 mM stock solution of 
CW were taken out of the freezer and warmed to room temperature. The solutions of 
DHR and CW were then centrifuged at 21,000 × g for 5 min in order to clear them of any 
aggregates of fluorophores. For cell cultures with a titre of ~ 107 cells/ml, 100 μl was 
taken out of the culture to be treated. If the cell titre was lower, proportionally larger 
volumes were used. 6 μl of the 1 mg/ml DHR and 1 μl of the 5 mM CW solutions were 
added to each 100 μl aliquot of culture. After a 2-h incubation in the dark at room 
temperature, the samples were centrifuged at 21,000 × g for 5 min. Pellets were 
resuspended in 10 μl of PBS buffer (20 mM KH2PO4/KOH, pH 7.5, and 150 mM NaCl). 
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Each sample was then supplemented with 5 μl of mounting medium, added to a 
microscope slide, covered with a coverslip, and sealed using nail polish. Once the slides 
were prepared, they were visualized under the Zeiss Axioplan fluorescence microscope 
mounted with a SPOT Insight 2 megapixel color mosaic digital camera. Several pictures 
of the cells on each slide were taken, with two pictures taken of each frame. One of the 
two pictures was of the cells seen through a rhodamine filter in order to detect cells dyed 
with DHR. The second picture was of the cells seen through a DAPI filter in order to 
visualize CW, and therefore all the cells present in the frame. 
          For evaluating the percentage of DHR-positive cells, the UTHSCSA Image Tool 
(Version 3.0) software was used to calculate both the total number of cells and the 
number of stained cells. Fluorescence of individual DHR-positive cells in arbitrary units 
was determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3-
5 independent experiments, the value of median fluorescence was calculated by analyzing 
at least 800-1000 cells that were collected at each time point. The median fluorescence 
values were plotted as a function of the number of days cells were cultured. 
 
Immunofluorescence microscopy 
Cell cultures were fixed in 3.7% formaldehyde for 45 min at room temperature. The cells 
were washed in solution B (100 mM KH2PO4/KOH pH 7.5, 1.2 M sorbitol), treated with 
Zymolyase 100T (MP Biomedicals, 1 μg Zymolyase 100T/1 mg cells) for 30 min at 30oC 
and then processed as previously described [249]. Monoclonal antibody raised against 
porin (Invitrogen, 0.25 μg/μl in TBSB buffer [20 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 
mg/ml BSA]) was used as a primary antibody. Alexa Fluor 568 goat anti-mouse IgG 
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(Invitrogen, 2 μg/μl in TBSB buffer) was used as a secondary antibody. The labeled 
samples were mounted in mounting solution (16.7 mM Tris/HCl pH 9.0, 1.7 mg/ml p-
phenylenediamine, 83% glycerol). Images were collected with a Zeiss Axioplan 
fluorescence microscope (Zeiss) mounted with a SPOT Insight 2 megapixel color mosaic 
digital camera (Spot Diagnostic Instruments). 
 
Oxygen consumption assay 
The rate of oxygen consumption by yeast cells recovered at various time points was 
measured continuously in a 2-ml stirred chamber using a custom-designed biological 
oxygen monitor (Science Technical Center of Concordia University) equipped with a 
Clark-type oxygen electrode. 1 ml of YP medium supplemented with 0.2% glucose was 
added to the electrode for approximately 5 minutes to obtain a baseline. Cultured cells of 
a known titre were spun down at 3,000 × g for 5 minutes. The resulting pellet was 
resuspended in YP medium supplemented with 0.2% glucose and then added to the 
electrode with the medium that was used to obtain a baseline. The resulting slope was 
used to calculate the rate of oxygen consumption in O2% x min-1 × 109 cells. 
 
Monitoring the mitochondrial membrane potrential  
The mitochondrial membrane potential (ΔΨ) was measured in live yeast by fluorescence 
microscopy of Rhodamine 123 (R123) staining. For R123 staining, 5 Ì 106 cells were 
harvested by centrifugation for 1 min at 21,000 Ì g at room temperature and then 
resuspended in 100 μl of 50 mM sodium citrate buffer (pH 5.0) containing 2% glucose. 
R123 (Invitrogen) was added to a final concentration of 10 μM. Following incubation in 
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the dark for 30 min at room temperature, the cells were washed twice in 50 mM sodium 
citrate buffer (pH 5.0) containing 2% glucose and then analyzed by fluorescence 
microscopy. Images were collected with a Zeiss Axioplan fluorescence microscope 
(Zeiss) mounted with a SPOT Insight 2 megapixel color mosaic digital camera (Spot 
Diagnostic Instruments). For evaluating the percentage of R123-positive cells or cells 
with fragmented nucleus the UTHSCSA Image Tool (Version 3.0) software was used to 
calculate both the total number of cells and the number of stained cells or cells with 
fragmented nucleus. Fluorescence of individual R123-positive cells in arbitrary units was 
determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3-6 
independent experiments, the value of median fluorescence was calculated by analyzing 
at least 800-1000 cells that were collected at each time-point. The median fluorescence 
values were plotted as a function of the number of days cells were cultured. 
 
Measurement of mitochondrial mutations and nuclear mutations affecting 
mitochondrial components 
The frequency of spontaneous single-gene (mit- and syn-) and deletion (rho- and rhoo) 
mutations in mtDNA and spontaneous single-gene nuclear mutations (pet-) affecting 
essential mitochondrial components was evaluated by measuring the fraction of 
respiratory-competent (rho+) yeast cells remaining in their aging population. rho+ cells 
maintained intact their mtDNA and their nuclear genes encoding essential mitochondrial 
components. Therefore, rho+ cells were able to grow on glycerol, a non-fermentable 
carbon source. In contrast, mutant cells deficient in mitochondrial respiration were unable 
to grow on glycerol. Most of these mutant cells carried mutations in mtDNA (including 
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single-gene mit- and syn- mutations or large deletions rho-) or completely lacked this 
DNA (rhoo mutants), whereas some of them carried so-called pet- mutations in nuclear 
genes that code for essential mitochondrial components [140]. Serial dilutions of cell 
samples removed from different phases of growth were plated in duplicate onto YP plates 
containing either 2% glucose or 3% glycerol as carbon source. Plates were incubated at 
30oC. The number of CFU on YP plates containing 2% glucose was counted after 2 d of 
incubation, whereas the number of CFU on YP plates containing 3% glycerol was 
counted after 6 d of incubation. For each culture, the percentage of respiratory-deficient 
(mit-, syn-, rho-, rhoo and pet-) cells was calculated as follows: 100 - [(number of CFU per 
ml on YP plates containing 3% glycerol/number of CFU per ml on YP plates containing 
2% glucose) × 100]. The frequency of spontaneous point mutations in the rib2 and rib3 
loci of mtDNA was evaluated by measuring the frequency of mtDNA mutations that 
caused resistance to the antibiotic erythromycin [141]. These mutations impair only 
mtDNA [142, 143]. In each of the seven independent experiments performed, ten 
individual yeast cultures were grown in YP medium containing 0.2%, 0.5%, 1% or 2% 
glucose as carbon source. A sample of cells was removed from each culture at various 
time-points. Cells were plated in duplicate onto YP plates containing 3% glycerol and 
erythromycin (1 mg/ml). In addition, serial dilutions of each sample were plated in 
duplicate onto YP plates containing 3% glycerol as carbon source for measuring the 
number of respiratory-competent (rho+) cells. The number of CFU was counted after 6 d 
of incubation at 30oC. For each culture, the frequency of mutations that caused resistance 
to erythromycin was calculated as follows: number of CFU per ml on YP plates 
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containing 3% glycerol and erythromycin/number of CFU per ml on YP plates containing 




6.4.1 The pex5Δ mutation causes the profound changes in mitochondrial structure 
and function, cell susceptibility to mitochondria-controlled apoptosis, and 
resistance to oxidative, thermal and osmotic stresses 
            To perform a chemical genetic screen for small molecules that increase the 
chronological lifespan of yeast by targeting lipid metabolism, our laboratory chose the 
single-gene-deletion mutant strain pex5Δ. Because pex5Δ lacks a cytosolic shuttling 
receptor for peroxisomal import of Fox1p and Fox2p, these two enzymes of the β-
oxidation of free fatty acids (FFA) reside in the cytosol of pex5Δ cells [40, 243]. In 
contrast, the Pex5p-independent peroxisomal import of Fox3p, the third enzyme of the 
FFA β-oxidation pathway, sorts it to the peroxisome in pex5Δ cells [40, 243]. By 
spatially separating Fox1p and Fox2p from Fox3p within a cell, the pex5Δ mutation 
impairs FFA oxidation. In chronologically aging yeast grown under CR conditions on 
0.2% or 0.5% glucose, peroxisomal FFA oxidation regulates longevity by 1) efficiently 
generating acetyl-CoA to synthesize the bulk of ATP in mitochondria; and 2) acting as a 
rheostat that modulates the age-related dynamics of FFA and diacylglycerol (DAG), two 
regulatory lipids known to promote longevity-defining cell death [32, 40, 44, 110, 114, 
244]. Unlike CR yeast, chronologically aging non-CR yeast grown on 1% or 2% glucose 
are unable to generate significant quantities of ATP by oxidizing peroxisome-derived 
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acetyl-CoA in mitochondria and, instead, produce the bulk of ATP via glycolytic 
oxidation of glycogen- and trehalose-derived glucose [32, 40, 44, 110, 114]. Consistent 
with the essential role of peroxisomal FFA oxidation as a longevity assurance process 
only under CR, we found that the pex5Δ mutation substantially shortened the 
chronological lifespan of CR yeast but caused a significantly lower reduction of longevity 
in non-CR yeast, especially in yeast grown on 2% glucose [40]. Our studies revealed that 
by impairing the ability of peroxisomal FFA oxidation to act as a rheostat that regulates 
cellular aging by modulating the age-related dynamics of FFA, diacylglycerols (DAG) 
and triacylglycerols (TAG) in the ER and lipid bodies (see Chapter 5 of this thesis), the 
pex5Δ mutation: 1) causes the accumulation of the closely apposed ER membranes and 
ER-originated lipid bodies in CR yeast; 2) increases the concentrations of FFA, DAG and 
TAG in CR yeast, promoting their build-up in the ER and lipid bodies; 3) leads to the 
buildup of the ER-derived and lipid bodies-deposited ergosteryl esters (EE), neutral lipid 
species; and 4) enhances the susceptibility of CR yeast to necrotic death caused by a 
short-term exposure to exogenous FFA or DAG, perhaps due to the increased 
concentrations of endogenous FFA and DAG seen in pex5Δ cells under CR [40].  
            In studies described in this chapter of my thesis, we examined the effects of the 
pex5Δ mutation on longevity-defining cellular processes that are confined to 
mitochondria. As we found, this mutation altered mitochondrial morphology and 
oxidation-reduction processes in mitochondria of CR yeast. In fact, the pex5Δ mutation 
caused the fragmentation of a tubular mitochondrial network into individual mitochondria 
under CR conditions (Figures 6.1A and 6.1B). Furthermore, in CR yeast the pex5Δ 
mutation 1) greatly reduced the rate of oxygen consumption by mitochondria (Figure 
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Figure 6.1. The pex5Δ mutation alters mitochondrial morphology and functions in CR yeast. (A) 
Morphology of mitochondria in WT and pex5Δ cells. Mitochondria were visualized by indirect 
immunofluorescence microscopy using monoclonal anti-porin primary antibodies and Alexa Fluor 568-
conjugated goat anti-mouse IgG secondary antibodies. (B) Percent of WT and pex5Δ cells exhibiting a 
tubular mitochondrial network or fragmented mitochondria. (C - E) Oxygen consumption (C) by WT and 
pex5Δ cells, their mitochondrial membrane potential ΔΨ (D) and their ROS levels (E). ΔΨ and ROS were 
visualized in living cells by fluorescence microscopy using fluorescent dyes Rhodamine 123 or 
Dihydrorhodamine 123, respectively. CR yeast grown on 0.2% glucose were taken for analyses at the 
indicated time-points. Data in B - E are presented as means ± SEM (n = 4-15; ***p < 0.001; **p < 0.01; *p 
< 0.05).  Abbreviation: D, diauxic growth phase. 
 136
6.1C); 2) substantially decreased the mitochondrial membrane potential (Figure 6.1D); 
and 3) diminished the level of intracellular ROS (Figure 6.1E), known to be generated 
mostly as by-products of mitochondrial respiration [245, 246]. Interestingly, all these 
mitochondrial abnormalities in pex5Δ yeast under CR were reminiscent of changes in 
mitochondrial morphology and functions seen in mice with hepatocyte-specific 
elimination of the PEX5 gene, a model for the peroxisome biogenesis disorder Zellweger 
syndrome [247]. 
            Besides    its   profound   effect   on   mitochondrial morphology and functions, 
the pex5Δ mutation also 1) reduced the resistance of chronologically aging CR yeast to 
chronic (long-term) oxidative, thermal and osmotic stresses  (Figure 6.2A);  2) sensitized 
CR yeast to death that was initiated in response to a short-term exposure to exogenous 
hydrogen peroxide or acetic acid (Figure 6.2B) and that is known to be caused by 
mitochondria-controlled apoptosis [248, 249]; and 3) elevated the frequencies of deletion 
and point mutations in mitochondrial and nuclear DNA of CR yeast (Figures 6.2C to 
6.2E). 
            Because of the profound changes in longevity-defining processes in mitochondria, 
resistance to chronic (long-term) stresses, susceptibility to mitochondria-controlled 
apoptosis, and frequencies of mutations in mitochondrial and nuclear DNA that we 
observed in pex5Δ yeast under CR conditions, our laboratory chose the single-gene-
deletion mutant strain pex5Δ as a short-lived strain for carrying out a chemical genetic 
screen for novel anti-aging compounds. This screen was aimed at the identification of 
small molecules that increase the chronological lifespan of yeast under CR conditions by 
targeting lipid metabolism and modulating housekeeping longevity assurance pathways. 
 137
 
Figure 6.2. The pex5Δ mutation reduces the resistance of CR yeast to stresses, sensitizes them to 
exogenously induced apoptosis and elevates the frequencies of mutations in their mitochondrial and nuclear 
DNA. (A) The resistance of WT and pex5Δ to chronic oxidative, thermal and osmotic stresses. (B) 
Viability of WT and pex5Δ cells treated for 1 h with hydrogen peroxide or acetic acid (AcOH) to induce 
mitochondria-controlled apoptosis. (C - E) The frequencies of rho- and rho0 deletion mutations in 
mitochondrial DNA (C), rib2 and rib3 point mutations in mitochondrial DNA (D), and of can1 point 
mutations in nuclear DNA (E) of WT and pex5Δ cells. CR yeast grown on 0.2% glucose were taken for 
analyses at the indicated time-points. Data in B to E are presented as means ± SEM (n = 6-9; ***p < 0.001; 
**p < 0.01; *p < 0.05). Abbreviations: AcOH, acetic acid; D, diauxic growth phase; L, logarithmic growth 
phase; PD, post-diauxic growth phase. 
 
6.4.2 LCA, a novel anti-aging compound, extends longevity of chronologically 
aging yeast by altering mitochondrial structure and function, reducing cell 
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susceptibility to mitochondria-controlled apoptosis, and increasing cell 
resistance to oxidative and thermal stresses 
            By screening the total of approximately 19,000 representative compounds from 
seven commercial libraries, we identified 24 small molecules that greatly extend the 
chronological lifespan of pex5Δ under CR and belong to 5 chemical groups [40]. One of 
these groups consisted of 6 bile acids, including LCA [40]. To define a compendium of 
cellular processes affected by LCA in wild-type (WT) yeast, in studies described in this 
chapter of the thesis we examined the effect of this bile acid on longevity-defining 
processes confined to mitochondria. 
          We found that in reproductively mature WT cells that entered the non-proliferative 
ST phase under CR conditions on 0.2% glucose, LCA 1) attenuated the fragmentation of 
a tubular mitochondrial  network  into individual mitochondria (Figure 6.3A);  2) 
elevated the rate of oxygen consumption by mitochondria (Figure 6.3B); 3) reduced the 
mitochondrial membrane potential (Figure 6.3C); and 4) decreased the level of 
intracellular ROS (Figure 6.3D) known to be generated mainly in mitochondria [245, 
246]. Moreover, we also found that in WT yeast reached reproductive maturation by 
entering into ST phase under CR conditions on 0.2% glucose, LCA 1) enhanced cell 
resistance to chronic oxidative and thermal (but not to osmotic) stresses (Figure 6.3E); 2) 
reduced cell susceptibility to death triggered by a short-term exposure to exogenous 
hydrogen peroxide or acetic acid (Figure 6.3F) known to be caused by mitochondria-
controlled apoptosis [248, 250]; and 3) decreased the frequencies of deletions and point 




Figure 6.3. In reproductively mature WT yeast that entered the non-proliferative stationary (ST) phase 
under CR, LCA modulates mitochondrial morphology and functions, enhances stress resistance, attenuates 
mitochondria-controlled apoptosis, and increases stability of nuclear and mitochondrial DNA. (A) Percent 
of WT cells grown in medium with or without LCA and exhibiting a tubular mitochondrial network or 
fragmented mitochondria. Mitochondria were visualized by indirect immunofluorescence microscopy using 
monoclonal anti-porin primary antibodies and Alexa Fluor 568-conjugated goat anti-mouse IgG secondary 
antibodies. (B - D) Oxygen consumption by WT cells grown in medium with or without LCA (B), their 
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mitochondrial membrane potential ΔΨ (C) and their ROS levels (D). ΔΨ and ROS were visualized in living 
cells by fluorescence microscopy using fluorescent dyes Rhodamine 123 or Dihydrorhodamine 123, 
respectively. (E) The resistance of WT cells pre-grown in medium with or without LCA to chronic 
oxidative, thermal and osmotic stresses. (F) Viability of WT cells pre-grown in medium with or without 
LCA and then treated for 1 h with hydrogen peroxide or acetic acid (AcOH) to induce mitochondria-
controlled apoptosis. (G - I) The frequencies of rho- and rho0 mutations in mitochondrial DNA (G), rib2 
and rib3 mutations in mitochondrial DNA (H), and of can1 (Canr) mutations in nuclear DNA (I) of WT 
cells grown in medium with or without LCA. Data in A - D and F - I are presented as means ± SEM (n = 4-
17; ***p < 0.001; **p < 0.01). WT cells grown on 0.2% glucose in the presence or absence of LCA were 
taken for analyses at day 7, when they reached reproductive maturation by entering into ST phase. 
 
6.5 Discussion 
            Our findings described in this chapter of my thesis, together with some recently 
published data from Dr. Titorenko laboratory [40, 114], identify a compendium of 
processes that compose LCA-targeted housekeeping longevity assurance pathways. 
These findings imply that LCA modulates such pathways by 1) suppressing the pro-aging 
process [32, 110, 114, 244] of lipid-induced necrotic cell death, perhaps due to its 
observed ability to reduce the intracellular levels of FFA and DAG that trigger such 
death; 2) attenuating the pro-aging process [32, 251, 252] of mitochondrial 
fragmentation, a hallmark event of age-related cell death; 3) altering oxidation-reduction 
processes in mitochondria - such as oxygen consumption, the maintenance of membrane 
potential and ROS production - known to be essential for longevity regulation [32, 245, 
253 - 255]; 4) enhancing cell resistance to oxidative and thermal stresses, thereby 
activating the anti-aging process [32, 110, 255 - 257] of stress response; 5) suppressing 
the pro-aging process [32, 251, 252] of mitochondria-controlled apoptosis; and 6) 
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enhancing stability of nuclear and mitochondrial DNA, thus activating the anti-aging 
process [32, 258, 259] of genome maintenance. The observed pleiotropic effect of LCA 
on a compendium of housekeeping longevity assurance processes implies that this bile 
acid is a multi-target life-extending compound that increases chronological lifespan in 
yeast by modulating a network of the highly integrated cellular events not controlled by 
the adaptable TOR and cAMP/PKA pathways. The major challenge now is to define the 
molecular mechanisms by which LCA modulates each of these pro- and anti-aging 
housekeeping processes and integrates them in chronologically aging yeast. 
 
6.6 Conclusions 
            Because of the profound changes in longevity-defining processes in mitochondria, 
resistance to chronic (long-term) stresses, susceptibility to mitochondria-controlled 
apoptosis, and frequencies of mutations in mitochondrial and nuclear DNA that we 
observed in the single-gene-deletion mutant strain pex5Δ under CR conditions, our 
laboratory chose this short-lived strain for carrying out a chemical genetic screen for 
novel anti-aging compounds. This screen was designed to identify small molecules that 
increase the chronological lifespan of yeast under CR conditions by targeting lipid 
metabolism and modulating housekeeping longevity assurance pathways. The screen 
identified LCA, a bile acid, as one of these novel anti-aging compounds. The described 
here pleiotropic effect of LCA on a compendium of housekeeping longevity assurance 
processes implies that this bile acid is a multi-target life-extending compound that 
increases chronological lifespan in yeast by modulating a network of the highly 
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            We provide evidence that in yeast grown under CR conditions on 0.2% glucose, 
there are two critical periods when the addition of LCA to growth medium can increase 
both their mean and maximum chronological lifespans. One of these two critical periods 
includes logarithmic and diauxic growth phases, whereas the other period exists in the 
early stationary (ST) phase of growth. In contrast, LCA does not cause a significant 
extension of the mean or maximum chronological lifespan of CR yeast if it is added in 
post-diauxic or late ST growth phases. 
            Because aging of multicellular and unicellular eukaryotic organisms affects 
numerous anti- and pro-aging processes within cells [2, 3, 7, 9, 14, 17 - 21, 27 - 36], we 
hypothesized that the observed ability of LCA to delay chronological aging of yeast 
grown under CR conditions only if added at certain critical periods (checkpoints) of their 
lifespan could be due to its differential effects on certain anti- and pro-aging processes at 
different checkpoints. To test the validity of our hypothesis, in studies described in this 
chapter of my thesis we examined how the addition of LCA at different periods of 
chronological lifespan in yeast grown under CR conditions influences anti- and pro-aging 
processes taking place during each of these periods. Our empirical validation of this 
hypothesis suggests a mechanism linking the ability of LCA to delay chronological aging 
of yeast only if added at certain periods (checkpoints) of their lifespan to the differential 
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effects of this natural anti-aging compound on certain anti- and pro-aging processes at 
each of these checkpoints.  
 
7.2 Introduction 
         One way to look at the complexity of the aging process, in which a limited number 
of master regulators orchestrate numerous cellular processes in space and time [3, 4, 6, 
17, 31, 33, 36], is to consider each of these processes as a functional module integrated 
with other modules into a longevity network [1, 6, 8, 31, 32]. The synergistic action of 
individual modules could establish the rate of aging. Furthermore, the relative impact of 
each module on the rate of aging in a particular organism or cell type could differ at 
various stages of its lifetime and could also vary in different organisms and cell types [1, 
6, 8, 31, 32]. In this conceptual framework, the longevity network could progress through 
a series of checkpoints. At each of these checkpoints, a distinct set of master regulators 
senses the functional states of critical modules comprising the network. Based on this 
information and considering the input of some environmental cues (such as caloric and 
dietary intake, environmental stresses, endocrine factors, etc.), master regulators 
modulate certain processes within monitored modules in order to limit the age-related 
accumulation of molecular and cellular damage [31, 32]. The resulting changes in the 
dynamics of individual modules comprising the network and in its general configuration 
are critically important for specifying the rate of aging during late adulthood. 
          A confirmation of this concept for a stepwise development of a longevity network 
configuration at a series of checkpoints, each being monitored by a limited set of 
checkpoint-specific master regulators, comes from studies that revealed distinctive timing 
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requirements for modulating the pace of chronological aging in the nematode 
Caenorhabditis elegans. It seems that this organism employs at least three independent 
regulatory systems that, by monitoring a particular cellular process or processes during a 
specific stage of life, use this information to establish the rate of chronological aging later 
in life (Figure 7.1A). The first of these three regulatory systems influences lifespan by 
operating only during larval development [261 - 263]. By monitoring mitochondrial 
respiration, electrochemical potential and ATP production early in life, during the L3/L4 
larval stage, it establishes the rate of chronological aging that persists during adulthood 
[261 - 263] (Figure 7.1A). Mechanisms underlying the essential role of this first 
regulatory system in defining longevity of C. elegans may involve 1) a remodeling of 
mitochondria-confined ATP production pathways during larval development, which may 
establish a specific configuration of the longevity-defining metabolic network in a cell-
autonomous manner [265, 266]; and 2) a retrograde signalling pathway that in response 
to mild mitochondrial impairment and stress during the L3/L4 larval stage activates UBL-
5/DVE-1-driven expression of the mitochondria-specific unfolded protein response 
(UPRmt) genes in the nucleus, thereby stimulating synthesis of a subset of UPRmt proteins 
that can extend longevity not only cell-autonomously but also in a cell-non-autonomous 
fashion [267, 268]. The second regulatory system operates exclusively during adulthood, 
mainly during early adulthood, to influence the lifespan of C. elegans via the insulin/IGF-
1 longevity signaling pathway and the transcription factor DAF-16 (Figure 7.1A) [269 - 
271]. Of note, the magnitude of the effect of this second regulatory system on lifespan 
declines with age, becoming insignificant after several days of adulthood [269]. The third 
regulatory system influences the lifespan of C. elegans in a diet-restriction-specific 
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fashion by operating exclusively during adulthood (Figure 7.1A) [272]. This system 
regulates longevity via the transcription factor PHA-4 only in response to reduced food 
intake. Importantly, the PHA-4-mediated regulatory system operates independently of the 
other two regulatory systems modulating the rate of chronological aging in C. elegans 
(Figure 7.1A) [272]. In the concept for a stepwise development of a longevity network 
configuration at a series of checkpoints, a genetic, dietary or pharmacological anti-aging 
intervention may modulate the key cellular process or processes that are monitored at a 
particular checkpoint by a master regulator of the longevity control system. In C. elegans, 
UBL-5/DVE-1, DAF-16 and PHA-4 may function as the checkpoint-specific master 
regulators of chronological lifespan by governing progression through the three 
consecutive checkpoints operating during larval development and early adulthood (Figure 
7.1A) [267, 269 - 272].  
          Importantly, some general aspects of the proposed concept of the longevity control 
system progressing through a series of checkpoints could be applicable to laboratory mice 
and rats. In fact, although a caloric restriction (CR) diet considerably extends lifespan in 
these organisms even if it is implemented at the age at which skeletal development is 
complete, the maximal benefit of this low-calorie diet for longevity can be achieved only 
if CR is initiated during the rapid growth period [273 - 275].  It is tempting to speculate 
that rodents 1) employ a CR-dependent longevity control system that, by monitoring 
some key, longevity-defining cellular processes, can establish a particular rate of 
chronological aging; and 2) have at least two checkpoints, one in early adulthood and 
another in late adulthood, at which the proposed CR-dependent longevity control system 
senses the rate and/or efficiency of the critical cellular processes that define longevity 
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(Figure 7.1B). It is conceivable therefore that the proposed CR-dependent longevity 
control system in rodents can extend longevity even if the rate and efficiency of the 
critical, CR-modulated cellular processes are appropriate only at the late-adulthood 
checkpoint, but not as markedly as if they are suitable already at the checkpoint in early 
adulthood.   
 
Figure 7.1. A concept for a stepwise development of a longevity network configuration at a series of 
checkpoints. In this concept, a genetic, dietary or pharmacological anti-aging intervention may modulate 
the key cellular process or processes that are monitored at a particular checkpoint by a master regulator of 
the longevity control system. (A) In C. elegans, UBL-5/DVE-1, DAF-16 and PHA-4 may function as the 
checkpoint-specific master regulators of chronological lifespan by governing progression through the three 
consecutive checkpoints operating during larval development and early adulthood. (B) In laboratory mice 
and rats, a CR-dependent longevity control system can establish a particular rate of chronological aging by 
monitoring some key, longevity-defining cellular processes at the two consecutive checkpoints operating 
during early and late adulthood, respectively. 
 
          According to the concept for a stepwise development of a longevity network 
configuration at a series of checkpoints, a pharmacological anti-aging intervention may 
 148
modulate the key longevity-defining cellular processes that are monitored at a particular 
checkpoint by a master regulator of the longevity control system. Several 
pharmacological anti-aging interventions are currently known for their ability to extend 
longevity across phyla and improve health by beneficially influencing age-related 
pathologies (Table 7.1). Only one of these anti-aging compounds, a macrocyclic lactone 
rapamycin synthesized by soil bacteria to inhibit growth of fungal competitors [276 - 
278], has been examined for its effects on lifespan and healthspan if implemented at 
different ages of an organism. If fed to genetically heterogeneous mice beginning at 270 
days or 600 days of age (i.e., at the ages approximately equivalent to 27 or 60 years, 
respectively, in humans), this specific inhibitor of the nutrient-sensory protein kinase 
mTORC1 has been shown to be equally efficient in extending lifespan and beneficially 
influencing age-related pathologies [279 - 284]. Our recent studies provided evidence that 
1) lithocholic acid (LCA), a bile acid, extends longevity of chronologically aging yeast if 
added to growth medium at the time of cell inoculation [40, 114]; and 2) longevity in 
chronologically aging yeast is programmed by the level of metabolic capacity and 
organelle organization they developed, in a diet-specific fashion, prior to entry into a 
non-proliferative state - and, thus, that chronological aging in yeast is the final step of a 
developmental program progressing through at least one checkpoint prior to entry into 
quiescence [32, 110, 114]. We therefore decided to investigate how LCA influences 
longevity and a compendium of longevity-defining cellular processes in chronologically 
aging yeast if added to growth medium at different periods of their lifespan. 
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Table 7.1. Known anti-aging compounds, their abilities to increase life span in different organisms (under 
caloric or dietary restriction [CR or DR, respectively], on a standard diet or fed a high-calorie diet), and the 
mechanisms of their anti-aging action. 
Compound  
 
Increases life span* Mechanism  




Caffeine Not tested (NT)  
 
+ (yeast, CLS) 
[285]  
 




governed by the TOR 
pathway [286, 287] 






transcription of genes 







processes [288] known 
to be influenced by 
age-related chromatin 
reorganization [289] 
Lipoic acid, propyl 





[290] (all); fruit 
flies [291] (lipoic 
acid))  
 
Antioxidants that may 





oxidative stress [290, 
291] 
Metformin, buformin 






[292]; mice [293]) 
 
Type 2 diabetes 
therapeutics that - by 
activating 
LKB1/AMPK 
signaling and thereby 
inhibiting TORC1 
[294, 295] - modulate 
unspecified longevity-
related processes [292, 
293] known to be 
governed by the TOR 
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increases life span - 












A serotonin receptor 
antagonist used as an 
antidepressant in 
humans; may increase 
life span by inhibiting 
neurotransmission 
related to food 
sensing, thereby 





+ (fruit flies) [299] 
 
+ (yeast, CLS 
[285, 296, 300] 
and RLS [301]; 
fruit flies [299]; 




- all RLS [296])  
 
By inhibiting TORC1 
(yeast and fruit flies) 
[285, 287, 299, 300] 
and mTORC1 
(mammals) [295, 287, 
302], increases life 
span by activating 
macroautophagy 
(yeast and fruit flies) 
[299, 303] and 
inhibiting cap-
dependent protein 
translation (fruit flies 
and mice) [299, 302] 






[296, 301], and 
increasing neutral lipid 
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- (yeast, RLS 
[304]; fruit flies 
[305]; mice [306])  
 
+ (yeast, RLS 
[304] but not CLS 
[304]; nematodes 
[305]; fruit flies 
[305]; fishes 





Increases life span by 
modulating a number 
of longevity-related 
processes (e.g., by 
altering transcription 
of numerous genes 






mitochondrial number,  
reducing IGF-1 levels, 
activating AMPK and 
PGC-1α, promoting 
ER stress response, 
repressing 
transcription of PPAR-






autophagy [304, 306, 
308 - 316]; its life-
extending ability in 
yeast, nematodes and 
fruit flies depends on 
Sir2p - a member of 











+ (fungi, daphnias, 
fruit flies, mice) 
[317]  
 
By being specifically 
targeted to 
mitochondria, acts as 
an antioxidant that 
may increase life span 
by preventing 
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oxidative damage to 





induced apoptosis and 
necrosis, and/or 
slowing down the age-
related 
phosphorylation of 
histone H2AX [317] 








expression of the 
human sirtuin SIRT1 
and thereby increasing 
the extent of SIRT1-
dependent histone H4 
lysine 16 
deacetylation, may 
cause the development 
of an anti-aging 
pattern of transcription 
of numerous genes 












By inhibiting histone 
acetyltransferases and 
promoting histone H3 
deacetylation, 




related genes; the 
resulting induction of 
autophagy suppresses 
age-related necrotic 
cell death [319] 







Is used as a mood 
stabilizer and an 
anticonvulsant in 
humans; may increase 
life span by promoting 
nuclear localization of 
the DAF-16 forkhead 
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transcription factor, 
thereby reducing the 












An inhibitor of 
phosphatidylinositol-
3-kinase that – by 
reducing mTORC1 
signaling [286, 287] – 
modulates unspecified 
longevity-related 
processes [321] known 
to be governed by the 










An inhibitor of the 
protein kinase MEK 
that – by reducing 
mTORC1 signaling 
[286, 287] – 
modulates unspecified 
longevity-related 
processes [321] known 
to be governed by the 
TOR pathway [286, 
287, 295] 
Aspirin NT + male, but not 




compound that inhibits 
the cyclooxygenases 
COX-1 and COX-2  
and activates the NF-
kappaB signaling 
pathway [331 - 336]  
Nordihydroguaiaretic 
acid 
NT + fruit flies [337]; 
mosquitoes [338]; 
rats [339]; male, 













activities of the 
insulin-like growth 





synthesis [340 - 347]  
 
* Mean, median and/or maximum life spans. 
** Nematodes carrying mutations that mimic DR under non-DR conditions [288, 290]. 
*** The ability of mianserin to increase nematode life span can only be seen in liquid media [298], whereas 
in solid media the compound reduces life span [322]. 
**** Increases the replicative life span of yeast grown under non-CR conditions [304] only in one out of four 
different yeast strain backgrounds [323]; one group has been unable to reproduce the life span extension by 
resveratrol in nematodes and fruit flies [324]; increases the life of mice only if fed a high-calorie diet, but 
not a standard diet [306, 309]. 
***** Although the life-extending ability of resveratrol in yeast, nematodes and fruit flies depends on Sir2p 
[304, 305, 310], it is currently debated whether this anti-aging compound binds to Sir2p (or SIRT1, a 
mammalian sirtuin) in vivo and/or activates Sir2p or SIRT1 in living cells [311, 323 - 327]; importantly, 
resveratrol has been shown to inhibit or activate many proteins other than sirtuins by interacting with them 
[328, 329].   
Abbreviations: AMPK, the AMP-activated serine/threonine protein kinase; CLS, chronological life span; 
IGF-1, insulin-like growth factor 1; LKB1, a serine/threonine protein kinase that phosphorylates and 
activates AMPK; mTORC1, the mammalian target of rapamycin complex 1; NT, not tested; PBMC, 
peripheral blood mononuclear cells; PGC-1α, peroxisome proliferator-activated receptor-γ co-activator 1α; 
RLS, replicative life span; TORC1, the yeast target of rapamycin complex 1. 
 
          Studies described in this chapter of the thesis provide evidence that LCA extends 
longevity of chronologically aging yeast only if added at certain critical periods of their 
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lifespan. Our findings imply that 1) during the lifespan of yeast grown under CR 
conditions on 0.2% glucose, there are two critical periods (checkpoints) when the 
addition of LCA can extend longevity; 2) one of these two critical periods, which we call 
period 1, includes logarithmic (L) and diauxic (D) growth phases; 3) the other critical 
period, which is called period 3, exists in the early stationary (ST) phase of growth; 4) 
LCA does not extend longevity of chronologically aging yeast if added at periods 2 or 4 
(which exist in post-diauxic (PD) or late ST growth phases, respectively); and 5) the 
observed ability of LCA to extend longevity of CR yeast only if it added at periods 1 or 3 
of their lifespan is due to differential effects of this bile acid on various anti- and pro-
aging processes at different checkpoints. 
 
7.3 Materials and Methods 
Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0) was grown in YP medium (1% yeast extract, 2% peptone) containing 0.2% or 
2% glucose as carbon source. Cells were cultured at 30oC with rotational shaking at 200 
rpm in Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1. 
 
Chronological lifespan assay 
A sample of cells was taken from a culture at a certain time-point. A fraction of the 
sample was diluted in order to determine the total number of cells using a 
hemacytometer. Another fraction of the cell sample was diluted and serial dilutions of 
cells were plated in duplicate onto YP plates containing 2% glucose as carbon source. 
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After 2 d of incubation at 30oC, the number of colony forming units (CFU) per plate was 
counted. The number of CFU was defined as the number of viable cells in a sample. For 
each culture, the percentage of viable cells was calculated as follows: (number of viable 
cells per ml/total number of cells per ml) × 100. The percentage of viable cells in mid-
logarithmic phase was set at 100%. The lifespan curves were validated using a 
LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's instructions. 
 
Pharmacological manipulation of chronological lifespan 
Chronological lifespan analysis was performed as described above in this section. The 
lithocholic (LCA; L6250) bile acid was from Sigma. The stock solution of LCA in 
DMSO was made on the day of adding this compound to cell cultures. LCA was added to 
growth medium at the final concentration of 50 µM immediately following cell 
inoculation into the medium or on days 1, 2, 3, 5, 7, 9, 11 or 14 of cell culturing in the 
medium, as indicated. The final concentration of DMSO in yeast cultures supplemented 
with LCA (and in the corresponding control cultures supplemented with drug vehicle) 
was 1% (v/v). 
 
Cell viability assay for monitoring the susceptibility of yeast to an apoptotic mode of 
cell death induced by hydrogen peroxide  
A sample of cells was taken from a culture at a certain time-point. A fraction of the 
sample was diluted in order to determine the total number of cells using a 
hemacytometer. 2 × 107 cells were harvested by centrifugation for 1 min at 21,000 × g at 
room temperature and resuspended in 2 ml of YP medium containing 0.2% glucose as 
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carbon source. Each cell suspension was divided into 2 equal aliquots. One aliquot was 
supplemented with hydrogen peroxide to the final concentration of 2.5 mM, whereas 
other aliquot remained untreated. Both aliquots were then incubated for 2 h at 30oC on a 
Labquake rotator set for 360o rotation. Serial dilutions of cells were plated in duplicate 
onto plates containing YP medium with 2% glucose as carbon source. After 2 d of 
incubation at 30oC, the number of colony forming units (CFU) per plate was counted. 
The number of CFU was defined as the number of viable cells in a sample. For each 
aliquot of cells exposed to hydrogen peroxide, the % of viable cells was calculated as 
follows: (number of viable cells per ml in the aliquot exposed to hydrogen 
peroxide/number of viable cells per ml in the control aliquot that was not exposed to 
hydrogen peroxide) × 100.  
 
Cell viability assay for monitoring the susceptibility of yeast to a necrotic mode of 
cell death induced by palmitoleic acid  
A sample of cells was taken from a culture at a certain time-point. A fraction of the 
sample was diluted in order to determine the total number of cells using a 
hemacytometer. 2 × 107 cells were harvested by centrifugation for 1 min at 21,000 × g at 
room temperature and resuspended in 2 ml of YP medium containing 0.2% glucose as 
carbon source. Each cell suspension was divided into 2 equal aliquots. One aliquot was 
supplemented with palmitoleic acid from a 50 mM stock solution (in 10% chloroform, 
45% hexane and 45% ethanol); the final concentration of palmitoleic acid was 0.15 mM 
(in 0.03% chloroform, 0.135% hexane and 0.135% ethanol). Other aliquot was 
supplemented with chloroform, hexane and ethanol added to the final concentrations of 
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0.03%, 0.135% and 0.135%, respectively. Both aliquots were then incubated for 2 h at 
30oC on a Labquake rotator set for 360o rotation. Serial dilutions of cells were plated in 
duplicate onto plates containing YP medium with 2% glucose as carbon source. After 2 d 
of incubation at 30oC, the number of colony forming units (CFU) per plate was counted. 
The number of CFU was defined as the number of viable cells in a sample. For each 
aliquot of cells exposed to palmitoleic acid, the % of viable cells was calculated as 
follows: (number of viable cells per ml in the aliquot exposed to palmitoleic acid/number 
of viable cells per ml in the control aliquot that was not exposed to palmitoleic acid) × 
100.  
 
Measurement of the frequency of nuclear mutations  
The frequency of spontaneous point mutations in the CAN1 gene of nuclear DNA was 
evaluated by measuring the frequency of mutations that caused resistance to the antibiotic 
canavanine [260]. A sample of cells was removed from each culture at various time-
points. Cells were plated in triplicate onto YNB (0.67% Yeast Nitrogen Base without 
amino acids) plates containing 2% glucose, L-canavanine (50 mg/L), histidine, leucine, 
lysine and uracil. In addition, serial dilutions of each sample were plated in triplicate onto 
YP plates containing 2% glucose for measuring the number of viable cells. The number 
of CFU was counted after 4 d of incubation at 30oC. For each culture, the frequency of 
mutations that caused resistance to canavanine was calculated as follows: number of CFU 
per ml on YNB plates containing 2% glucose, L-canavanine (50 mg/L), histidine, leucine, 
lysine and uracil/number of CFU per ml on YP plates containing 2% glucose. 
 
 159
Measurement of the frequency of mitochondrial mutations affecting mitochondrial 
components 
The frequency of spontaneous single-gene (mit- and syn-) and deletion (rho- and rhoo) 
mutations in mtDNA affecting essential mitochondrial components was evaluated by 
measuring the fraction of respiratory-competent (rho+) yeast cells remaining in their 
aging population. rho+ cells maintained intact their mtDNA and their nuclear genes 
encoding essential mitochondrial components. Therefore, rho+ cells were able to grow on 
glycerol, a non-fermentable carbon source. In contrast, mutant cells deficient in 
mitochondrial respiration were unable to grow on glycerol. These mutant cells carried 
mutations in mtDNA (including single-gene mit- and syn- mutations or large deletions 
rho-) or completely lacked this DNA (rhoo mutants) [140]. Serial dilutions of cell samples 
removed from different phases of growth were plated in triplicate onto YP plates 
containing either 2% glucose or 3% glycerol as carbon source. Plates were incubated at 
30oC. The number of CFU on YP plates containing 2% glucose was counted after 2 d of 
incubation, whereas the number of CFU on YP plates containing 3% glycerol was 
counted after 6 d of incubation. For each culture, the percentage of respiratory-deficient 
(mit-, syn-, rho-, rhoo and pet-) cells was calculated as follows: 100 - [(number of CFU per 
ml on YP plates containing 3% glycerol/number of CFU per ml on YP plates containing 
2% glucose) × 100].  
          The frequency of spontaneous point mutations in the rib2 and rib3 loci of mtDNA 
was evaluated by measuring the frequency of mtDNA mutations that caused resistance to 
the antibiotic erythromycin [141]. These mutations impair only mtDNA [142, 143]. A 
sample of cells was removed from each culture at various time-points. Cells were plated 
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in triplicate onto YP plates containing 3% glycerol and erythromycin (1 mg/ml). In 
addition, serial dilutions of each sample were plated in triplicate onto YP plates 
containing 3% glycerol as carbon source for measuring the number of respiratory-
competent (rho+) cells. The number of CFU was counted after 6 d of incubation at 30oC. 
For each culture, the frequency of mutations that caused resistance to erythromycin was 
calculated as follows: number of CFU per ml on YP plates containing 3% glycerol and 
erythromycin/number of CFU per ml on YP plates containing 3% glycerol.  
 
Plating assays for the analysis of resistance to various stresses 
For the analysis of hydrogen peroxide (oxidative stress) resistance, serial dilutions (1:100 
to 1:105) of cells removed from each culture at various time-points were spotted onto two 
sets of plates. One set of plates contained YP medium with 2% glucose alone, whereas 
the other set contained YP medium with 2% glucose supplemented with 5 mM hydrogen 
peroxide. Pictures were taken after a 3-day incubation at 30oC. 
          For the analysis of thermal stress resistance, serial dilutions (1:100 to 1:105) of 
wild-type and mutant cells removed from each culture at various time-points were spotted 
onto two sets of plates containing YP medium with 2% glucose. One set of plates was 
incubated at 30oC. The other set of plates was initially incubated at 55oC for 30 min, and 
was then transferred to 30oC. Pictures were taken after a 3-day incubation at 30oC. 
          For the analysis of osmotic stress resistance, serial dilutions (1:100 to 1:105) of 
wild-type and mutant cells removed from each culture at various time-points were spotted 
onto two sets of plates. One set of plates contained YP medium with 2% glucose alone, 
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whereas the other set contained YP medium with 2% glucose supplemented with 1 M 
sorbitol. Pictures were taken after a 3-day incubation at 30oC. 
 
Statistical analysis 
Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated using an 




7.4.1 LCA delays chronological aging of yeast grown under CR or non-CR 
conditions only if added at certain critical periods of their lifespan 
            We sought to examine if the addition of LCA to chronologically aging yeast at 
different periods of their lifespan has an effect on the longevity-extending efficacy of this 
bile acid. Yeast were grown in YP medium under CR conditions on 0.2% glucose or 
under non-CR conditions on 2% glucose, and LCA was added to a cell culture 
immediately following cell inoculation into the medium (on day 0) or on days 1, 2, 3, 5, 
7, 9, 11 or 14 of cell culturing in this growth medium. LCA was used at the final 
concentration of 50 µM, at which this natural anti-aging compound has been shown to 
exhibit the greatest beneficial effect on longevity of chronologically aging yeast under 




Figure 7.2. In yeast grown under CR conditions on 0.2% glucose, there are two critical periods when the 
addition of LCA to growth medium can extend longevity. Yeast were cultured in YP medium initially 
containing 0.2% glucose, and LCA was added at the final concentration of 50 µM to a cell culture 
immediately following cell inoculation into the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 14 of 
cell culturing in this growth medium. Chronological lifespan analysis was performed as described in 
“Materials and Methods”. Data are presented as mean ± SEM (n = 8).  Abbreviations: diauxic (D), 




Figure 7.3. In yeast grown under non-CR conditions on 2% glucose, there is only one critical period when 
the addition of LCA to growth medium can extend longevity. Yeast were cultured in YP medium initially 
containing 2% glucose, and LCA was added at the final concentration of 50 µM to a cell culture 
immediately following cell inoculation into the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 14 of 
cell culturing in this growth medium. Chronological lifespan analysis was performed as described in 
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“Materials and Methods”. Data are presented as mean ± SEM (n = 5-6).  Abbreviations: diauxic (D), 
logarithmic (L), post-diauxic (PD) or stationary (ST) phase. 
 
 
Figure 7.4. In yeast grown under CR conditions on 0.2% glucose, there are two critical periods when the 
addition of LCA to growth medium can extend longevity. In yeast grown under non-CR conditions on 2% 
glucose, there is only one such a period. The mean (A) and maximum (B) chronological lifespans of 
different yeast cultures are shown. Yeast were cultured under CR or non-CR conditions and LCA was 
added as described in the legends for Figures 7.2 and 7.3, respectively. Chronological lifespan analysis was 
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performed as described in “Materials and Methods”. Data are presented as mean ± SEM (n = 5-8); *p < 
0.01 (relative to the mean or maximum chronological lifespan of yeast not exposed to LCA). 
Abbreviations: diauxic (D), logarithmic (L), post-diauxic (PD) or stationary (ST) phase. 
 
            We found that in yeast grown under CR conditions on 0.2% glucose, there are two 
critical periods when the addition of LCA to growth medium can increase both their 
mean and maximum chronological lifespans (Figures 7.2 and 7.4). One of these two 
critical periods, which we call period 1, includes logarithmic (L) and diauxic (D) growth 
phases. The other critical period, which is called period 3, exists in the early stationary 
(ST) phase of growth. In contrast, LCA did not cause a significant extension of the mean 
or maximum chronological lifespan of CR yeast if it was added at periods 2 or 4; these 
two periods exist in post-diauxic (PD) or late ST growth phases, respectively (Figures 7.2 
and 7.4).   
            We also found that in yeast grown under non-CR conditions on 2% glucose, there 
is only one critical period, during L and D phases, when the addition of LCA to growth 
medium can increase both their mean and maximum chronological lifespans (Figures 7.3 
and 7.4). However, if LCA was added to non-CR yeast at any time-point after this critical 
period ended, it did not cause a significant extension of their mean or maximum 
chronological lifespan (Figures 7.3 and 7.4). Thus, unlike a substantial beneficial effect 
of LCA on yeast longevity seen if it was added in early ST phase under CR conditions, 
this bile acid was unable to delay yeast chronological aging under non-CR conditions if 
added in the same phase of growth.  
 
 166
7.4.2 The ways through which LCA could differentially influence longevity if 
added to CR yeast at different periods of their lifespan  
            Aging of multicellular and unicellular eukaryotic organisms affects numerous 
anti- and pro-aging processes within cells [2, 3, 7, 9, 14, 17 - 21, 27 - 36]. It is 
conceivable therefore that the observed ability of LCA to delay chronological aging of 
yeast grown under CR conditions only if added at certain critical periods (checkpoints) of 
their lifespan could be due to its differential effects on certain anti- and pro-aging 
processes at different checkpoints. There are several ways through which LCA could 
differentially influence some anti- and pro-aging processes if it is added at different 
checkpoints of the chronological lifespan of yeast (Figure 7.5). For example, LCA could 
activate an anti-aging process (or several processes) during the checkpoints 1 and 2 in 
L/D and early ST growth phases (respectively), without influencing pro-aging processes 
during these checkpoints or having an effect on anti- and pro-aging processes during PD 
and late ST phases (Figure 7.5; the 1st way). Alternatively, LCA could inhibit a pro-aging 
process (or several processes) during the checkpoints 1 and 2 in L/D and early ST phases 
(respectively), without influencing anti-aging processes during these checkpoints or 
having an effect on anti- and pro-aging processes during PD and late ST phases (Figure 
7.5; the 2nd way). Moreover, the observed ability of LCA to delay chronological aging of 
yeast grown under CR conditions only if added at certain checkpoints of their lifespan 
could be also due to various combinations of the 1st and the 2nd ways outlined above 
(Figure 7.5; other ways). We therefore sought to examine how the addition of LCA at 
different periods of chronological lifespan in yeast grown under CR conditions influences 
anti- and pro-aging processes taking place during each of these periods.  
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Figure 7.5. There are several ways through which LCA could differentially influence some anti- and pro-
aging processes if it is added at different checkpoints of the chronological lifespan of yeast. In the 1st way, 
LCA could activate an anti-aging process (or several processes) during the checkpoints 1 and 2 in L/D and 
early ST growth phases (respectively), without influencing pro-aging processes during these checkpoints or 
having an effect on anti- and pro-aging processes during PD and late ST phases. In the 2nd way, LCA could 
inhibit a pro-aging process (or several processes) during the checkpoints 1 and 2 in L/D and early ST 
phases (respectively), without influencing anti-aging processes during these checkpoints or having an effect 
on anti- and pro-aging processes during PD and late ST phases. The observed ability of LCA to delay 
chronological aging of yeast grown under CR conditions only if added at certain checkpoints of their 
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lifespan could be also due to various combinations of the 1st and the 2nd ways, here referred to as “other 
ways”. 
 
7.4.3 LCA makes yeast cells resistant to mitochondria-controlled apoptotic death, 
a pro-aging process, only if added at periods 1, 2 or 3 of their chronological 
lifespan 
            A short-term exposure of yeast to hydrogen peroxide, acetic acid, hyperosmotic 
stress or α pheromone causes apoptotic cell death [348 - 351] that has been linked to 
mitochondrial fragmentation, mitochondrial outer membrane permeabilization and the 
release of several intermembrane space proteins from mitochondria [352 - 359]. The exit 
of the apoptosis inducing factor Aif1p and endonuclease G (Nuc1p) from yeast 
mitochondria and their subsequent import into the nucleus trigger such exogenously 
induced apoptosis by promoting DNA cleavage [354, 357]. Another intermembrane space 
protein that is released from yeast mitochondria during exogenously induced apoptosis is 
cytochrome c [352, 355, 359]. Although some data suggest that - akin to its essential role 
in triggering the apoptotic caspase cascade in mammalian cells [360, 361] - cytochrome c 
in the cytosol of yeast cells activates the metacaspase Yca1p [355, 362 - 365], the 
involvement of cytosolic cytochrome c in Yca1p activation remains a controversial issue 
[359, 366]. Importantly, chronologically aging yeast die, in an Aif1p-, Nuc1p- and 
Yca1p-dependent fashion, exhibiting characteristic markers of apoptosis such as 
chromatin condensation, nuclear fragmentation, DNA cleavage, phosphatidylserine 
externalization, ROS production and caspase activation [354, 357, 367 - 370]. Thus, the 
chronological aging of yeast is linked to an apoptosis-like, mitochondria-controlled 




Figure 7.6. LCA makes yeast cells resistant to mitochondria-controlled apoptotic death, a pro-aging 
process, only if added at periods 1, 2 or 3 of their chronological lifespan. Yeast were cultured in YP 
medium initially containing 0.2% glucose, and LCA was added at the final concentration of 50 µM to a cell 
culture immediately following cell inoculation into the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 
14 of cell culturing in this growth medium. Cell viability assay for monitoring the susceptibility of yeast to 
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an apoptotic mode of cell death induced by a 1-h exposure to exogenous hydrogen peroxide was performed 
as described in “Materials and Methods”. Data are presented as mean ± SEM (n = 3 - 5); *p < 0.01 (relative 
to the % of alive cells in yeast cultures not exposed to LCA). Abbreviations: diauxic (D), logarithmic (L), 
post-diauxic (PD) or stationary (ST) phase. 
 
pro-apoptotic proteins as well as such potent anti-aging interventions as a CR diet and 
LCA 1) extend longevity of chronologically aging yeast; 2) delay age-related apoptotic  
death controlled by mitochondria; and 3) reduce the susceptibility of yeast to cell death 
triggered by a short-term exposure to exogenous hydrogen peroxide and known to be 
caused by mitochondria-controlled apoptosis [32, 40, 114, 348, 349, 351, 353, 354, 357, 
367 - 375].   
            Taken together, these findings strongly support the notion that mitochondria-
controlled apoptotic death plays an essential role in regulating longevity of 
chronologically aging yeast. This form of longevity-defining cell death can be triggered 
by a brief exposure of yeast to exogenous hydrogen peroxide [32, 40, 348, 349, 351, 
353]. We therefore examined how the addition of LCA at different periods of 
chronological lifespan influences a pro-aging process of mitochondria-controlled 
apoptotic cell death in yeast grown under CR on 0.2% glucose. To attain this objective, 
we monitored the susceptibility of yeast to cell death triggered by a short-term (for 1 h) 
exposure to exogenous hydrogen peroxide known to cause mitochondria-controlled 
apoptosis. We found that if added to growth medium on days 0, 1, 2, 3, 5, 7, 9 or 11, 
LCA reduces the susceptibility of CR yeast to apoptosis induced by a brief exposure to 
exogenous hydrogen peroxide following LCA addition (Figure 7.6). In contrast, if added 
to growth medium on day 14, LCA does not have effect on the susceptibility of CR yeast 
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to this form of apoptotic cell death (Figure 7.6). Thus, LCA makes yeast cells resistant to 
mitochondria-controlled apoptotic death, a pro-aging process, only if added at periods 1, 
2 or 3 of their chronological lifespan. Period 1 includes L and D growth phases, period 2 
exists in PD phase, whereas periods 3 and 4 include early and late ST phases 
(respectively) (Figures 7.4 and 7.5).  
 
7.4.4 LCA differentially influences the susceptibility of chronologically aging yeast 
to palmitoleic acid-induced necrotic cell death, a pro-aging process, if added 
at different periods of their lifespan 
            In our model for a mechanism linking yeast longevity and lipid dynamics in the 
endoplasmic reticulum, lipid bodies and peroxisomes (Figure 5.5), a remodeling of lipid 
metabolism in chronologically aging non-CR yeast shortens their lifespan by causing 
premature death in part due to necrotic cell death triggered by the accumulation of free 
fatty acids [32, 40, 44, 110, 114]. Importantly, both CR and LCA not only extend 
longevity of chronologically aging yeast but also reduce their susceptibility to a form of 
necrotic cell death triggered by a short-term exposure to exogenous palmitoleic fatty acid 
[32, 40, 44, 110, 114]. These imply that palmitoleic acid-induced necrotic cell death plays 
an essential role in regulating longevity of chronologically aging yeast. We therefore 
examined how the addition of LCA at different periods of chronological lifespan 
influences a pro-aging process of necrotic cell death in yeast grown under CR on 0.2% 
glucose. To attain this objective, we monitored the susceptibility of yeast to cell death 
triggered by a short-term (for 2 h) exposure to exogenous palmitoleic acid. We found that 
if added to growth medium on days 0, 1 or 2, LCA reduces the susceptibility of CR yeast  
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Figure 7.7. LCA differentially influences the susceptibility of chronologically aging yeast to palmitoleic 
acid-induced necrotic cell death, a pro-aging process, if added at different periods of their lifespan. Yeast 
were cultured in YP medium initially containing 0.2% glucose, and LCA was added at the final 
concentration of 50 µM to a cell culture immediately following cell inoculation into the medium (on day 0) 
or on days 1, 2, 3, 5, 7, 9, 11 or 14 of cell culturing in this growth medium. Cell viability assay for 
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monitoring the susceptibility of yeast to a necrotic mode of cell death induced by a 2-h exposure to 
exogenous palmitoleic acid was performed as described in “Materials and Methods”. Data are presented as 
mean ± SEM (n = 4); *p < 0.01 (relative to the % of alive cells in yeast cultures not exposed to LCA). 
Abbreviations: diauxic (D), logarithmic (L), post-diauxic (PD) or stationary (ST) phase. 
 
to necrosis induced by a brief exposure to palmitoleic acid following LCA addition 
(Figure 7.7). In contrast, LCA either does not influence (if added on days 3, 9, 11 or 14) 
or increases (if added on days 5 or 7) the susceptibility of CR yeast to this form of 
necrotic cell death (Figure 7.7). 
            Thus, LCA makes yeast cells resistant to palmitoleic acid-induced necrotic death, 
a pro-aging process, only if added at period 1 of their chronological lifespan; this period 
includes L and D growth phases when LCA addition can extend longevity (Figures 7.2, 
7.4 and 7.5).  It is conceivable that the observed inability of LCA to delay aging of yeast 
if added at period 2 of their chronological lifespan (Figures 7.2 and 7.4) could be due to 
its stimulating effect on the pro-aging process of necrotic cell death (Figure 7.7); this 
period exists in PD phase (Figures 7.4 and 7.5). Furthermore, despite LCA extends 
longevity of chronologically aging yeast if added at period 3 (which includes early ST 
phase; see Figures 7.2, 7.4 and 7.5), it does not affect their susceptibility to necrotic cell 
death if added at this period (Figure 7.7). Moreover, the observed lack of an effect of 
LCA on yeast longevity if added at period 4 of chronological lifespan (Figures 7.2, 7.4 
and 7.5) coincides with its inability to alter cell susceptibility to necrotic cell death if 
added at this period in late ST phase (Figure 7.7).   
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7.4.5 In chronologically aging yeast, LCA differentially influences the anti-aging 
processes of nuclear and mitochondrial genomes maintenance if added at 
different periods of their lifespan 
            A body of evidence supports the view that the maintenance of nuclear DNA 
(nDNA) and mitochondrial DNA (mtDNA) integrity is an essential anti-aging process in 
evolutionarily distant organisms, including yeast [2, 7, 15, 21, 32, 40, 258, 259]. We 
therefore examined how the addition of LCA to yeast grown under CR on 0.2% glucose 
at different periods of chronological lifespan influences 1) the frequency of spontaneous 
point mutations in the CAN1 gene of nDNA; 2) the frequencies of spontaneous single-
gene (mit- and syn-) and deletion (rho- and rhoo) mutations in mtDNA, all causing a 
deficiency in mitochondrial respiration and impairing growth on glycerol; and 3) the 
frequencies of spontaneous point mutations in the rib2 and rib3 loci of mtDNA.        
            We found that if added to growth medium on days 0, 1 or 2, LCA reduces the 
frequency of spontaneous point mutations in the CAN1 gene of nDNA following LCA 
addition (Figure 7.8). In contrast, LCA either does not influence (if added on days 3, 9, 
11 or 14) or increases (if added on days 5 or 7) the frequency of these spontaneous point 
mutations in nDNA (Figure 7.8). Thus, LCA stimulates the maintenance of nDNA 
integrity, an essential anti-aging process, only if added at period 1 of their chronological 
lifespan; this period includes L and D growth phases when LCA addition can extend 
longevity (Figures 7.2, 7.4 and 7.5). Our findings also suggest that the observed 
inhibitory effect of LCA on the maintenance of nDNA integrity if it is added at period 2 
of yeast chronological lifespan (Figure 7.8) could in part be responsible for the inability 
of LCA to delay aging of yeast if added at this period during PD phase (Figures 7.2, 7.4   
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Figure 7.8. LCA differentially influences the maintenance of nDNA integrity, an essential anti-aging 
process, if added at different periods of yeast lifespan. Yeast were cultured in YP medium initially 
containing 0.2% glucose, and LCA was added at the final concentration of 50 µM to a cell culture 
immediately following cell inoculation into the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 14 of 
cell culturing in this growth medium. The frequency of spontaneous point mutations in the CAN1 gene of 
nDNA was measured as described in “Materials and Methods”. Data are presented as mean ± SEM (n = 3); 
 176
*p < 0.01 (relative to the frequency of spontaneous point mutations in the CAN1 gene of nDNA in yeast 
cultures not exposed to LCA). Abbreviations: diauxic (D), logarithmic (L), post-diauxic (PD) or stationary 
(ST) phase. 
 
and 7.5). Furthermore, despite LCA extends longevity of chronologically aging yeast if 
added at period 3 (which includes early ST phase; see Figures 7.2, 7.4 and 7.5), it does 
not influence the maintenance of nDNA integrity if added at this period (Figure 7.8). 
Moreover, the observed lack of an effect of LCA on yeast longevity if added at period 4 
of chronological lifespan (Figures 7.2, 7.4 and 7.5) coincides with its inability to alter the 
efficacy of the maintenance of nDNA integrity if added at this period in late ST phase 
(Figure 7.8). 
            We also found that if added to growth medium on days 0, 1, 2, 3, 5, 7, 9 or 11, 
LCA reduces 1) the frequencies of spontaneous single-gene (mit- and syn-) and deletion 
(rho- and rhoo) mutations in mtDNA, all causing a deficiency in mitochondrial respiration 
and impairing growth on glycerol (Figure 7.9); and 2) the frequencies of spontaneous 
point mutations in the rib2 and rib3 loci of mtDNA (Figure 7.10). In contrast, if added to 
growth medium on day 14, LCA does not have effect on the frequencies of these 
spontaneous mutations in mtDNA (Figures 7.9 and 7.10). Thus, LCA stimulates the 
maintenance of mtDNA integrity, an essential anti-aging process, only if added at periods 
1, 2 or 3 of yeast chronological lifespan. Period 1 includes L and D growth phases, period 
2 exists in PD phase, whereas periods 3 and 4 include early and late ST phases 
(respectively) (Figures 7.4 and 7.5). Moreover, the observed lack of an effect of LCA on 
yeast longevity if added at period 4 of chronological lifespan (Figures 7.2, 7.4  
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Figure 7.9. LCA differentially influences the maintenance of mtDNA integrity, an essential anti-aging 
process, if added at different periods of yeast lifespan. Yeast were cultured in YP medium initially 
containing 0.2% glucose, and LCA was added at the final concentration of 50 µM to a cell culture 
immediately following cell inoculation into the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 14 of 
cell culturing in this growth medium. The frequencies of spontaneous single-gene (mit- and syn-) and 
deletion (rho- and rhoo) mutations in mtDNA, all causing a deficiency in mitochondrial respiration and 
impairing growth on glycerol, were measured as described in “Materials and Methods”. Data are presented 
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as mean ± SEM (n = 5-6); *p < 0.01 (relative to the frequencies of spontaneous mit-, syn-, rho- and rhoo 
mutations in mtDNA in yeast cultures not exposed to LCA). Abbreviations: diauxic (D), logarithmic (L), 




Figure 7.10. LCA differentially influences the maintenance of mtDNA integrity, an essential anti-aging 
process, if added at different periods of yeast lifespan. Yeast were cultured in YP medium initially 
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containing 0.2% glucose, and LCA was added at the final concentration of 50 µM to a cell culture 
immediately following cell inoculation into the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 14 of 
cell culturing in this growth medium. The frequencies of spontaneous point mutations in the rib2 and rib3 
loci of mtDNA were measured as described in “Materials and Methods”. Data are presented as mean ± 
SEM (n = 3-4); *p < 0.01 (relative to the frequencies of spontaneous rib2 and rib3 mutations in mtDNA in 
yeast cultures not exposed to LCA). Abbreviations: diauxic (D), logarithmic (L), post-diauxic (PD) or 
stationary (ST) phase. 
 
and 7.5) coincides with its inability to alter the efficacy of the maintenance of mtDNA 
integrity if added at this period in late ST phase (Figures 7.9 and 7.10). 
 
7.4.6 In chronologically aging yeast, LCA differentially influences the anti-aging 
processes of development of resistance to chronic (long-term) oxidative, 
thermal and osmotic stresses if added at different periods of their lifespan 
            It is well established that the development of resistance to chronic (long-term) 
oxidative, thermal and osmotic stresses is an essential anti-aging process in evolutionarily 
distant organisms, including yeast [2, 3, 7, 16 - 19, 22, 27, 32, 35, 40, 84 - 86, 91 - 93]. 
We therefore examined how the addition of LCA to yeast grown under CR on 0.2% 
glucose at different periods of chronological lifespan influences their resistance to each of 
these chronic stresses. 
            We found that if added to growth medium on days 0, 1, 2 or 3, LCA increases the 
resistance of yeast to chronic oxidative and thermal stresses, but does not alter cell 
susceptibility to chronic osmotic stress (Figures 7.11, 7.12, 7.13, 7.14, 7.15, 7.16 and  
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Figure 7.11. Effect of LCA added at different periods of yeast chronological lifespan on cell growth under 
non-stressful conditions. Yeast were cultured in YP medium initially containing 0.2% glucose, and LCA 
was added at the final concentration of 50 µM to a cell culture immediately following cell inoculation into 
the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 14 of cell culturing in this growth medium. Spot 
assays were performed as described in “Materials and Methods”. Serial ten-fold dilutions of cells were 
spotted on plates with solid YP medium containing 2% glucose as carbon source. All pictures were taken 




Figure 7.12. Effect of LCA added at different periods of chronological lifespan on the ability of yeast to 
resist chronic oxidative stress. Yeast were cultured in YP medium initially containing 0.2% glucose, and 
LCA was added at the final concentration of 50 µM to a cell culture immediately following cell inoculation 
into the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 14 of cell culturing in this growth medium. 
Spot assays for monitoring oxidative stress resistance were performed as described in “Materials and 
Methods”. Serial ten-fold dilutions of cells were spotted on plates with solid YP medium containing 2% 
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Figure 7.13. LCA differentially influences the anti-aging process of development of resistance to chronic 
oxidative stress if added at different periods of yeast chronological lifespan. A graphic presentation of the 
results of spot assays for monitoring oxidative stress resistance, which is shown in Figure 7.12.   
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Figure 7.14. Effect of LCA added at different periods of chronological lifespan on the ability of yeast to 
resist chronic thermal stress. Yeast were cultured in YP medium initially containing 0.2% glucose, and 
LCA was added at the final concentration of 50 µM to a cell culture immediately following cell inoculation 
into the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 14 of cell culturing in this growth medium. 
Spot assays for monitoring thermal stress resistance were performed as described in “Materials and 
Methods”. Serial ten-fold dilutions of cells were spotted on plates with solid YP medium containing 2% 
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glucose as carbon source. Plates were initially incubated at 55oC for 30 min, and were then transferred to 




Figure 7.15. LCA differentially influences the anti-aging process of development of resistance to chronic 
thermal stress if added at different periods of yeast chronological lifespan. A graphic presentation of the 




Figure 7.16. Effect of LCA added at different periods of chronological lifespan on the ability of yeast to 
resist chronic osmotic stress. Yeast were cultured in YP medium initially containing 0.2% glucose, and 
LCA was added at the final concentration of 50 µM to a cell culture immediately following cell inoculation 
into the medium (on day 0) or on days 1, 2, 3, 5, 7, 9, 11 or 14 of cell culturing in this growth medium. 
Spot assays for monitoring osmotic stress resistance were performed as described in “Materials and 
Methods”. Serial ten-fold dilutions of cells were spotted on plates with solid YP medium containing 2% 




Figure 7.17. LCA differentially influences the anti-aging process of development of resistance to chronic 
osmotic stress if added at different periods of yeast chronological lifespan. A graphic presentation of the 
results of spot assays for monitoring osmotic stress resistance, which is shown in Figure 7.16.   
 
7.17). Moreover, LCA increases the resistance of yeast to all three chronic stresses if 
added to growth medium on days 7, 9 or 11 (Figures 7.11, 7.12, 7.13, 7.14, 7.15, 7.16 and 
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7.17). In contrast, LCA does not alter cell susceptibility to any of these chronic stresses if 
added on days 5 or 14 (Figures 7.11, 7.12, 7.13, 7.14, 7.15, 7.16 and 7.17). 
            Thus in chronologically aging yeast LCA stimulates the anti-aging processes of 
development of resistance to chronic oxidative and thermal stresses if added at period 1 
(which includes L and D growth phases). If added at period 3 (which includes early ST 
phase), LCA not only stimulates the development of resistance to chronic oxidative and 
thermal stresses but also enhances the anti-aging process of developing resistance to 
chronic osmotic stress. If added at any of these two periods, LCA addition can extend 
longevity (Figures 7.2, 7.4 and 7.5). Noteworthy, the observed lack of an effect of LCA 
on yeast longevity if added at period 2 or period 4 of chronological lifespan (Figures 7.2, 
7.4 and 7.5) coincides with its inability to alter cell susceptibility to any of these stresses 
at these two periods in PD and late ST phases, respectively.   
 
7.5 Discussion 
            Findings described in this chapter of my thesis imply that in yeast grown under 
CR conditions on 0.2% glucose, there are two critical periods when the addition of LCA 
to growth medium can increase both their mean and maximum chronological lifespans. 
One of these two critical periods, which we call period 1, includes L and D growth 
phases. The other critical period, which is called period 3, exists in the early ST phase of 
growth. In contrast, LCA does not cause a significant extension of the mean or maximum 
chronological lifespan of CR yeast if it was added at periods 2 or 4; these two periods 
exist in PD or late ST growth phases, respectively (Figures 7.2 and 7.4). In contrast, in 
yeast grown under non-CR conditions on 2% glucose, there is only one critical period, 
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during L and D phases, when the addition of LCA to growth medium can increase both 
their mean and maximum chronological lifespans (Figures 7.3 and 7.4). However, if LCA 
was added to non-CR yeast at any time-point after this critical period ended, it did not 
cause a significant extension of their mean or maximum chronological lifespan (Figures 
7.3 and 7.4). Thus, unlike a substantial beneficial effect of LCA on yeast longevity seen 
if it was added in early ST phase under CR conditions, this bile acid was unable to delay 
yeast chronological aging under non-CR conditions if added in the same phase of growth. 
          Because aging of multicellular and unicellular eukaryotic organisms affects 
numerous anti- and pro-aging processes within cells [2, 3, 7, 9, 14, 17 - 21, 27 - 36], we 
hypothesized that the observed ability of LCA to delay chronological aging of yeast 
grown under CR conditions only if added at certain critical periods (checkpoints) of their 
lifespan could be due to its differential effects on certain anti- and pro-aging processes at 
different checkpoints (Figure 7.5). To test the validity of our hypothesis, we examined 
how the addition of LCA at different periods of chronological lifespan in yeast grown 
under CR conditions influences anti- and pro-aging processes taking place during each of 
these periods.  
            Findings described in this chapter of my thesis suggest the following mechanism 
linking the ability of LCA to delay chronological aging of CR yeast only if added at 
certain critical periods (checkpoints) of their lifespan to the differential effects of this 
natural anti-aging compound on certain anti- and pro-aging processes at different 
checkpoints (Figure 7.18).  
            The ability of LCA to delay aging in yeast if added at period 1 of their 
chronological lifespan could be due to its following effects on different longevity- 
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Figure 7.18. A mechanism linking the ability of LCA to delay chronological aging of CR yeast only if 
added at certain critical periods (checkpoints) of their lifespan to the differential effects of this natural anti-
aging compound on certain anti- and pro-aging processes at different checkpoints. See text for details. 
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defining processes during this critical period: 1) LCA makes yeast cells resistant to 
mitochondria-controlled apoptotic death, a pro-aging process; 2) LCA increases cell 
resistance to the pro-aging process of palmitoleic acid-induced necrotic death; 3) LCA 
stimulates the anti-aging processes of nuclear and mitochondrial genome maintenance; 
and 4) LCA stimulates the anti-aging processes of development of resistance to chronic 
oxidative and thermal stresses (Figure 7.18). The ability of LCA to delay aging in yeast if 
added at period 1 of chronological lifespan by imposing all these beneficial effects on 
longevity-defining cellular processes could be enhanced by the lack of any pro-aging 
effect of LCA added at period 1 on the various lifespan-defining processes monitored in 
this study (Figure 7.18). 
            Although the addition of LCA at period 2 imposes some beneficial effects on 
longevity-defining cellular process (i.e., it enhances cell resistance to mitochondria-
controlled apoptotic death and stimulates mitochondrial genome maintenance), the 
observed inability of the compound to delay aging in yeast if added at this period of 
chronological lifespan could be due to the two pro-aging effects that LCA exhibits when 
added at period 2. These pro-aging effects of LCA added during period 2 include a 
reduction of cell resistance to the pro-aging process of palmitoleic acid-induced necrotic 
death and a decrease of the efficacy with which the integrity of nuclear genome is 
maintained (Figure 7.18). 
            The ability of LCA to delay aging in yeast if added at period 3 of their 
chronological lifespan could be due to its following effects on different longevity-
defining processes during this critical period: 1) LCA makes yeast cells resistant to 
mitochondria-controlled apoptotic death, a pro-aging process; 2) LCA stimulates the anti-
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aging process of mitochondrial genome maintenance; and 3) LCA stimulates the anti-
aging processes of development of resistance to chronic oxidative, thermal and osmotic 
stresses (Figure 7.18). It is conceivable that the ability of LCA to delay aging in yeast if 
added at period 3 of chronological lifespan by imposing these beneficial effects on 
longevity-defining cellular processes could be enhanced by the lack of any pro-aging 
effect of LCA added at period 3 on the various lifespan-defining processes monitored in 
this study (Figure 7.18). 
            Because the addition of LCA at period 4 does not influence any of the various 
longevity-defining processes monitored in this study, it is not surprising that it is unable 




            Findings presented in this chapter of my thesis provide conclusive evidence that 
the natural anti-aging compound LCA extends longevity of chronologically aging yeast 
only if added at certain critical periods of their lifespan. Our data imply that during the 
chronological lifespan of yeast grown under CR conditions on 0.2% glucose, there are 
two critical periods (checkpoints) when the addition of LCA can extend longevity. One of 
these two critical periods (which we call period 1) includes L and D growth phases, 
whereas the other period (which is called period 3) exists in the early ST phase of growth. 
In contrast, LCA does not extend longevity of chronologically aging yeast if added at 
periods 2 or 4. These two periods exist in PD and late ST growth phases, respectively. 
Based on our findings, we propose a mechanism that links the ability of LCA to delay 
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chronological aging of CR yeast only if added at certain critical periods (checkpoints) of 
their lifespan to the differential effects of this bile acid on certain anti- and pro-aging 




8 Mitophagy is a longevity assurance process that in yeast sustains functional 
mitochondria and protects cells from apoptotic and necrosis-like “lipoptotic” 
modes of cell death 
 
8.1 Abstract 
            Recent findings in mammals suggest that mitophagy, a selective macroautophagic 
removal of dysfunctional mitochondria, is an essential cellular process aimed at 
maintaining mitochondrial functionality and suppressing cellular and organismal 
pathologies that arise due to dysfuntion of mitochondria. However, the physiological 
roles of mitophagy in yeast and underlying mechanisms remained to be discovered. This 
chapter of my thesis describes studies aimed at exploring possible roles of mitophagy in 
regulating yeast longevity, maintaining functional mitochondria, and protecting yeast 
from apoptotic and a recently discovered by our laboratory necrosis-like “lipoptotic” 
modes of age-related cell death. In studies described in this chapter of my thesis, we used 
a combination of functional genetic, chemical biological, cell biological and electron 
microscopical analyses to carry out comparative analyses of the single-gene-deletion 
mutant strain atg32Δ, which is impaired only in the mitophagic pathway of selective 
macroautophagy, and wild-type (WT) strain. atg32Δ is known to lack a mitochondrial 
outer membrane protein Atg32p whose binding to an adaptor protein Atg11p drives the 
recruitment of mitochondria to the phagophore assembly site, thereby initiating the 
mitophagy process. Our findings imply that mitophagy defines yeast longevity, facilitates 
yeast chronological lifespan extension by a recently discovered anti-aging natural 
compound, sustains functional mitochondria, and protects yeast from apoptotic and 
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necrosis-like “lipoptotic” forms of cell death. 
 
8.2   Introduction 
            Autophagy is an evolutionarily conserved process for degradation of damaged and 
dysfunctional organelles or portions of cytoplasm following their sequestration and 
delivery to lysosomes in mammalian cells or vacuoles in yeast cells (see Chapter 1 of this 
thesis for a comprehensive discussion of this topic) [126 - 129]. As an essential 
cytoprotective mechanism initiated in response to various cellular stresses, autophagic 
degradation plays an essential role in longevity regulation and has been implicated in the 
incidence of diverse age-related pathologies, including neurodegeneration and cancer 
[126 - 130].  In addition to non-selective degradation of cellular components sequestered 
into double-membrane vesicles called autophagosomes and then targeted to 
lysosomes/vacuoles via a so-called non-selective macroautophagy pathway (see Chapter 
1 of this thesis), autophagy can selectively degrade specific organelles and 
supramolecular cellular assemblies [126 - 128]. The selective degradation of 
mitochondria via autophagy is called mitophagy [126, 128 - 130]. Although recent 
findings in evolutionarily distant organisms from yeast to mammals suggest that 
mitophagy may operate as an essential mechanism in ensuring quality control of 
mitochondria, the physiological roles of mitophagy and underlying mechanisms remain 
to be determined. The objective of studies described in this chapter of my thesis was to 
explore the involvement of mitophagy in regulating yeast longevity, maintaining 
functional mitochondria, and protecting yeast from apoptotic and a recently discovered 
by our laboratory necrosis-like “lipoptotic” modes of age-related cell death. 
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8.3 Materials and Methods 
 
Yeast strains and growth conditions 
The wild-type (WT) strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) and the 
single-gene-deletion mutant strain atg32Δ (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 
atg32Δ::kanMX4) in the BY4742 genetic background (both from Open Biosystems) were 
grown in YP medium (1% yeast extract, 2% peptone) containing 0.2% or 2% glucose as 
carbon source. Cells were cultured at 30oC with rotational shaking at 200 rpm in 
Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1. 
 
Chronological lifespan assay 
A sample of cells was taken from a culture at a certain time-point. A fraction of the 
sample was diluted in order to determine the total number of cells using a 
hemacytometer. Another fraction of the cell sample was diluted and serial dilutions of 
cells were plated in duplicate onto YP plates containing 2% glucose as carbon source. 
After 2 d of incubation at 30oC, the number of colony forming units (CFU) per plate was 
counted. The number of CFU was defined as the number of viable cells in a sample. For 
each culture, the percentage of viable cells was calculated as follows: (number of viable 
cells per ml/total number of cells per ml) × 100. The percentage of viable cells in mid-
logarithmic phase was set at 100%. The lifespan curves were validated using a 
LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's instructions. 
 
Pharmacological manipulation of chronological lifespan 
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Chronological lifespan analysis was performed as described above in this section. The 
lithocholic (LCA; L6250) bile acid was from Sigma. The stock solution of LCA in 
DMSO was made on the day of adding this compound to cell cultures. LCA was added to 
growth medium immediately following cell inoculation. It was used at a final 
concentration of 50 µM, at which it displays the greatest beneficial effect on both the 
mean and maximum chronological lifespans of WT strain [40]. The final concentration of 
DMSO in yeast cultures supplemented with LCA (and in the corresponding control 
cultures supplemented with drug vehicle) was 1% (v/v). 
 
Oxygen consumption assay 
A sample of cells was taken from a culture at a certain time-point. Cells were pelleted by 
centrifugation and resuspended in 1 ml of fresh YP medium containing 0.05% glucose. 
Oxygen uptake by cells was measured continuously in a 2-ml stirred chamber using a 
custom-designed biological oxygen monitor (Science Technical Center of Concordia 
University) equipped with a Clark-type oxygen electrode. 
 
Electron microscopy 
Whole cells were fixed in 1.5% (w/v) KMnO4 at room temperature for 20 min, incubated 
with 0.5% (w/v) sodium periodate for 15 min and exposed to 1% (w/v) ammonium 
chloride for 15 min. Cells were then post-stained in 1% (w/v) uranyl acetate overnight, 
dehydrated by successive incubations in increasing concentrations of ethanol (60%, 80%, 
95%, 98% and 100%), followed by wash in propylene oxide (100%) and gradually 
infiltrated with Epon resin.  Ultrathin sections were cut with a diamond knife, stained 
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with 4% aqueous uranyl acetate and 0.2% lead citrate, and then examined in a T12 
transmission electron microscope at 120 KV at different magnification. 
 
Cell viability assay for monitoring the susceptibility of yeast to an apoptotic mode of 
cell death induced by hydrogen peroxide  
Cells were cultured in YP medium initially containing 0.2% or 2% glucose. A 5-ml 
sample of cells was taken from a culture at days 1, 2 and 4. A 10-µl aliquot of the sample 
was diluted in order to determine the total number of cells using a hemacytometer. An 
aliquot of the culture containing the total of 4 × 107 cells was subjected to centrifugation 
for 3 min at 16,000 × g at room temperature. The pellet of cells was then resuspended in 
4 ml of YP medium supplemented with 0.2% or 2% glucose. Cell suspension was divided 
into four 1-ml aliquots, and 10-µl aliquots of a serially diluted stock solution of 30% 
hydrogen peroxide in MilliQ water were added to the indicated final concentrations 
ranging from 0.1 to 20 mM. A control aliquot of cells was supplemented with 10 µl of 
MilliQ water. Cells were incubated for 2 h at 30oC on a Labquake tube shaker/rotator. A 
100 µl-aliquot of each sample was serially diluted in 10-fold steps. To determine cell 
viability by plate assay, a 100 µl-aliquot of each dilution was plated in duplicate onto YP 
plates containing 2% glucose as carbon source. After 2 d of incubation at 30oC, the 
number of colony forming units (CFU) per plate was counted. The number of CFU was 
defined as the number of viable cells in a sample. For each culture, the percentage of 
viable cells was calculated as follows: (number of viable cells per ml/107 [i.e., the total 
number of cells per ml]) × 100. The percentage of viable cells in a control cell aliquot, 
which was supplemented with 10 µl of MilliQ water, was set at 100%.  
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Cell viability assay for monitoring the susceptibility of yeast to a necrotic mode of 
cell death induced by palmitoleic acid  
Cells were cultured in YP medium initially containing 0.2% or 2% glucose. A 5-ml 
sample of cells was taken from a culture at days 1, 2 and 4. A 10-µl aliquot of the sample 
was diluted in order to determine the total number of cells using a hemacytometer. An 
aliquot of the culture containing the total of 4 × 107 cells was subjected to centrifugation 
for 3 min at 16,000 × g at room temperature. The pellet of cells was then resuspended in 
4 ml of YP medium supplemented with 0.2% or 2% glucose. Cell suspension was divided 
into four 1-ml aliquots, and 10-µl aliquots of a serially diluted stock solution of 50 mM 
palmitoleic acid in a Chloroform/Hexane/Ethanol (1:4.5:4.5) mix were added to the 
indicated final concentrations ranging from 0.05 to 0.8 mM. A control aliquot of cells 
was supplemented with 10 µl of the Chloroform/Hexane/Ethanol (1:4.5:4.5) mix. Cells 
were incubated for 2 h at 30oC on a Labquake tube shaker/rotator. A 100 µl-aliquot of 
each sample was serially diluted in 10-fold steps. To determine cell viability by plate 
assay, a 100 µl-aliquot of each dilution was plated in duplicate onto YP plates containing 
2% glucose as carbon source. After 2 d of incubation at 30oC, the number of colony 
forming units (CFU) per plate was counted. The number of CFU was defined as the 
number of viable cells in a sample. For each culture, the percentage of viable cells was 
calculated as follows: (number of viable cells per ml/107 [i.e., the total number of cells 
per ml]) × 100. The percentage of viable cells in a control cell aliquot, which was 




DAPI staining for visualizing nuclei 
An aliquot containing the total of 107 cells was subjected to centrifugation for 1 min at 
16,000 × g at room temperature. Cells were washed twice in a PBS buffer (20 mM 
KH2PO4/KOH, pH 7.5; 150 mM NaCl), each time by re-suspending the cell pellet in the 
buffer and harvesting cells by centrifugation for 1 min at 16,000 × g at room temperature. 
The pellet of cells was resuspended in 250 µl of the PBS buffer. Cell suspension was 
supplemented with 12.5 µl of a stock solution of 0.1 mg/ml DAPI in PBS to the final 
concentration of 5 µg/ml DAPI. Samples were incubated in the dark for 10 min at room 
temperature. Cells were washed 5 times in PBS, each time by re-suspending the cell 
pellet in the buffer and harvesting cells by centrifugation for 1 min at 16,000 × g at room 
temperature. The pellet of washed cells was resuspended in 20 µl of the PBS buffer. Cells 
were analyzed by fluorescence microscopy. Images were collected with a Zeiss Axioplan 
fluorescence microscope (Zeiss) mounted with a SPOT Insight 2 megapixel color mosaic 
digital camera (Spot Diagnostic Instruments). For evaluating the percentage of cells with 
fragmented nucleus the UTHSCSA Image Tool (Version 3.0) software was used to 
calculate both the total number of cells and the number of stained cells or cells with 
fragmented nucleus. In each of 2-5 independent experiments, the percentage of cells with 
fragmented nuclei was calculated by analyzing at least 500 cells. 
 
Statistical analysis 
Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated using an 




8.4.1 Mitophagy is a longevity assurance process  
            As the first step towards addressing a possible role of selective macroautophagic 
mitochondrial removal in sustaining essential biological processes, we evaluated the 
importance of mitophagy in longevity assurance in the yeast Saccharomyces cerevisiae. 
We compared the chronological lifespan of the single-gene-deletion mutant strain 
atg32Δ, which is impaired only in the mitophagic pathway of selective macroautophagy 
[376, 377], to that of wild-type (WT) strain. atg32Δ lacks a mitochondrial outer 
membrane protein Atg32p whose binding to an adaptor protein Atg11p drives the 
recruitment of mitochondria to the phagophore assembly site, thereby initiating the 
mitophagy process [376, 377]. We assessed the importance of mitophagy in longevity 
assurance in chronologically aging yeast grown in the nutrient-rich YP medium either 
under lifespan-extending caloric restriction (CR) conditions on 0.2% glucose or under 
lifespan-shortening non-CR conditions on 2% glucose [32, 40]. We found that the atg32Δ 
mutation substantially shortens both the mean and maximum chronological lifespans of 
yeast not only under CR at 0.2% glucose (Figure 8.1) but also under non-CR conditions 
administered by culturing cells in medium initially containing 2% glucose (unpublished 
data; a personal communication from Alejandra Gomez-Perez in our laboratory). We 
therefore concluded that under both CR and non-CR conditions mitophagy is an essential 





Figure 8.1. Under CR conditions, the atg32Δ-dependent mutational block of mitophagy substantially 
shortens both the mean and maximum chronological life spans (CLS) of yeast. Wild-type (WT) and atg32Δ 
strains were cultured in YP medium initially containing 0.2% glucose. Data are presented as means ± SEM 
(n = 4; ***p < 0.001).  
 
8.4.2 Mitophagy is required for longevity extension by an anti-aging compound 
            In a recent study, we found that lithocholic acid (LCA), a bile acid, greatly 
increases the chronological lifespan of yeast grown under CR and non-CR conditions 
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[40]. To assess a role of selective macroautophagic mitochondrial removal in longevity 
extension by LCA, we tested if this bile acid added to growth medium at the time of cell 
inoculation is able to extend longevity of the mitophagy-deficient atg32Δ mutant. As we 
found, the atg32Δ mutation abolishes the ability of LCA to increase both the mean and 
maximum chronological lifespans of yeast not only under CR at 0.2% glucose (Figure 
8.2) but also under non-CR conditions on 2% glucose (unpublished data; a personal 
communication from Alejandra Gomez-Perez in our laboratory). Thus, mitophagy is 
essential for the ability of LCA to extend longevity of chronologically aging yeast. 
 
8.4.3 Mitophagy is essential for maintaining functional mitochondria 
            A decline in mitochondrial function is a common feature of aging cells and one of 
the driving forces in cellular and organismal aging [378]. The age-related mitochondrial 
dysfunction is manifested in reduced respiration, which not only causes a decline in the 
mitochondrial membrane potential (ΔΨ) and ATP synthesis but also leads to the 
excessive production of reactive oxygen species (ROS) known to be generated mainly in 
mitochondria [379]. The gradual, age-related increase in mitochondrial ROS production 
elicits the progressive oxidative damage to mitochondrial DNA, proteins and lipids – 
thereby driving a “vicious cycle” accelerating a self-perpetuating decline in 
mitochondrial function and eventually leading to mitochondrial outer membrane 
permeabilization (MOMP), permeability transition pore complex (PTPC) activation and 
the resulting mitochondrial permeability transition (MPT). By promoting the release of 
soluble mitochondrial membrane proteins and ΔΨ dissipation, MOMP and MPT drive 




Figure 8.2. Under CR conditions, the atg32Δ-dependent mutational block of mitophagy abolishes the 
ability of LCA to increase both the mean and maximum chronological lifespans (CLS) of yeast. Wild-type 
(WT) and atg32Δ strains were cultured in YP medium initially containing 0.2% glucose in the presence or 
absence of 50 µM LCA. Data are presented as means ± SEM (n = 4; ***p < 0.001). 
 
before this cycle of events can cause cell death, mitophagy has been hypothesized to 
function as a mitochondrial quality control mechanism having an essential cytoprotective 
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role that decelerates cellular and organismal aging [378, 381]. Our finding that mitophagy 
is a longevity assurance process provides the first, to our best knowledge, experimental 
confirmation of such a hypothesis. In addition, this our finding suggests that a deficiency 
in selective macroautophagic mitochondrial removal may result in accumulation of 
dysfunctional mitochondria displaying reduced respiration, declined ΔΨ and excessive 
ROS production. To evaluate the validity of this suggestion, we compared the rate of 
oxygen consumption (a process of cellular respiration confined mainly to mitochondria) 
by prematurely aging atg32Δ cells to that by WT cells. We found that under both CR and 
non-CR conditions the rate of oxygen consumption by chronologically aging WT cells 
was 1) significantly increased when these cells entered diauxic (D) growth phase; and 2) 
gradually declined through the following post-diauxic (PD) and stationary (ST) growth 
phases (Figure 8.3; unpublished data for non-CR conditions are not shown [a personal 
communication from Alejandra Gomez-Perez in our laboratory]). Although prematurely 
aging atg32Δ cells exhibited a similar to WT cells amplitude of the increase in oxygen 
consumption by mitochondria upon entry into D growth phase, they displayed a greatly 
accelerated (as compared to WT cells) decline in the rate of mitochondrial oxygen 
consumption during the subsequent PD phase (Figure 8.3). This trend of the atg32Δ 
mutation has been observed under both CR (Figure 8.3) and non-CR (unpublished data; a 
personal communication from Alejandra Gomez-Perez in our laboratory) conditions. 
Thus, the atg32Δ-dependent mutational block of mitophagy indeed leads to accumulation 







Figure 8.3. Under CR conditions, the atg32Δ-dependent mutational block of mitophagy leads to 
accumulation of dysfunctional mitochondria displaying reduced respiration. WT and atg32Δ strains were 
cultured in medium initially containing 0.2% glucose. Data are presented as means ± SEM (n = 6). 
 
            Recent unpublished findings from our laboratory imply that mitochondria in 
prematurely aging atg32Δ cells also exhibit declined ΔΨ and produce excessive levels of 
ROS (unpublished data; a personal communication from Alejandra Gomez-Perez in our 
laboratory). We therefore concluded that in chronologically aging yeast mitophagy is 
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essential for maintaining functional mitochondria both under lifespan-extending CR 
conditions and under lifespan-shortening non-CR conditions.  
            Furthermore, our finding that mitophagy is essential for the ability of LCA to 
extend longevity of chronologically aging yeast suggests that a deficiency in selective 
macroautophagic mitochondrial removal may alter the previously described effects of this 
bile acid [40] on mitochondrial respiration, ΔΨ and/or ROS. We found that under both 
CR and non-CR conditions the rate of oxygen consumption by chronologically aging WT 
cells exposed to LCA 1) was increased to a much lesser extent during D growth phase 
than it was in WT cells not exposed to this bile acid; and 2) reached a plateau in late PD 
growth phase and remained mainly uncharged during the following ST growth phase 
(Figure 8.4; unpublished data for non-CR conditions are not shown [a personal 
communication from Alejandra Gomez-Perez in our laboratory]). In contrast, LCA had 
no significant effect on oxygen consumption by mitochondria in prematurely aging 
atg32Δ cells impaired in mitophagy (Figure 8.4). This trend of the atg32Δ mutation has 
been observed under both CR (Figure 8.4) and non-CR conditions. Recent unpublished 
findings from our laboratory imply that the atg32Δ mutation abolishes the ability of LCA 
to alter the age-related dynamics of changes in ΔΨ and ROS (a personal communication 
from Alejandra Gomez-Perez). We therefore concluded that in chronologically aging 
yeast mitophagy is mandatory for the ability of LCA to cause longevity-increasing 
changes in mitochondrial respiration, ΔΨ and ROS both under lifespan-extending CR 
conditions and under lifespan-shortening non-CR conditions. 




Figure 8.4. Under CR conditions, the atg32Δ-dependent mutational block of mitophagy abolishes the 
ability of LCA to cause longevity-increasing changes in mitochondrial respiration. Wild-type (WT) and 
atg32Δ strains were cultured in YP medium initially containing 0.2% glucose in the presence or absence of 
50 µM LCA. Data are presented as means ± SEM (n = 6). 
 
8.4.4 Mitophagy protects yeast cells from mitochondria-controlled apoptotic death 
caused by exogenous hydrogen peroxide 
            A short-term exposure to exogenous hydrogen peroxide has been shown to cause 
mitochondria-controlled apoptotic death of yeast cells [382 - 384]. As we mentioned 
above, by removing dysfunctional mitochondria before the “vicious cycle” of events 




Figure 8.5. Under CR conditions, the atg32Δ mutation significantly enhances susceptibility of yeast to 
apoptotic cell death triggered by a brief exposure to exogenous hydrogen peroxide. Wild-type (WT) and 
atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells recovered at days 1, 2 
and 4 were exposed for 2 h to various concentrations of exogenous hydrogen peroxide. Data are presented 




Figure 8.6. Under non-CR conditions, the atg32Δ mutation significantly enhances susceptibility of yeast to 
apoptotic cell death triggered by a brief exposure to exogenous hydrogen peroxide. Wild-type (WT) and 
atg32Δ strains were cultured in YP medium initially containing 2% glucose. Cells recovered at days 1, 2 
and 4 were exposed for 2 h to various concentrations of exogenous hydrogen peroxide. Data are presented 
as means ± SEM (n = 3). 
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mitophagy is believed to function as a mitochondrial quality control mechanism that 
decelerates cellular and organismal aging by preventing apoptotic and necrotic cell death  
 [378, 381]. Our finding that in chronologically aging yeast mitophagy is essential for  
maintaining functional mitochondria prompted us to investigate if selective 
macroautophagic mitochondrial removal could protect yeast from mitochondria-
controlled apoptotic death caused by exogenous hydrogen peroxide. We revealed that 
under both CR and non-CR conditions the atg32Δ mutation significantly enhances cell 
susceptibility to apoptotic cell death triggered by a short-term, 2-h exposure to exogenous 
hydrogen peroxide (Figures 8.5 and 8.6). Thus, by removing dysfunctional mitochondria, 
mitophagy protects yeast cells from mitochondria-controlled apoptotic death caused by 
exogenous hydrogen peroxide. 
  
8.4.5 Mitophagy protects yeast from a mode of cell death triggered by exposure to 
palmitoleic fatty acid 
            A brief exposure of yeast cells to exogenous palmitoleic fatty acid has been 
shown to cause their death [40]. Noteworthy, the pex5Δ mutation previously known only 
for its ability to impair peroxisomal fatty acid oxidation [243] recently has been 
demonstrated not only to greatly reduce mitochondrial respiration and ΔΨ but also to 
enhance the susceptibility of yeast to a mode of cell death elicited by a short-term 
exposure to exogenous palmitoleic acid [40]. We therefore decided to investigate if 
selective macroautophagic mitochondrial removal could protect yeast from this form of 
cell death. We found that under both CR and non-CR conditions the atg32Δ mutation 
significantly enhances cell susceptibility to cell death elicited by a brief, 2-h exposure to 
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Figure 8.7. Under CR conditions, the atg32Δ mutation significantly enhances susceptibility of yeast to 
apoptotic cell death triggered by a brief exposure to exogenous palmitoleic fatty acid. Wild-type (WT) and 
atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells recovered at days 1, 2 
and 4 were exposed for 2 h to various concentrations of exogenous palmitoleic acid. Data are presented as 
means ± SEM (n = 4). 
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Figure 8.8. Under non-CR conditions, the atg32Δ mutation significantly enhances susceptibility of yeast to 
apoptotic cell death triggered by a brief exposure to exogenous palmitoleic fatty acid. Wild-type (WT) and 
atg32Δ strains were cultured in YP medium initially containing 2% glucose. Cells recovered at days 1, 2 
and 4 were exposed for 2 h to various concentrations of exogenous palmitoleic acid. Data are presented as 
means ± SEM (n = 4). 
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exogenous palmitoleic acid (Figures 8.7 and 8.8). Hence, by removing dysfunctional 
mitochondria, mitophagy protects yeast from a mode of cell death triggered by this fatty 
acid. 
 
8.4.6 Microscopical analyses confirm the essential role of mitophagy in protecting 
yeast from mitochondria-controlled apoptotic cell death      
            Based on our finding that the atg32Δ mutation significantly enhances the 
susceptibility of yeast to apoptotic cell death triggered by a short-term exposure to 
exogenous hydrogen peroxide (see above), we concluded that selective macroautophagic 
mitochondrial removal protects yeast from this mitochondria-controlled mode of death. 
Our electron microscopical (EM) analysis of WT and atg32Δ cells treated with various 
concentration of exogenously added hydrogen peroxide confirmed the validity of this 
conclusion. Following their 2-h exposure to this oxidant, pre-grown under CR conditions 
and recovered at day 1 cells of both WT and atg32Δ exhibited nuclear fragmentation 
(Figure 8.9A), a characteristic marker of the mitochondria-controlled apoptotic mode of 
cell death [385, 386] (A similar trend was observed for WT and atg32Δ cells pre-grown 
under CR conditions and recovered at days 2 and 4 for a 2-h exposure to various 
concentrations of exogenous hydrogen peroxide; data not shown). It should be stressed 
that, although the percentage of cells displaying this hallmark of apoptotic death was 
proportional to the concentration of exogenous hydrogen peroxide for both strains, the 
atg32Δ mutation significantly increased the fraction of such cells (Figure 8.9B). Recent 
fluorescence microscopical analyses of pre-grown under CR conditions yeast exposed for 
2 h to hydrogen peroxide revealed that the atg32Δ mutation also significantly increases 
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the percentage of cells exhibiting other characteristic markers of apoptosis, including 
phosphatidylserine translocation from the inner to the outer leaflet of the plasma 
membrane and cleavage of chromosomal DNA (unpublished data; a personal 
communication from Alejandra Gomez-Perez in our laboratory). In sum, these 
microscopical analyses provide further confirmation of the essential role of mitophagy in 
protecting yeast from mitochondria-controlled apoptotic cell death. 
 
 
Figure 8.9. Under CR conditions, the atg32Δ mutation significantly increases the percentage of cells 
exhibiting nuclear fragmentation, a characteristic marker of the mitochondria-controlled apoptotic mode of 
cell death. (A) Transmission electron micrographs of wild-type (WT) and atg32Δ cells that were exposed to 
various concentrations of exogenously added hydrogen peroxide. WT and atg32Δ strains were cultured in 
YP medium initially containing 0.2% glucose. Cells recovered at day 1 were exposed for 2 h to various 
concentrations of exogenous hydrogen peroxide. (B) The percentage of cells displaying nuclear 
fragmentation, based on quantitation of transmission electron micrographs some of which are shown in 
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Figure 8.9A. WT and atg32Δ strains were cultured in medium initially containing 0.2% glucose. Cells 
recovered at days 1, 2 and 4 were exposed for 2 h to various concentrations of exogenous hydrogen 
peroxide. For each concentration of exogenously added hydrogen peroxide, at least 100 cells of each strain 
were used. Abbreviation: N, nucleus.  
 
8.4.7 EM analysis implies that exogenous palmitoleic fatty acid triggers a necrosis-
like “lipoptotic” cell death and confirms the essential role of mitophagy in 
protecting yeast from this previously unknown mode of death 
            As we found, the atg32Δ mutation significantly enhances the susceptibility of 
yeast to a mode of cell death elicited by a short-term exposure to exogenous palmitoleic 
acid (see above). Our finding implies that the macroautophagic removal of dysfunctional 
mitochondria is mandatory for protecting yeast from this cell death modality. As a first 
step towards understanding the molecular mechanisms underlying the essential role of 
mitophagy in enhancing yeast resistance to a cell death mode triggered by exogenous 
palmitoleic acid, we used EM analysis of WT and atg32Δ cells pre-grown under CR 
conditions and then treated with various concentration of this fatty acid to 1) define 
morphological traits characteristic of this cell death subroutine; 2) compare these traits to 
the well-established [385, 386] morphological features of several currently known cell 
death modalities; and 3) examine how the atg32Δ-dependent block of mitophagy affects 
these traits.  
            We found that, unlike significant portions of briefly exposed to exogenous 
hydrogen peroxide WT and atg32Δ cells that undergo a mitochondria-controlled 
apoptotic mode of cell death by displaying such characteristic marker of apoptosis as 
nuclear fragmentation, only minor fractions of WT and atg32Δ cells briefly treated with 
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various concentrations of palmitoleic acid exhibit this hallmark event of apoptotic cell 
death (Figure 8.10). Recent fluorescence microscopical analyses revealed that, unlike 
significant portions of WT and atg32Δ cells undergoing apoptosis in response to a short-
term exposure to exogenous hydrogen peroxide, only minor fractions of WT and atg32Δ  
 
Figure 8.10. Unlike significant portions of briefly exposed to exogenous hydrogen peroxide wild-type 
(WT) and atg32Δ cells that display nuclear fragmentation (Figure 8.9), only minor fractions of WT and 
atg32Δ cells briefly treated with various concentrations of palmitoleic acid (PA) exhibit this hallmark event 
of apoptotic cell death. (A) Transmission electron micrographs of WT and atg32Δ cells that were exposed 
to various concentrations of exogenously added PA. WT and atg32Δ strains were cultured in YP medium 
initially containing 0.2% glucose. Cells recovered at day 1 were exposed for 2 h to various concentrations 
of exogenous PA. (B) The percentage of cells displaying nuclear fragmentation, based on quantitation of 
transmission electron micrographs some of which are shown in Figures 8.9A (for hydrogen peroxide-
 217
treated cells) and 10A (for PA-treated cells). WT and atg32Δ strains were cultured in YP medium initially 
containing 0.2% glucose. Cells recovered at days 1, 2 and 4 were exposed for 2 h to various concentrations 
of exogenous hydrogen peroxide or PA. For each concentration of exogenously added hydrogen peroxide 
or PA, at least 100 cells of each strain were used. Abbreviation: N, nucleus. 
 
 
Figure 8.11. Under CR conditions, wild-type (WT) and atg32Δ cells briefly treated with various 
concentrations of palmitoleic acid (PA) do not exhibit such hallmark event of necrotic cell death as plasma 
membrane rupture. (A) Transmission electron micrographs of WT and atg32Δ cells that were exposed to 
various concentrations of exogenously added PA. WT and atg32Δ strains were cultured in YP medium 
initially containing 0.2% glucose. Cells recovered at day 1 were exposed for 2 h to various concentrations 
of exogenous PA. (B) The percentage of cells displaying plasma membrane rupture, based on quantitation 
of transmission electron micrographs some of which are shown in Figures 8.10A and 8.11A. WT and 
atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells recovered at days 1, 2 
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and 4 were exposed for 2 h to various concentrations of exogenous PA. For each concentration of 
exogenously added PA, at least 100 cells of each strain were used. 
 
cells briefly treated with various concentrations of palmitoleic acid display such other 
characteristic markers of apoptotic cell death as phosphatidylserine translocation from the 
inner to the outer leaflet of the plasma membrane and cleavage of chromosomal DNA 
(unpublished data; a personal communication from Alejandra Gomez-Perez in our 
laboratory). Altogether, these microscopical analyses provide evidence that a mode of 
cell death elicited by a short-term exposure of both WT and atg32Δ yeast to exogenous 
palmitoleic acid is not an apoptotic cell death modality. 
            Furthermore, our EM analysis revealed that WT and atg32Δ cells briefly treated 
with various concentrations of palmitoleic acid do not exhibit such hallmark event of 
necrotic cell death [387 - 390] as plasma membrane rupture (Figure 8.11). Thus, a mode 
of cell death elicited by a short-term exposure of both WT and atg32Δ yeast to exogenous 
palmitoleic acid is not a necrotic cell death modality. However, it should be stressed that 
fluorescence microscopical analyses show that the vast majority of WT [40] and atg32Δ 
cells (unpublished data; a personal communication from Alejandra Gomez-Perez in our 
laboratory) briefly exposed to exogenous palmitoleic acid display propidium iodide 
positive staining. This staining pattern is characteristic of the loss of plasma membrane 
integrity and considered as a hallmark event of necrotic cell death in yeast [388, 389]. We 
therefore concluded that exogenously added palmitoleic acid triggers a previously 
unknown mode of cell death in yeast. We coin the name “lipoptosis” for this novel cell 
death modality. Although lipoptotic cell death elicited by exposure of yeast to exogenous 
palmitoleic acid does not lead to plasma membrane rupture (a hallmark event of necrotic 
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cell death), akin to necrotic cell death modality it results in compromised plasma 
membrane integrity.  
 
 
Figure 8.12. Under CR conditions, wild-type (WT) cells briefly treated with various concentrations of 
palmitoleic acid (PA) exhibit excessive accumulation of lipid droplets (LD), and the atg32Δ mutation 
significantly reduces the fraction of cells that display this feature following PA treatment. (A) Transmission 
electron micrographs of WT and atg32Δ cells that were exposed to various concentrations of exogenously 
added PA. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells 
recovered at day 1 were exposed for 2 h to various concentrations of exogenous PA. (B) The percentage of 
cells displaying excessive accumulation of LD, based on quantitation of transmission electron micrographs 
some of which are shown in Figures 8.10A and 8.11A. WT and atg32Δ strains were cultured in YP medium 
initially containing 0.2% glucose. Cells recovered at days 1, 2 and 4 were exposed for 2 h to various 
concentrations of exogenous PA. For each concentration of exogenously added PA, at least 100 cells of 




Figure 8.13. Under CR conditions, wild-type (WT) cells briefly treated with various concentrations of 
palmitoleic acid (PA) exhibit an irregularly shaped nucleus, and the atg32Δ mutation significantly reduces 
the fraction of cells that display this feature following PA treatment. (A) Transmission electron 
micrographs of WT and atg32Δ cells that were exposed to various concentrations of exogenously added 
PA. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells recovered 
at day 1 were exposed for 2 h to various concentrations of exogenous PA. (B) The percentage of cells 
displaying an irregularly shaped nucleus, based on quantitation of transmission electron micrographs some 
of which are shown in Figures 8.10A and 8.11A. WT and atg32Δ strains were cultured in medium initially 
containing 0.2% glucose. Cells recovered at days 1, 2 and 4 were exposed for 2 h to various concentrations 
of PA. For each concentration of exogenously added PA, at least 100 cells of each strain were used. 
Abbreviation: N, nucleus. 
 




Figure 8.14. Under CR conditions, a short-term exposure of wild-type (WT) strain to various 
concentrations of palmitoleic acid (PA) reduces the fraction of cells that contain vacuoles, and the atg32Δ 
mutation further decreases the portion of such cells following PA treatment. (A) Transmission electron 
micrographs of WT and atg32Δ cells that were exposed to various concentrations of exogenously added 
PA. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells recovered 
at day 1 were exposed for 2 h to various concentrations of exogenous PA. (B) The percentage of cells 
containing vacuoles, based on quantitation of transmission electron micrographs some of which are shown 
in Figures 8.10A and 8.11A. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% 
glucose. Cells recovered at days 1, 2 and 4 were exposed for 2 h to various concentrations of exogenous 
PA. For each concentration of exogenously added PA, at least 100 cells of each strain were used. 






Figure 8.15. Under CR conditions, a short-term exposure of wild-type (WT) strain to various 
concentrations of palmitoleic acid (PA) reduces the fraction of cells that contain the nucleus, and the 
atg32Δ mutation further decreases the portion of such cells following PA treatment. (A) Transmission 
electron micrographs of WT and atg32Δ cells that were exposed to various concentrations of exogenously 
added PA. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells 
recovered at day 1 were exposed for 2 h to various concentrations of exogenous PA. (B) The percentage of 
cells containing the nucleus, based on quantitation of transmission electron micrographs some of which are 
shown in Figures 8.10A and 8.11A. WT and atg32Δ strains were cultured in medium initially containing 
0.2% glucose. Cells recovered at days 1, 2 and 4 were exposed for 2 h to various concentrations of 
exogenous PA. For each concentration of exogenously added PA, at least 100 cells of each strain were 





Figure 8.16. Under CR conditions, a short-term exposure of wild-type (WT) strain to various 
concentrations of palmitoleic acid (PA) reduces the fraction of cells that contain the ER, and the atg32Δ 
mutation further decreases the portion of such cells following PA treatment. (A) Transmission electron 
micrographs of WT and atg32Δ cells that were exposed to various concentrations of exogenously added 
PA. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells recovered 
at day 1 were exposed for 2 h to various concentrations of exogenous PA. (B) The percentage of cells 
containing the ER, based on quantitation of transmission electron micrographs some of which are shown in 
Figures 8.10A and 8.11A. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% 
glucose. Cells recovered at days 1, 2 and 4 were exposed for 2 h to various concentrations of exogenous 
PA. For each concentration of exogenously added PA, at least 100 cells of each strain were used. 





Figure 8.17. Under CR conditions, a short-term exposure of wild-type (WT) strain to various 
concentrations of palmitoleic acid (PA) reduces the fraction of cells that contain mitochondria, and the 
atg32Δ mutation further decreases the portion of such cells following PA treatment. (A) Transmission 
electron micrographs of WT and atg32Δ cells that were exposed to various concentrations of exogenously 
added PA. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells 
recovered at day 1 were exposed for 2 h to various concentrations of exogenous PA. (B) The percentage of 
cells containing mitochondria, based on quantitation of transmission electron micrographs some of which 
are shown in Figures 8.10A and 8.11A. WT and atg32Δ strains were cultured in YP medium initially 
containing 0.2% glucose. Cells recovered at days 1, 2 and 4 were exposed for 2 h to various concentrations 
of exogenous PA. For each concentration of exogenously added PA, at least 100 cells of each strain were 
used. Abbreviation: M, mitochondrion. 
 




Figure 8.18. Under CR conditions, a short-term exposure of wild-type (WT) strain to various 
concentrations of palmitoleic acid (PA) increases the fraction of cells lacking all organelles, and the atg32Δ 
mutation further decreases the portion of such cells following PA treatment. (A) Transmission electron 
micrographs of WT and atg32Δ cells that were exposed to various concentrations of exogenously added 
PA. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% glucose. Cells recovered 
at day 1 were exposed for 2 h to various concentrations of exogenous PA. (B) The percentage of cells 
lacking all organelles, based on quantitation of transmission electron micrographs some of which are shown 
in Figures 8.10A and 8.11A. WT and atg32Δ strains were cultured in YP medium initially containing 0.2% 
glucose. Cells recovered at days 1, 2 and 4 were exposed for 2 h to various concentrations of exogenous 
PA. For each concentration of exogenously added PA, at least 100 cells of each strain were used.  
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            What combination of morphological traits is characteristic of the novel mode of 
cell death that we identified in yeast? Our EM analysis revealed the following hallmark 
events of the lipoptotic cell death triggered by a brief exposure of WT yeast to various 
concentrations of exogenous palmitoleic acid: 1) the excessive accumulation of lipid 
droplets, a deposition site for stockpiling non-esterified (“free”) fatty acids and sterols in 
the form of triacylglycerols and ergosteryl esters following their synthesis in the 
endoplasmic reticulum (ER) (Figure 8.12); 2) an irregularly shaped nucleus (Figure 
8.13); 3) a reduced fraction of cells containing vacuoles (Figure 8.14), the nucleus 
(Figure 8.15), the ER (Figure 8.16) or mitochondria (Figure 8.17); and 4) an increased 
portion of cells lacking all these organelles (Figure 8.18). 
            Importantly, our EM analysis revealed that, although the percentage of cells 
displaying each of these hallmarks of the lipoptotic cell death triggered by a brief 
exposure of yeast to various concentrations of exogenous palmitoleic acid was 
proportional to the concentration of palmitoleic acid for both strains, the atg32Δ mutation 
1) significantly reduced the fraction of cells that accumulate lipid droplets (Figure 8.12) 
or exhibit irregularly shaped nucleus (Figure 8.13); 2) considerably decreased the portion 
of cells containing vacuoles (Figure 8.14), the nucleus (Figure 8.15), the ER (Figure 8.16) 
or mitochondria (Figure 8.17); and 3) substantially increased the portion of cells lacking 
all these organelles (Figure 8.18). 
            In sum, the enhanced susceptibility of atg32Δ yeast to a mode of cell death 
elicited by a short-term exposure to exogenous palmitoleic acid and the observed effects 
of the atg32Δ mutation on the morphological traits characteristic of such previously 
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unknown cell death mode provide evidence of the essential role of mitophagy in 
protecting yeast from this cell death modality.  
 
8.5 Discussion 
            Although recent findings in mammals suggest that mitophagy - a selective 
macroautophagic removal of dysfunctional mitochondria - may operate as an essential 
mechanism in ensuring quality control of mitochondria and suppressing pathologies 
caused by mitochondrial dysfunction, the physiological roles of mitophagy in yeast and 
underlying mechanisms remain to be established. We sought to explore the involvement 
of mitophagy in regulating yeast longevity, maintaining functional mitochondria, and 
protecting yeast from apoptotic and a recently discovered by our laboratory necrosis-like 
“lipoptotic” modes of age-related cell death. In studies described in this chapter of my 
thesis, we used a combination of functional genetic, chemical biological, cell biological 
and electron microscopical analyses to address this challenge and to elucidate the 
mechanisms by which mitophagy defines yeast longevity, enables lifespan extension by a 
novel anti-aging compound, sustains functional mitochondria and protects yeast from 
various cell death modalities. Our findings provide the first comprehensive evidence that 
mitophagy 1) is an essential longevity assurance process under both lifespan-extending 
CR conditions and lifespan-shortening non-CR conditions; 2) is mandatory for the ability 
of LCA - a recently discovered anti-aging and anti-cancer compound - to extend 
longevity of chronologically aging yeast; 3) is required for sustaining functional 
mitochondria by modulating mitochondrial respiration, mitochondrial membrane 
potential and mitochondrial reactive oxygen species; 4) protects yeast from a 
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mitochondria-controlled apoptotic cell death mode elicited by a short-term exposure to 
exogenous hydrogen peroxide; and 5) is essential for protecting yeast from a cell death 
modality that is triggered by a brief exposure to exogenous palmitoleic acid and differs 
from both apoptotic and necrotic cell death modes (we coined the name “lipoptosis” for 
this previously unknown cell death modality). We revealed a unique combination of 
morphological and biochemical traits characteristic of the lipoptotic cell death subroutine, 
and defined the spatiotemporal dynamics and molecular mechanisms underlying the 
progression of these traits. 
 
8.6 Conclusions 
            Using a combination of functional genetic, chemical biological, cell biological 
and electron microscopical analyses, we provided the first evidence for the essential role 
of mitophagy - a selective macroautophagic removal of dysfunctional mitochondria - in 
defining yeast longevity, enabling lifespan extension by a recently discovered natural 
anti-aging compound, sustaining functional mitochondria and protecting yeast from 




9 Conclusions and suggestions for future work 
9.1 General conclusions 
9.1.1 Caloric restriction (CR) modulates oxidation-reduction processes and ROS 
production in yeast mitochondria, reduces the frequency of mitochondrial 
DNA (mtDNA) mutations, and alters the abundance and mtDNA-binding 
activity of mitochondrial nucleoid-associated proteins 
            As a first step towards the use of high-throughput empirical data on cell metabolic 
history of chronologically aging yeast for defining the molecular causes of cellular aging, 
we recently conducted the mass spectrometry-based identification and quantitation of 
proteins recovered from purified mitochondria of CR and non-CR yeast [32]. Our 
comparative analysis of mitochondrial proteomes of these yeast revealed that CR altered 
the levels of numerous proteins that function in essential processes confined to 
mitochondria. In studies described in chapter 2, we established a spectrum of 
mitochondria-confined processes affected by CR. We found that CR modulates 
oxidation-reduction processes and ROS production in yeast mitochondria, reduces the 
frequency of mtDNA mutations, and alters the abundance and mtDNA-binding activity of 
mitochondrial nucleoid-associated proteins. Findings described in chapter 2 provide 
evidence that these mitochondrial processes play essential roles in regulating longevity of 
chronologically active yeast by defining their viability following cell entry into a 
quiescent state. Based on these findings, we propose a hypothesis that ROS, which are 
mostly generated as by-products of mitochondrial respiration, play a dual role in 
regulating longevity of chronologically aging yeast. On the one hand, if yeast 
mitochondria are unable (due to a dietary regimen) to maintain ROS concentration below 
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a toxic threshold, ROS promote aging by oxidatively damaging certain mitochondrial 
proteins and mtDNA. On the other hand, if yeast mitochondria can (due to a dietary 
regimen) maintain ROS concentration at a certain “optimal” level, ROS delay 
chronological aging. We propose that this “optimal” level of ROS is insufficient to 
damage cellular macromolecules but can activate certain signaling networks that extend 
lifespan by increasing the abundance or activity of stress-protecting and other anti-aging 
proteins. In addition, studies presented in chapter 2 of my thesis imply that mtDNA 
mutations do not contribute to longevity regulation in yeast grown under non-CR 
conditions but make important contribution to longevity regulation in yeast placed on a 
CR diet. 
 
9.1.2 CR extends yeast chronological lifespan by altering a pattern of age-related 
changes in trehalose concentration 
            The nonreducing disaccharide trehalose has been long considered only as a 
reserve carbohydrate. However, recent studies in yeast suggested that this osmolyte can 
protect cells and cellular proteins from oxidative damage elicited by exogenously added 
reactive oxygen species (ROS). Trehalose has been also shown to affect stability, folding 
and aggregation of bacterial and firefly proteins heterologously expressed in heat-
shocked yeast cells. Our recent investigation of how a lifespan-extending CR diet alters 
the metabolic history of chronologically aging yeast suggested that their longevity is 
programmed by the level of metabolic capacity - including trehalose biosynthesis and 
degradation - that yeast cells developed prior to entry into quiescence [32]. To investigate 
whether trehalose homeostasis in chronologically aging yeast may play a role in 
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longevity extension by CR, in studies described in chapter 3 we examined how single-
gene-deletion mutations affecting trehalose biosynthesis and degradation impact 1) the 
age-related dynamics of changes in trehalose concentration; 2) yeast chronological 
lifespan under CR conditions; 3) the chronology of oxidative protein damage, 
intracellular ROS level and protein aggregation; and 4) the timeline of thermal 
inactivation of a protein in heat-shocked yeast cells and its subsequent reactivation in 
yeast returned to low temperature. Our data imply that CR extends yeast chronological 
lifespan in part by altering a pattern of age-related changes in trehalose concentration. We 
propose a model for molecular mechanisms underlying the essential role of trehalose in 
defining yeast longevity by modulating protein folding, misfolding, unfolding, refolding, 
oxidative damage, solubility and aggregation throughout lifespan. 
 
9.1.3 A proper balance between the biosynthesis and degradation of glycogen is 
obligatory for lifespan extension by CR 
            Our recent comparative analysis of cellular proteomes of CR and non-CR yeast 
revealed that the administration of a low-calorie diet increased the levels of key enzymes 
involved in the biosynthesis of glycogen [32], known to be the major glucose store in 
yeast [169]. Moreover, CR reduced the levels of key enzymes catalyzing the degradation  
of glycogen in chronologically aging yeast [32]. To evaluate a potential role of glycogen 
metabolism in lifespan extension by CR, in studies described in chapter 4 we monitored 
the dynamics of age-related changes in its intracellular level. We also assessed how 
various single-gene-deletion mutations that differently alter glycogen concentrations in 
pre-quiescent and quiescent yeast cells affect longevity of chronologically aging yeast 
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under CR conditions. Our findings provide evidence that a proper balance between the 
biosynthesis and degradation of glycogen is obligatory for lifespan extension by CR. 
 
9.1.4 CR extends yeast chronological lifespan by reducing ethanol concentration   
            In studies described in chapter 5, we monitored the dynamics of age-related 
changes in ethanol concentration in chronologically aging yeast cultured under CR and 
non-CR conditions. We also assessed how single-gene-deletion mutations eliminating 
Adh1p (an enzyme that is required for ethanol synthesis) or Adh2p (an enzyme that 
catalyzes ethanol degradation) affect longevity of chronologically aging yeast under CR 
and non-CR conditions. Furthermore, we examined the effects of the adh1Δ and adh2Δ 
mutations on the intracellular levels of trehalose, glycogen, neutral lipids, free fatty acids 
(FFA) and diacylglycerols (DAG) in chronologically aging yeast under non-CR 
conditions. Moreover, we monitored how single-gene-deletion mutations eliminating 
Adh1p or Adh2p influence the abundance of Fox1p, Fox2p and Fox3p, all of which are 
the core enzymes of fatty acid β-oxidation in peroxisomes. Our findings provide evidence 
that ethanol accumulated in yeast placed on a calorie-rich diet represses the synthesis of 
Fox1p, Fox2p and Fox3p, thereby suppressing peroxisomal oxidation of FFA that 
originate from triacylglycerols synthesized in the endoplasmic reticulum (ER) and 
deposited within LBs. The resulting build-up of arrays of FFA (so-called gnarls) within 
LBs of non-CR yeast initiates several negative feedback loops regulating the metabolism 
of triacylglycerols. Due to the action of these negative feedback loops, chronologically 
aging non-CR yeast not only amass triacylglycerols in LBs but also accumulate DAG and 
FFA in the ER. The resulting remodeling of lipid dynamics in chronologically aging non-
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CR yeast shortens their lifespan by causing their premature death due to 1) necrosis 
triggered by the inability of their peroxisomes to oxidize FFA; 2) lipoapoptosis initiated 
in response to the accumulation of DAG and FFA; and 3) the DAG-induced 
reorganization of the protein kinase C-dependent signal transduction network affecting 
multiple longevity-related cellular targets. 
 
9.1.5 LCA, a novel anti-aging compound, alters mitochondrial structure and 
function, reduces cell susceptibility to mitochondria-controlled apoptosis, 
and increases cell resistance to oxidative and thermal stresses 
            We sought to identify small molecules that increase the chronological lifespan of 
yeast under CR conditions by targeting lipid metabolism and modulating “housekeeping” 
longevity assurance pathways. We predicted that such housekeeping pathways 1) 
modulate longevity irrespective of the organismal and intracellular nutrient and energy 
status; and 2) do not overlap (or only partially overlap) with the “adaptable” longevity 
pathways that are under the stringent control of calorie and/or nutrient availability. In 
studies presented in this chapter of my thesis, we found that in yeast grown under CR 
conditions the pex5Δ mutation not only remodels lipid metabolism but also causes the 
profound changes in longevity-defining processes in mitochondria, resistance to chronic 
(long-term) stresses, susceptibility to mitochondria-controlled apoptosis, and frequencies 
of mutations in mitochondrial and nuclear DNA. We therefore chose the single-gene-
deletion mutant strain pex5Δ as a short-lived strain for carrying out a chemical genetic 
screen aimed at the identification of novel anti-aging compounds targeting housekeeping 
longevity assurance pathways. By screening the total of approximately 19,000 
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representative compounds from seven commercial libraries, our laboratory recently 
identified 24 small molecules that greatly extend the chronological lifespan of pex5Δ 
under CR conditions and belong to 5 chemical groups. One of these groups consisted of 6 
bile acids, including LCA. Findings presented in chapter 6 imply that LCA modulates 
housekeeping longevity assurance pathways by 1) attenuating the pro-aging process of 
mitochondrial fragmentation, a hallmark event of age-related cell death; 2) altering 
oxidation-reduction processes in mitochondria - such as oxygen consumption, the 
maintenance of membrane potential and ROS production - known to be essential for 
longevity regulation; 3) enhancing cell resistance to oxidative and thermal stresses, 
thereby activating the anti-aging process of stress response; 4) suppressing the pro-aging 
process of mitochondria-controlled apoptosis; and 5) enhancing stability of nuclear and 
mitochondrial DNA, thus activating the anti-aging process of genome maintenance. The 
observed pleiotropic effect of LCA on a compendium of housekeeping longevity 
assurance processes implies that this bile acid is a multi-target life-extending compound 
that increases chronological lifespan in yeast by modulating a network of the highly 
integrated cellular events that are not controlled by the adaptable AMP-activated protein 
kinase/target of rapamycin (AMPK/TOR) and cAMP/protein kinase A (cAMP/PKA) 
pathways. 
 
9.1.6 LCA extends longevity of chronologically aging yeast only if added at certain 
critical periods of their lifespan 
            Findings described in chapter 7 provide evidence that in yeast grown under CR 
conditions on 0.2% glucose, there are two critical periods when the addition of LCA to 
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growth medium can increase both their mean and maximum chronological lifespans. One 
of these two critical periods includes logarithmic and diauxic growth phases, whereas the 
other period exists in the early stationary (ST) phase of growth. In contrast, LCA does not 
cause a significant extension of the mean or maximum chronological lifespan of CR yeast 
if it is added in post-diauxic or late ST growth phases. Because aging of multicellular and 
unicellular eukaryotic organisms affects numerous anti- and pro-aging processes within 
cells [2, 3, 7, 9, 14, 17 - 21, 27 - 36], we hypothesized that the observed ability of LCA to 
delay chronological aging of yeast grown under CR conditions only if added at certain 
critical periods (checkpoints) of their lifespan could be due to its differential effects on 
certain anti- and pro-aging processes at different checkpoints. To test the validity of our 
hypothesis, in studies described in chapter 7 we examined how the addition of LCA at 
different periods of chronological lifespan in yeast grown under CR conditions influences 
anti- and pro-aging processes taking place during each of these periods. Our empirical 
validation of this hypothesis suggests a mechanism linking the ability of LCA to delay 
chronological aging of yeast only if added at certain periods (checkpoints) of their 
lifespan to the differential effects of this natural anti-aging compound on certain anti- and 
pro-aging processes at each of these checkpoints. 
 
9.1.7 Mitophagy is a longevity assurance process that in yeast sustains functional 
mitochondria and protects cells from apoptotic and necrosis-like “lipoptotic” 
modes of cell death 
            Recent findings in mammals suggest that mitophagy, a selective macroautophagic 
removal of dysfunctional mitochondria, is an essential cellular process aimed at 
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maintaining mitochondrial functionality and suppressing cellular and organismal 
pathologies that arise due to dysfuntion of mitochondria. However, the physiological 
roles of mitophagy in yeast and underlying mechanisms remained to be discovered. 
Chapter 8 describes studies aimed at exploring possible roles of mitophagy in regulating 
yeast longevity, maintaining functional mitochondria, and protecting yeast from apoptotic 
and a recently discovered by our laboratory necrosis-like “lipoptotic” modes of age-
related cell death. In studies described in chapter 8, we used a combination of functional 
genetic, chemical biological, cell biological and electron microscopical analyses to carry 
out comparative analyses of the single-gene-deletion mutant strain atg32Δ, which is 
impaired only in the mitophagic pathway of selective macroautophagy, and wild-type 
(WT) strain. atg32Δ is known to lack a mitochondrial outer membrane protein Atg32p 
whose binding to an adaptor protein Atg11p drives the recruitment of mitochondria to the 
phagophore assembly site, thereby initiating the mitophagy process. Our findings imply 
that mitophagy defines yeast longevity, facilitates yeast chronological lifespan extension 
by a recently discovered anti-aging natural compound, sustains functional mitochondria, 
and protects yeast from apoptotic and necrosis-like “lipoptotic” forms of cell death. 
 
9.2 Suggestions for future work 
            As the reported in chapter 2 investigation of a spectrum of mitochondrial 
processes affected by CR revealed, the low-calorie diet modulates oxidation-reduction 
processes and ROS production in yeast mitochondria, reduces the frequency of mtDNA 
mutations, and alters the abundance and mtDNA-binding activity of mitochondrial 
nucleoid-associated proteins. These findings provide evidence that these mitochondria-
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confined processes play essential roles in regulating longevity of chronologically active 
yeast by defining cell viability following entry into a quiescent state.  A challenge for the 
future will be to examine whether the pattern established in yeast cells grown under CR 
conditions can be reversed upon their transfer to calorie-rich medium. Another challenge 
for the future will be to test the validity of the proposed here hypothesis that 
chronologically aging CR yeast protect their mitochondrial nucleoids from oxidative 
damage by turning on the RTG signaling pathway, which then activates transcription of 
ACO1 and other genes encoding bifunctional mtDNA-binding proteins known to 
maintain the integrity of mtDNA under respiratory conditions. It is conceivable that this 
knowledge will be instrumental for designing high-throughput screens aimed at 
discovering novel anti-aging drugs and natural compounds that can increase lifespan by 
modulating the longevity-defining processes confined to mitochondria.  
            Findings presented in chapter 3 of my thesis provide evidence that CR extends 
yeast chronological lifespan in part by altering a pattern of age-related changes in 
trehalose concentration. Based on these findings, we propose a model for molecular 
mechanisms underlying the essential role of trehalose in defining yeast longevity by 
modulating cellular proteostasis throughout lifespan. A challenge now is to get a greater 
insight into these mechanisms. To address this challenge, many important questions need 
to be answered. What are the identities of oxidatively damaged proteins whose 
accumulation in pre-quiescent WT cells proliferating under CR conditions is reduced by 
genetic manipulations that elevate trehalose concentration prior to entry into quiescence? 
Are these proteins known for their essential role in defining longevity? Will genetic 
manipulations eliminating any of these proteins or altering their levels affect the 
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chronological lifespan of yeast? What kind of proteins form insoluble aggregates that 
accumulate, in a trehalose-dependent fashion, in WT cells prior to and/or following entry 
into a quiescent state? Are they known to be modifiers of lifespan in yeast? How will 
genetic manipulations eliminating any of these proteins or altering their levels influence 
longevity of chronologically aging yeast? Do oxidatively damaged and/or aggregated 
protein species concentrate in certain protein quality control compartments, such as the 
juxtanuclear quality control compartment, the insoluble protein deposit compartment 
and/or aggresome [195, 200, 201], or are they randomly distributed throughout a cell 
prior to and/or following entry into quiescence? Does trehalose reside, permanently or 
temporarily, in any of these protein quality control compartments or is this osmolyte 
dispersed within a cell before and/or after it enters a quiescent state? What molecular 
chaperones constitute the proteostasis machinery whose ability to refold aberrantly folded 
proteins is compromised by trehalose in quiescent cells? We shall have to answer these 
important questions if we want to understand the complexity of the proteostasis network 
that defines longevity by sensing the dynamics of age-related changes in trehalose 
concentration. 
            Along with other data from our laboratory on the molecular mechanism 
underlying the ability of CR to extend longevity of chronologically aging yeast [32, 40, 
110, 114], findings presented in chapter 4 imply that, by activating the synthesis of 
enzymes catalyzing the biosynthesis of glycogen and by suppressing the synthesis of 
enzymes required for its degradation, CR promotes the accumulation of this major 
reserve carbohydrate. Our functional analysis of the role for age-dependent glycogen 
dynamics in lifespan extension by CR with the help of a collection of mutants, each 
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lacking a single protein that functions in glycogen biosynthesis or degradation, provides 
evidence that lifespan extension by CR relies in part on the establishment of a proper 
balance between the biosynthesis and degradation of glycogen. A challenge now is to get 
a greater insight into the molecular mechanisms underlying the longevity-defining role of 
such balance in chronologically aging yeast. 
            Findings described in this chapter 6, together with some recently published data 
from our laboratory [40, 114], identify a compendium of processes that compose LCA-
targeted housekeeping longevity assurance pathways. These findings imply that LCA 
modulates such pathways by 1) suppressing the pro-aging process [32, 110, 114, 244] of 
lipid-induced necrotic cell death, perhaps due to its observed ability to reduce the 
intracellular levels of FFA and DAG that trigger such death; 2) attenuating the pro-aging 
process [32, 251, 252] of mitochondrial fragmentation, a hallmark event of age-related 
cell death; 3) altering oxidation-reduction processes in mitochondria - such as oxygen 
consumption, the maintenance of membrane potential and ROS production - known to be 
essential for longevity regulation [32, 245, 253 - 255]; 4) enhancing cell resistance to 
oxidative and thermal stresses, thereby activating the anti-aging process [32, 110, 255 - 
257] of stress response; 5) suppressing the pro-aging process [32, 251, 252] of 
mitochondria-controlled apoptosis; and 6) enhancing stability of nuclear and 
mitochondrial DNA, thus activating the anti-aging process [32, 258, 259] of genome 
maintenance. The observed pleiotropic effect of LCA on a compendium of housekeeping 
longevity assurance processes implies that this bile acid is a multi-target life-extending 
compound that increases chronological lifespan in yeast by modulating a network of the 
highly integrated cellular events not controlled by the adaptable TOR and cAMP/PKA 
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pathways. The major challenge now is to define the molecular mechanisms by which 
LCA modulates each of these pro- and anti-aging housekeeping processes and integrates 
them in chronologically aging yeast. 
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